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Abstract 
  
 In  the  last  few  decades,  evidence  has  been  accumulating  for  a  role  for  xanthine 
oxidoreductase (XOR)-generated toxic reactive oxygen species (ROS) in a variety of 
pathological conditions that affect different organ systems. This enzyme in mammals 
exists in two inter-convertible forms: xanthine dehydrogenase (XDH) (the predominant 
intracellular  form  under  physiological  conditions)  and  xanthine  oxidase  (XO).  A 
combination of XO and its oxidizable substrate xanthine (X) (or hypoxanthine (HX)) is 
widely used as a model to produce ROS and to study their effects in a variety of cell 
culture  studies.  However,  the  effect  of  the  combination  of  XOR  and  the  reduced 
nicotinamide adenine dinucleotide (NADH) in cell cultures is much less studied. NADH 
is another oxidizable substrate for XOR that binds to a different site on the enzyme from 
that of X binding.  
 
The aim of this project was to investigate some aspects of the in vitro toxicity of XOR, 
which might provide more insights into its in vivo toxicity. The main investigation was 
a comparison between the well studied X / XO and the much less studied NADH / XO 
toxicity models. Also, secondary studies were undertaken to investigate those aspects of 
X / XO toxicity where there are uncertainties about them.  
 
These studies were performed using primary cell cultures. Cell cultures are now widely 
used to study different diseases, and although they have their drawbacks, they have their 
advantages  over  the  in  vivo  studies.  For  this  project,  primary  cultures  of  cerebellar 
granule neurons (CGNs) were used. In the beginning, some problems were encountered 
with  CGNs.  The  main  problem  was  the  immediate  damage  induced  to  the  neurons 
(including those in the control groups) at the intervention/experiments day (i.e. day 8 or 
9 after plating) by manipulating the cultures (i.e. aspirating the culture medium, adding 
treatment and control vehicles, and adding the restoration medium).     
 
After  several  months  of  investigation,  it  was  serendipitously  discovered  that  the 
immediate damage seen in the neurons (including those in the control groups) when 
they  are  manipulated  at  the  experiments/intervention  day  was  due  to  glutamate 
excitotoxicity  (through  activating  its  N-methyl-D-aspartate  (NMDA)  receptors).  The 
source of  glutamate was the fresh serum which is present at 10% V/V in the fresh   3 
culture medium that is added to the cultures at that day. After solving this problem, it 
was possible to conduct reliable experiments to investigate XO toxicity models.  
 
 Regarding investigating XO toxicity, it was found that both of the X / XO and NADH / 
XO  combinations  were  toxic  to  cultures  of  CGNs.  However,  the  concentration  of 
NADH needed to cause the toxicity was much higher than that of the other substrate, X, 
which is in agreement with previous cell-free experiments that showed that NADH is a 
much weaker substrate than X for the bovine milk XO used here. Blocking the site of X 
binding on XO prevented X / XO toxicity, but did not prevent NADH / XO toxicity. On 
the other hand, blocking the site of NADH binding prevented both X / XO and NADH 
/XO toxicities. Another difference between the two systems was that deactivating either 
superoxide or hydrogen peroxide (both are ROS) generated by XO prevented NADH / 
XO  toxicity,  whereas  although  deactivating  hydrogen  peroxide  prevented  X  /  XO 
toxicity, deactivating superoxide generated from this combination did not. In the NADH 
/  XO  system,  an  extracellular  metal  contaminant  (likely  contaminating  XO 
powder/preparation) seemed to be involved in the toxicity. The two toxicity models 
were similar in the mediation of toxicity by intracellular iron ion. In X / XO toxicity, 
although superoxide generated extracellularly from the combination has no role in the 
toxicity, intracellularly produced superoxide seemed to play a role.  
 
Conclusions:  
 
1.  Culturing/experimental conditions have been optimised for viability studies in 
CGNs cultures. 
2.  The combination of NADH and XO induces damage to CGNs, where although 
blocking the NADH binding site prevents this damage, blocking the X binding 
site does not. It is feasible that the oxidation of NADH by some forms of XOR 
(other than the one used here) that are known to be very efficient in oxidizing 
NADH might produce in vivo toxicity. 
3.  A possibility raised by this study is that a metal (like the metal contaminant 
proposed to play a role in NADH / XO toxicity in this study) might contribute to 
XOR toxicity in vivo. 
4.  Intracellular superoxide often mediates XOR toxicity. 
5.  The  results  add  support  to  many  previous  studies  which  suggested  that 
intracellular hydroxyl radical (or a similar species) is involved in XOR toxicity.   4 
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1  Introduction 
 
1.1 Reactive oxygen species and disease 
 
Oxygen consumption by the body is safely handled to produce useful products, mainly 
energy  in  the  form  of  adenosine  triphosphate  (ATP).  Un-needed  extra-products  e.g. 
excess carbon dioxide can be detoxified. Also, the consumption of oxygen produces 
potentially toxic metabolites called reactive oxygen species (ROS). These ROS are kept 
under low levels (by naturally occurring antioxidants) in normal situations and some of 
these  ROS  do  even  exert  physiological  roles.  Examples  of  ROS  include  hydrogen 
peroxide, superoxide, hydroxyl radical, nitric oxide, and peroxynitrite. When there is an 
overproduction of ROS and/or deficiency in antioxidant mechanisms, a damaging event 
called  oxidative  stress  ensues  [Turrens,  2003,  Halliwell,  2006,  Halliwell  and  Whiteman, 
2004, Fatokun et al., 2008a].  
 
ROS  can  be  generated  in  vivo  by  many  sources.  Superoxide  is  generated  in  the 
mitochondria, at more than one site in the respiratory chain, and as a product of some 
other  mitochondrial  enzymes  e.g.  the  enzyme  complex  alpha-ketoglutarate 
dehydrogenase [Turrens, 2003, Starkov et al., 2004]. Other cellular sources of superoxide 
include  cytochrome  P450-dependent  oxygenases  [Turrens,  2003].  Another  important 
source of superoxide is the enzyme NADPH-oxidase [Turrens, 2003], which is expressed 
largely in some immune system cells (e.g. macrophages), where although ROS released 
by these immune cells are meant to kill invading microorganisms, they may also insult 
nearby host tissues. Also, another important in vivo source of superoxide is the enzyme 
xanthine oxidoreductase (XOR) [Harrison, 2002]. Hydrogen peroxide can be produced 
by the dismutation of superoxide, where this dismutation can be either spontaneous or 
through  the  action  of  the  antioxidant  enzyme  superoxide  dismutase  (SOD)  [Turrens, 
2003,  Starkov  et  al.,  2004,  Fridovich,  2004].  Hydrogen  peroxide  can  also  be  produced 
directly  by  some  enzymes  e.g.  XOR  [Harrison,  2002,  Fridovich,  1970].  Hydrogen 
peroxide can be converted, through interaction with a reduced metal ion e.g. iron or 
copper, to the very reactive and toxic hydroxyl radical [Fridovich, 1998, Turrens, 2003]. 
Nitric oxide is produced by nitric oxide synthases (NOSs), where the powerful oxidant   18 
molecule peroxynitrite is produced by reaction of nitric oxide with superoxide [Guzik et 
al., 2003, Turrens, 2003].  
 
Many ROS are free radicals i.e. have an unpaired electron, so they seek to attract an 
electron from (or donate their unpaired electron to) a non-radical biological molecule 
(e.g. a fatty acid, a protein, or a DNA molecule) to be chemically stable, rendering the 
attacked molecule with an unpaired electron (i.e. a new free radical) which can in turn 
attack  another  non-radical  biological  molecule  and  so  on,  which  can  lead  to  the 
destruction of cellular components [Halliwell, 2006]. Not all ROS are free radicals, and 
some  important  ROS  that  are  not  free  radicals  include  hydrogen  peroxide  and 
peroxynitrite,  which  can  exert  their  toxic  effects  either  directly  or  through  their 
conversion to free radicals.  
 
There  are numerous  antioxidant mechanisms which deactivate ROS in vivo.  These 
include  antioxidant  molecules  (small  and  large)  e.g.  glutathione,  thioredoxin,  alpha-
tocopherol (vitamin E), ascorbic acid (vitamin C), and coenzyme Q. Antioxidants also 
include enzymes e.g. SOD (which deactivates superoxide by converting two molecules 
of it into one molecule of hydrogen peroxide plus oxygen), catalase (which deactivates 
hydrogen peroxide by converting it into oxygen and water), and glutathione peroxidase 
(which  also deactivates  hydrogen peroxide) [Halliwell,  2006,  Fridovich,  1998,  Turrens, 
2003].  Antioxidants  may  also  include  proteins  e.g.  albumin  which  can  work  as 
antioxidants in the circulation [Roche et al., 2008] and neuroglubin which may work as 
antioxidant in the brain [Garry and Mammen, 2003, Wang et al., 2008].   
 
Body  tissues  differ  in  their  vulnerability  to  oxidative  stress.  For  example,  brain  is 
particularly vulnerable to oxidative stress. It contains an elevated amount of iron (see 
later the role of metals in oxidative stress), and consumes a high amount of oxygen. 
Also, the brain contains a high amount of unsaturated fatty acids which can be easily 
attacked by free radicals. The major excitatory neurotransmitter in the brain, glutamate, 
when  present  in  excessive  amounts  at  the  synaptic  cleft,  can  elicit  damage  through 
stimulating postsynaptic intracellular  generation of ROS [Halliwell, 2006,  Patel et al., 
1996]. Moreover, mature neurons do not divide, and hence neuronal tissues may not be 
able to undergo repair/regeneration when damaged by ROS. 
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Countless  number  of  pre-clinical  studies,  both  in  vivo  and  in  vitro,  has  shown  that 
antioxidant interventions do attenuate the damage observed in models of some of those 
human diseases where signs of oxidative stress are observed in the patients affected 
[Behl et al., 1994, Carney and Floyd, 1991, Cherny et al., 2001, Przedborski et al., 1992, Pong 
et al., 2000, Eliasson et al., 1999, Ayata et al., 1997, van der Worp et al., 1999, Hantraye et al., 
1996, Moussaoui et al., 2000] (see also the section on XOR).  On the other hand, clinical 
trials of antioxidants in the treatment of the relevant diseases were much less successful 
than the pre-clinical studies [Willcox et al., 2008, Canter et al., 2007, Halliwell, 2006]. 
 
 So, why have many  clinical studies failed? We can only speculate, and only some 
explanations will be discussed here. There are many differences between humans and 
animals in the patho-physiology of the relevant diseases. However, it is unlikely that 
oxidative  stress  plays  a  central  role  in  some  diseases  like  brain  or  heart  ischemic 
diseases in animals while it has no role at all in those diseases in humans, for many 
reasons. One reason is that not all clinical trials have failed, where many clinical trials, 
small  and  large,  with  antioxidants  in  the  treatment  of  the  relevant  diseases  showed 
positive results [Behr et al., 1997, Demedts et al., 2005, Tomioka et al., 2005, Stephens et al., 
1996, Angstwurm et al., 2007, Boaz  et al., 2000, Fang et al., 2002, Thies et al., 1998, Weigand 
et al.,2001, Cerwenka et al., 1999, Murray et al., 2008,  Milman et al., 2008, Hager et al., 2007, 
Sanders et al., 2007,  Di Prospero et al., 2007, Plantinga et al., 2007, Yamaguchi et al., 1998] 
(see  also  the  section  on  XOR).  Also,  oxidative  stress  is  not  alone  in  the  failure  in 
clinical  trials.  For  examples,  although  some  other  damaging  events  (e.g.  glutamate 
receptor activation and disruption of calcium homeostasis) were very evidently shown 
to play a major role in acute ischemic brain diseases in animal models, many clinical 
trials directed against these damaging events have failed [Ginsberg, 2008].   
 
Also, in animals, a closer look at (or manipulation of) oxidative stress (almost direct 
intervention) can be achieved e.g. in animals it is possible to knock out or over-express 
an antioxidant or a pro-oxidant gene, but this is not possible in humans. Also, many 
clinical trials have tried direct free radical scavengers, where although this is perhaps 
the most feasible way in the clinical situation, it is not the best way to treat oxidative 
stress. The reason is that a free radical is generally non selective in its reactions, and to 
scavenge it, a scavenger needs to be applied in a very high concentration in order to 
outcompete the many biological vulnerable targets (i.e. scavengers) of the free radical. 
For example, dimethyl sulfoxide (DMSO), a classical hydroxyl radical scavenger, when   20 
applied in a cell-free system at 1 mM in the presence of only one competing hydroxyl 
radical scavenger (mannitol, 10 mM), can scavenge only 50% of the hydroxyl radicals 
that it can scavenge in the absence of mannitol [Babbs and Griffin, 1989] (though the case 
with other ROS may not be as bad as the case with hydroxyl radical). A better way is to 
prevent the generation of ROS.  
 
Moreover, we like to mention the possibility that some researchers tend not to publish 
their results if they were negative in the pre-clinical studies. Unfortunately, this in our 
opinion is possibly due to a less appreciated environment in the academic journals of 
negative results compared to positive results. We were enlightened to know that some 
others in the scientific community share our opinion [Knight, 2003, Rockwell et al., 2006]. 
On the other hand, in clinical trials, although there is evidence for bias against negative 
results [Rockwell et al., 2006], we believe that (we might be wrong) it is not as bad as 
with pre-clinical studies. A possible reason for the appreciation of negative results in 
clinical studies is that large trials are announced/registered from the outset of the study, 
and  hence  the  results  have  to  be  announced  as  well.  This  might  give  too  great  an 
impression  that  clinical  trials  have  failed  more  than  pre-clinical  studies.  A  lot  is 
unknown about bias against negative results, which demands a systematic investigation, 
which  has  already  been  started  in  clinical  studies  literature,  but  rarely  done  in  pre-
clinical studies literature.  
 
Finally, some authors have discussed the possibility that many previous clinical trials 
with antioxidants were not well designed e.g. lower than optimal dose with no dose 
response curve, short duration of the study (or inappropriate timing of intervention), no 
carful  selection  of  the  antioxidant  intervention,  or  no  careful  selection  of  the  study 
population [Willcox et al., 2008, Ginsberg, 2008]. Anyway, the future will indeed bring the 
true explanation(s) to the light.  
 
1.2  Interplay  between  oxidative  stress  and  other  damaging 
events 
 
The  damage  observed  in  pathologic  conditions  where  signs  of  oxidative  stress  are 
observed usually involves damage cascades, where many damaging events including 
oxidative stress can trigger each other. These include: energy depletion, mitochondrial   21 
dysfunction,  disruption  of  calcium  homeostasis,  metal  accumulation,  inflammation, 
oxidative stress, and (in the brain) glutamate receptor-mediated excitation (see later). In 
this section, some examples of the toxic interplay between oxidative stress and the other 
damaging  events  will  be  discussed.  More  examples  will  also  be  encountered  in  the 
section on XOR.  
 
1.2.1 Mitochondrial dysfunction 
 
Mitochondrial dysfunction is thought to be an early event in the damage observed in 
acute ischemic models of many diseases e.g. myocardial infarction and stroke, and also 
of many chronic neurodegenerative diseases [Chinopoulos and Adam-Vizi, 2006, Starkov et 
al., 2004, Halliwell, 2006, Turrens, 2003, Keating, 2008, Moro et al., 2005, Lesnefsky et al., 
2001]. In acute ischemic disease models, the ischemic phase is thought to induce defects 
in the mitochondria which can lead to, upon reperfusion (i.e. re-delivery of oxygen to 
mitochondria), ROS generation at more than one site in the respiratory chain, and also 
at  other  sites  in  the  mitochondria  e.g.  the  enzyme  complex:  α-ketoglutarate 
dehydrogenase complex (KGDHC) [Chinopoulos and Adam-Vizi, 2006, Starkov et al., 2004, 
Lesnefsky et al., 2001]. The KGDHC complex is also a vulnerable target for ROS, whose 
deactivation will deactivate the Krebs cycle.  Interestingly, deactivated  KGDHC is  a 
common feature of many neurodegenerative diseases [Halliwell, 2006].   
 
1.2.2 Glutamate  
 
In the brain, the major excitatory neurotransmitter, glutamate, when present in excess 
amount at the synaptic cleft (as in stroke), can elicit damage through stimulating its 
postsynaptic receptors leading to intracellular generation of toxic ROS [Reynolds and 
Hastings, 1995, Dawson et al., 1993, Araújo et al., 2004, Carriedo et al., 1998, Dawson et al., 
1996, Patel et al., 1996, Lafon-Cazal et al., 1993]. ROS can exacerbate the damage by 
blocking glutamate uptake into the cells (i.e. blocking its clearance from the synaptic 
cleft) [Trotti et al., 1996]. Also it was shown in neuronal cultures that glutamate, when 
present extracellularly (≥ 300  M), can induce intracellular oxidative stress through a 
glutamate  receptor-independent mechanism, which is the inhibition of the uptake of 
cystine, a precursor involved in the synthesis of the universal antioxidant glutathione 
[Murphy et al., 1989, Murphy et al., 1990].  
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1.2.3 Disruption of Ca
2+ homeostasis 
 
Disruption of Ca
2+ homeostasis is a central player in the damage cascade observed in 
many pathological conditions that affect different organ systems. This disruption in Ca
2+ 
homeostasis  can  be  induced  by  disruption  of  the  ATP-dependent  plasma  membrane 
Na
+/K
+ ATPase pump or by other mechanisms [Inserte et al., 2005]. In the brain, this can 
also be induced by glutamate-receptor activation. Increased intracellular levels of Ca
2+ 
can activate some ROS generating enzymes e.g. NOS. Also, ROS can activate a lethal 
atypical type of Ca
2+ and cation currents across the cell membrane called non-selective 
cation currents. These currents are likely mediated by a member(s) of atypical cation 
channels permeable to Ca
2+ on the cell membrane called transient receptor potential 
(TRP) cation channels [Chinopoulos and Adam-Vizi, 2006, Aarts et al., 2003]. In a neuronal 
culture study that used prolonged oxygen-glucose deprivation as a toxicity model, it was 
shown that Ca
2+ influx and the subsequent cell damage was not blocked by treatment 
with typical calcium channels blockers e.g. glutamate ionotropic receptor blockers or an 
L-type  Ca
2+  channel  blocker,  but  was  blocked  by  treatment  with  either  some  ROS 
suppressors or by blocking the above mentioned atypical cation channels [Aarts et al., 
2003]. Another example of the harmful augmentation between Ca
2+ and ROS is that 
Ca
2+ is shown to accumulate inside the mitochondria under an ischemic insult [Babcock 
et al., 1997, Herrington et al., 1996, Zaidan and Sims, 1994], and participates with ROS in 
the  opening  of  the  so-called  mitochondrial  permeability  transition  (MPT)  pore,  
initiating many damaging events [Chinopoulos and Adam-Vizi, 2006].  
 
1.2.4 Inflammation 
 
Toxic interplay is observed between ROS and some components of inflammation in 
many  pathological  conditions  in  different  organ  systems,  including  the  brain.  For 
example, A-beta (a peptide whose aggregation is observed in patients with Alzheimer’s 
disease) stimulated the microglia (which are considered resident macrophages in the 
brain)  in  vitro  to  produce  nitric  oxide  [Ii  et  al.,  1996].  In  the  same  study,  the  pro-
inflammatory  molecule,  interferon-gamma,  augmented  A-beta  in  activating  the 
microglia to produce nitric oxide, where A-beta alone or in combination with interferon-
gamma, in the presence of microglia, caused toxicity to co-cultured neurons that was 
inhibited by a NOS inhibitor. Interestingly also in the same study, the production of 
nitric oxide by microglia activated by A-beta (and interferon-gamma) was inhibited by   23 
aspirin  and  indomethacin  (members  of  the  non-steroidal  anti-inflammatory  drugs 
(NSAIDs)). A-beta used at a lower concentration than that used in the above study, 
caused  toxicity  in  a  mixed  culture  of  neurons  and  microglia  that  was  mediated  by 
superoxide produced by NADPH-oxidase located in the microglia [Qin et al., 2002]. In a 
cell culture model of Parkinson’s disease, it was also observed that the presence of 
microglia in a neuronal culture, again through producing superoxide by the NADPH-
oxidase located in the microglia, very significantly enhanced the observed damage to 
the dopaminergic neurons [Gao et al., 2002].  
 
1.2.5 Metals 
 
It is known that, at least in some pathological conditions, traces of reactive metals are 
present in vivo either free or bound (chelated) to molecules/proteins, where this binding 
may  not  prevent  the  reactivity  of  these  metals  (actually  it  may  enhance  their 
reactivity/toxicity in some situations) [Graf et al., 1984, Hallaway et al., 1989, Engelmann 
et al., 2003, Gutteridge, 1987, Sayre et al., 1999, Ong and Halliwell, 2004, Thompson et al., 
2001,  Darley-Usmar  and  Halliwell,  1996,  Halliwell  and  Gutteridge,  1992,  Liochev,  1996, 
Halliwell, 2006]. In many cases, these metals exert their toxicity through some sort of a 
reaction with ROS. As mentioned earlier, some metals (usually iron or copper) can react 
with hydrogen peroxide to produce the very reactive and toxic hydroxyl radical. In a 
previous study, it was shown that hydrogen peroxide added to cultures of hepatocytes 
exerted  an  intracellular  toxicity  that  was  mediated  by  both  intracellular  iron  and 
intracellularly  generated  superoxide  [Starke  and  Farber,  1985].  Superoxide  or 
peroxynitrite can deactivate some enzymes through interacting with their iron clusters. 
In this process, in addition to the deactivation of these enzymes, iron is released from 
the clusters in a reactive form capable of causing oxidative stress. Superoxide can also 
release iron in a reactive form from the storage protein ferritin. Also, peroxynitrite can 
release copper in a reactive form from the plasma protein caeruloplasmin. Hydrogen 
peroxide can degrade haem proteins, which results in the release of iron from them in a 
reactive form [Liochev, 1996, Darley-Usmar and Halliwell, 1996]. To mention an example 
of the diseases affected by ROS  and metals interplay, it was discussed that a toxic 
interaction between some metals and some ROS might play a role in atherosclerosis 
[Darley-Usmar and Halliwell, 1996, Ong and Halliwell, 2004].  
 
   24 
1.3 Fate of cells damaged by ROS 
 
The fate of cells insulted by lethal amounts of ROS (or in disease models where ROS 
are  secondarily  produced)  is  said  to  be  an  eventual  death  induced  through  either 
apoptosis or necrosis. Apoptosis is a term used to describe the programmed, cascaded, 
controlled, active, and  ‘gentle’ events that lead to cell death.  In  contrast, the acute, 
accidental, passive, and uncontrolled cell death with cell membrane rupture is termed 
necrosis  [McHugh  and  Turina,  2006,  Chandra  et  al.,  2000,  Samali  et  al.,  1999].  The 
distinction between apoptosis and necrosis is vague, which is manifested in the attempts 
by some researchers to classify the mode of cell death into necrosis and programmed 
cell death (PCD), and then classifying PCD further into classical apoptosis, apoptosis-
like PCD, and necrosis-like PCD [Krantic et al., 2005]. Although this classification might 
turn out to be correct, it is also possible that there might be a spectrum of cell death 
signals  rather  than  just  apoptosis  and  necrosis  (and  even  rather  than  just  PCD  and 
necrosis).  So  these  obscurities  should  be  considered  during  reading  the  following 
discussion of apoptosis and necrosis. Apoptosis is usually achieved by the activation of 
several protease families, with caspases being the most prominent among them [Chandra 
et al., 2000].  
 
It  seems  that  mitochondria  play  an  important  role  in  triggering  apoptosis  and  even 
necrosis [Bras et al., 2005]. Toxic ROS can release Cytochrome c from the mitochondria 
into the cytoplasm, where it can activate caspases there. ROS can also release a protein 
called apoptosis-inducing factor (AIF) from the mitochondria into the cytoplasm where 
it  can  induce  apoptosis  through  caspase-independent  mechanisms  (see  below). 
Treatment of lymphocyte cultures with hydrogen peroxide resulted in the appearance of 
Cytochrome c in the cytoplasm within 2 hours. One hour later, caspase activation was 
observed  [Stridh  et  al.,  1998].  Matsura  and  co-workers  (1999)  found  that,  by  using 
human  promyelocytic  leukemia  HL-60  cells,  caspase-3  (but  not  caspase-1)  was 
responsible for the hydrogen peroxide-mediated apoptosis observed in their study.  
 
In acute neuronal toxicity (e.g. in stroke), the severely insulted neurons may die through 
necrosis,  while  the  other  neurons  that  are  less  severely  insulted  may  die  through 
apoptosis [Xu et al., 2006, Hou et al., 2008]. Although apoptosis in the case of glutamate 
receptor-mediated acute excitotoxicity in neurons can be induced by caspase activation, 
it seems that AIF is also a major trigger of apoptosis, where in this type of toxicity some   25 
ROS are thought to be involved in the release of AIF from the mitochondria [Cheung et 
al., 2005, Dawson and Dawson, 2004]. Regarding chronic neurodegeneration, in an in vivo 
model  of  Parkinson’s  disease,  it  was  proposed  that  cell  death  proceeds  through 
apoptosis mediated by ROS-dependent AIF release from the mitochondria [Wang et al., 
2003]. Regarding amyotrophic lateral
 sclerosis (ALS), an in vivo animal study showed 
that  the  cell  death  proceeds  through  an  apoptotic  pathway,  where  nitric  oxide, 
superoxide, and possibly peroxynitrite play a crucial role, since NOS deficient mice or 
over-expression  of  SOD  resulted  in  the  protection  against  the  observed  apoptosis 
[Martin et al., 2005].  
 
The  interaction  between  oxidative  stress  and  apoptosis  is  complex.  Logically,  since 
ROS exert their toxicity through attacking biological molecules, there is no reason for 
the ‘active’ enzymes that induce apoptosis not to be ‘inactivated’ by direct attack of 
ROS. In cultured hepatic HepG2 cells, it was observed that treatment with menadione, a 
toxic  compound  known  to  exert  its  toxicity  through  producing  ROS  (especially 
superoxide  and  hydrogen  peroxide),  treated  at  250   M  for  6  hr  killed  the  cells  by 
necrosis,  and  did  not  activate  caspases.  In  that  study,  adding  menadione  to  cells 
undergoing apoptosis inhibited the apoptosis (and induced necrosis), where this anti-
apoptotic effect of menadione was blocked by catalase (which deactivates hydrogen 
peroxide)! [Samali et al., 1999]. In another study that used lymphocytes it was shown that 
hydrogen peroxide at high concentrations was able to suppress the activation/activity of 
caspases possibly through oxidizing the cysteine residues on these enzymes, while at 
low concentrations hydrogen peroxide was able to activate caspases, suggesting that the 
level of ROS can determine the mode of cell death [Hampton and Orrenius, 1997]. In 
contrast  to  the  above  menadione  study  that  used  HepG2  cells,  Sun  and  co-workers 
(1997) have shown that menadione, treated at 200  M for 3 hr, induced apoptosis in 
cultured osteoblasts, suggesting that cell type might also be a determining factor. Also, 
using cell cultures, nitric oxide was shown to shift cell death from apoptosis to necrosis 
through an effect that might have involved S-nitrosylation (and hence inhibition) of the 
cysteine-containing apoptotic enzymes [Melino et al., 1997]. Nitric oxide was also shown 
to inhibit the apoptosis of Jurkat lymphoma cells by a mechanism different from S-
nitrosylation of caspases, possibly involving an inhibition of mitochondrial synthesis of 
ATP, and hence inhibition of the energy-dependent release of apoptotic proteins from 
the mitochondria. Restoration of ATP levels by supplementation with glucose recovered 
the apoptotic ability of those cells. In that study, inhibiting the mitochondrial synthesis   26 
of ATP by rotenone, an inhibitor of complex I of the respiratory chain, mimicked the 
effect of nitric oxide in inhibiting apoptosis and mediating necrosis [Leist et al., 1999].  
 
From the above discussion, it seems that the exact conditions under which oxidative 
stress  causes  either  apoptosis  or  necrosis  need  further  investigation,  though  the 
concentration of ROS and the cell type seem to be determining factors. Also, it should 
be  considered,  as  mentioned,  that  the  distinction  between  apoptosis  and  necrosis  is 
vague, and that there is possibly a spectrum of death signals rather than just apoptosis 
and necrosis.  
 
1.4 Xanthine oxidoreductase (XOR)-generated ROS 
 
In  the  last  few  decades,  evidence  has  been  accumulating  for  a  role  for  xanthine 
oxidoreductase (XOR)-generated ROS in a variety of pathological conditions that affect 
different organ systems. Many examples will be mentioned later, but for a thorough 
reference, see  [Zweier et al., 1994, Brown et al., 1988, Harrison, 2002, Berry and Hare, 2004, 
Okuda et al., 1996, Wiezorek, 1994, Phan et al., 1989, Osarogiagbon et al., 2000, Thom, 1992, 
Terada  et  al.,  1992a,  Weinbroum  et  al.,  1995,  Nakazono  et  al.,1991,  Jankov  et  al.,  2008, 
Widmer et al., 2007, Ohta et al., 2007, Inkster et al., 2007, Castro-Gago et al., 2006, Flaishon 
et al., 2006, White et al., 1996, Schröder et al., 2006, Baldus et al., 2006, Nakai et al., 2006, 
Minhas et al., 2006, Zeki et al., 2002, Rieger et al., 2002, Desco et al., 2002, Saavedra et al., 
2002, Kumagai et al., 2002, Matsumura et al., 1998, Beetsch et al., 1998, Suzuki et al., 1998, 
Lamarque and Whittle, 1995, Xia and Zweier, 1995, Terada et al., 1992b, Han et al., 2007, 
Pacher et al., 2006, Abramov et al., 2007].  
 
1.4.1 XOR structure and properties 
 
The enzyme in mammals exists in two inter-convertible forms: xanthine dehydrogenase 
(XDH) (which is the predominant intracellular  form under physiological conditions) 
and xanthine oxidase (XO). The enzyme is a homodimer (i.e. composed of two identical 
subunits), where each subunit works generally independently from the other, and thus it 
is strange that little investigation has been undertaken to reveal the reason(s) of the 
presence  of  two  instead  of  one  subunit.  Each  subunit  contains  three  distinct 
parts/domains:  a  molybdenum  (Mo)  containing  domain  (contains  one  Mo  atom),  an 
iron-sulphur containing domain (contains four atoms of iron and four atoms of sulphur),   27 
and  a  flavin  adenine  dinucleotide  (FAD)  containing  domain  (contains  one  FAD 
molecule) [Harrison, 2002, Hille and Nishino, 1995, Berry and Hare, 2004]. 
 
The conceived function of XOR is the conversion of hypoxanthine (HX) to xanthine 
(X), and X to uric acid, the final product of purine metabolism in humans [Harrison, 
2002].  The  enzyme  couples  the  oxidation  of  X  (or  HX)  to  the  reduction  of  either 
primarily NAD
+ or secondarily oxygen in the case of XDH, or the reduction of only 
oxygen in the case of XO (NAD
+ can not oxidize (i.e. can not be reduced by) XO). If 
oxygen  is  the  oxidizing  substrate,  hydrogen  peroxide  and  superoxide  are  directly 
produced (the enzyme here can be either XDH or XO), whereas NADH is produced if 
NAD
+ is the oxidizing substrate (the enzyme here will be only in the form of XDH) 
(Fig. 1-1) [Harrison, 2002, Hille and Nishino, 1995, Berry and Hare, 2004, Fridovich, 1970, 
Olson et al., 1974].   
 . 
To add more complication to the picture, XOR can also oxidize NADH, and in this 
case,  oxygen  (not  NAD
+)  will  always  be  the  oxidizing  substrate  (this  will  generate 
hydrogen peroxide and superoxide directly) regardless of whether the enzyme is in the 
form of XDH or XO. Generation of ROS (i.e. superoxide and hydrogen peroxide) by the 
XDH  form  is  strongly  inhibited  by  NAD
+  (which  is  available  in  relatively  high 
concentrations in cells) when oxidizing NADH or X. On the other hand, the generation 
of ROS by the form XO is less inhibited (compared to XDH) by NAD
+ when oxidizing 
NADH and even much less inhibited (compared to XDH) by NAD
+ when oxidizing X. 
The site of NADH binding, the FAD site, is different from that of X binding, the Mo 
site (Fig. 1-1) [Harrison, 2002, Hille and Nishino, 1995, Berry and Hare, 2004, Gilbert, 1963, 
Landon and Myles, 1967,  Rajagopalan and Handler, 1967, Nakamura et al., 1978, Harris and 
Massey, 1997, Maia et al., 2007, Sanders et al., 1997, Zhang et al., 1998]. 
 
If the Mo site is removed/inhibited, the enzyme will of course not be able to oxidize X, 
but can still oxidize NADH and reduce oxygen leading to ROS generation. On the other 
hand, if the FAD site is removed/inhibited, the enzyme will of course not be able to 
oxidize  NADH,  but  can  still  oxidize  X  (or  HX)  only  in  the  presence  of  a  suitable 
artificial oxidizing agent, but importantly not oxygen in this case, and hence no ROS 
will be generated [Komai et al., 1969, Sanders et al., 1997, Olson et al., 1974, Nakamura, 
1991, Berry and Hare, 2004, Harrison, 2002]. In other words, in vivo, the FAD site on 
XOR is the site of oxygen reduction (and hence ROS generation) regardless of whether   28 
the reducing substrate binds to the Mo site (i.e. X or HX) or to the  FAD site (i.e. 
NADH) (Fig. 1.1).   
 
The  enzyme  shows  a  striking  variation  in  properties/functions  among  the  different 
species, and also among the different organs in one species. For example, avian XOR is 
present only in the XDH form and does not undergo conversion to XO [Landon and 
Myles, 1967, Harrison, 2002]. Deficiency of XOR is fatal to mice, but not to humans 
[Harrison,  2002].  Surprisingly,  some  reports  show  that  some  human  forms  of  XOR 
exhibits a much weaker X oxidase activity than the bovine XOR, although human XOR 
still  keeps  a  potent  NADH  oxidase  activity.  Human  milk  XOR  exhibits  weaker  X 
oxidase activity than human liver XOR [Harrison, 2002, Sanders et al., 1997, Zhang et al., 
1998].  
 
The enzyme exhibits an ability to oxidize, and to a lesser extent reduce, an unusually 
wide range of endogenous and artificial substrates [Harrison, 2002, Berry and Hare, 2004], 
which  has  left  some  researchers  wondering  if  this  enzyme  has  unknown  important 
regularly functions, at least in some species. Relatively recently, the enzyme was shown 
to be able to reduce nitrate to nitrite, and nitrite to nitric oxide [Harrison, 2002, Zhang et 
al., 1998, Millar et al., 1998, Li et al., 2004]. The first thing that comes to the mind is that, 
as it was demonstrated, nitric oxide and superoxide that can be directly generated by 
XOR can join together to form the very reactive and oxidant molecule, peroxynitrite. 
Also, unlike NOS, XOR generation of nitric oxide can proceeds even under anaerobic 
conditions. This raises the possibility that, while NOS (which requires oxygen for its 
function) will fail to generate nitric oxide under pathological ischemic conditions, XOR 
will be able to do so, which might lead to nitric oxide-mediated beneficial or harmful 
effects in the vasculature and/or other tissues [Harrison, 2002, Millar et al., 1998, Zhang et 
al., 1998, Li et al., 2004].  The role of XOR in regulating nitric oxide system and other 
aspects of XOR structure and properties is now an active area of research. Although the 
research on XOR spans more than a century, the enzyme seems still to be hiding many 
unrevealed secrets.  
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Figure 1-1: Expected action of in vivo XOR. A: action of XO when X (or HX) is the available reducing 
substrate. XO oxidizes X (or HX) at the Mo site and couples this oxidation to the reduction of oxygen at the 
FAD site. This process can be only very weakly inhibited by NAD
+. B: action of XDH when X (or HX) is the 
available  reducing  substrate.  XDH  oxidizes  X  (or  HX)  at  the  Mo  site  and  couples  this  oxidation  to  the 
reduction of either primarily NAD
+ or secondarily oxygen at the FAD site. So the reduction of NAD
+ strongly 
inhibits (outcompetes) the reduction of oxygen, so ROS generation is inhibited. C: action of XO when NADH 
is the available reducing substrate. XO oxidizes NADH at the FAD site, and couples this oxidation to the 
reduction of oxygen at also the FAD site. Although XO weakly oxidizes NADH, this oxidation might be 
significant because NAD
+ only weakly inhibits this oxidation. D: action of XDH when NADH is the available 
reducing substrate. XDH oxidizes NADH at the FAD site, and couples this oxidation to the reduction of 
oxygen at also the FAD site. Although XDH strongly oxidizes NADH, this oxidation might be insignificant 
because NAD
+ (which is present in relatively high concentrations in cell) strongly inhibits this oxidation. 
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The enzyme distributes unevenly throughout the body organs. It is concentrated in the 
liver and intestine [Harrison, 2002, Berry and Hare, 2004]. Brain and heart, especially in 
humans, contain a minute amount of the enzyme based on a whole organ purification 
[Harrison, 2002, Berry and Hare, 2004]. However, further investigation showed that XOR 
is  present  at  high  levels  in  sub-localizations  in  the  brain  and  heart.  For  example, 
endothelial cells of the cardiac and cerebral vasculature contain a significant amount of 
XOR [Betz, 1985, Harrison, 2002, Berry and Hare, 2004, Zweier et al., 1994, Terada et al., 
1991a].  The  enzyme  is  also  present  in  the  circulation  in  an  active  form  (see  later). 
Intracellularly, the enzyme is localized in the cytoplasm, and in possibly some sub-
cellular organelles, but not in the mitochondria [Berry and Hare, 2004].  
 
Since  XO  accepts  electrons  from  X  (or  HX)  and  can  then  only  transfer  them  to 
molecular oxygen producing ROS, whereas XDH can transfer the electrons to either 
primarily NAD
+ or secondarily molecular oxygen producing either primarily NADH or 
secondarily ROS, the in vivo intracellular conversion of XDH to XO was thought to be 
required  for  the  toxicity  of  the  enzyme  [Harrison,  2002].  Xanthine  dehydrogenase 
(XDH)  was  shown  to  be  converted  to  XO  in  cells  (or  in  tissues)  under  some 
pathological conditions [Wiezorek, 1994, Phan et al., 1989, Osarogiagbon et al., 2000, Thom, 
1992, Schröder et al., 2006, Ischiropoulos et al., 1996, Park et al., 1998]. However, in many 
other cases, this conversion was shown to be either absent or too slow/too small to 
account for the observed tissue damage [Harrison, 2002, Xia and Zweier, 1995, Terada et 
al.,  1992b,  Cighetti  et  al.,  1990,  Mink  et  al.,  1990,  Marubayashi  1991,  Betz  et  al.,  1991, 
Frederiks  and  Bosch,  1996,  Kooij  et  al.,  1994,  Battelli  et  al.,  1998].    It  can  be  argued, 
however, that this conversion may not be necessary for the toxicity of the enzyme for 
two reasons. First, if a pathological condition increases the  activity/expression of the 
total  enzyme  (XDH  +  XO),  as  it  was  shown  in  some  conditions,    then  the  XO 
activity/expression will also increase in parallel even in the absence of a significant 
conversion from XDH to XO. Secondly, it was shown that XDH is also capable of 
producing  significant  amount  of  ROS.  It  should  be  remember  that  if  NADH  is  the 
reducing substrate, the enzyme can only transfer the electrons to molecular oxygen (not 
to NAD
+), and hence ROS will be generated regardless of whether the enzyme is in the 
form of XO or XDH. However, although XDH is indeed more efficient than XO in 
oxidizing  NADH,  its  generation  of  ROS  is  strongly  inhibited  by  NAD
+  (which  is 
available in relatively high concentrations in cells) when oxidizing NADH or X. On the 
other  hand,  the  generation  of  ROS  by  XO  is  less  inhibited  (compared  to  XDH)  by   32 
NAD
+ when oxidizing NADH and even much less inhibited (compared to XDH) by 
NAD
+ when oxidizing X (see above in Fig. 1-1) [Maia et al., 2007, Sanders et al., 1997, 
Zhang et al., 1998, Hille and Nishino, 1995, Harris et al., 1999, Maia et al., 2005].  
 
An important observation is that the enzyme is present in the circulation in an active 
form under normal conditions and gets even much increased (it can increase several 
hundred-fold) under some acute pathological states. In both cases the enzyme was found 
in the circulation to be largely in the form of XO or, under some cases of organ damage, 
was found to leak to the circulation largely in the form of XDH and then gets rapidly 
converted to XO [Harrison, 2002, Terada et al., 1992a, White et al., 1996, Kooij et al., 1994, 
Friedl et al., 1990, Tan et al., 1995, McHale et al., 1979]. From the discussion in this and the 
previous paragraphs, it does not seem clear which isoform of the enzyme will be more 
injurious under pathological conditions when oxidizing X (or HX) or especially NADH. 
Regardless of the isoform, and as we mentioned before (also see later), the evidence 
points out to the responsibility of the enzyme for many pathological conditions.  
 
There are many fairly specific blockers of the molybdenum (Mo) site on XOR. On the 
other hand, to date, there are still no specific blockers of the FAD site on the enzyme. 
Although  diphenyleneiodonium  (DPI)  can  block  the  FAD  site  on  XOR,  it  can  also 
inhibit  many  other  enzymes  [Harrison,  2002,  Pacher  et  al.,  2006].  The  two  classical 
blockers of the Mo site on XOR are allopurinol and oxypurinol. They have been used 
clinically for decades to treat hyperuricemia-related disorders. Besides their blockade of 
XOR, these two compounds exhibit some other nonspecific activities e.g. scavenging 
hydroxyl radical and/or chelating copper ions [Pacher et al., 2006, Ko and Godin, 1990, 
Lapenna  et  al.,  1997,  Moorhouse  et  al.,  1987,  Malkiel  et  al.,  1993].  From  a  clinical 
perspective,  although  these  two  compounds  have  fairly  good  tolerability,  they  have 
some unpleasant adverse effects e.g. allergy  and, in patients with  renal impairment, 
renal toxicity [Pacher et al., 2006]. Since the discovery of allopurinol and oxypurinol, 
there has been a quest for more selective and better XOR blockers, which resulted in the 
development of generations of XOR blockers. One of the newly developed and very 
selective blockers of the Mo site on the enzyme is febuxostat, which has already entered 
many clinical trials [Pacher et al., 2006]. 
 
Another elegant way to inhibit the Mo site on the enzyme that has been used frequently 
in in vivo animal studies is through feeding the animals with tungsten, which results   33 
with time in the incorporation of tungsten instead of molybdenum at the Mo site on the 
enzyme, rendering it inactive (see later). However, in cases when tungsten was the only 
used way to inhibit XOR, it can not be ruled out that a protective effect of tungsten 
treatment was due to inhibiting enzymes other than XOR that have a molybdenum atom 
at their active sites e.g.  aldehyde oxidase and sulfite oxidase (see later). 
 
Like many other enzymes, XOR can be deactivated/inhibited by some (if not all) of its 
products: uric acid, NAD
+, NADH, or especially ROS [Tan et al., 1993, Terada et al., 
1991b,  Sanders  et  al.,  1997,  Landon  and  Myles,  1967].  This  can  complicate  the 
interpretation of results of treatments that interfere with XOR. A theoretical example is 
that  if  scavenging  ROS  showed  protection  against  a  disease  model  where  XOR 
involvement was suspected, then although these scavengers would appear to have been 
protective through preventing toxic effects of XOR-generated ROS, they might have 
actually  been  protective  through  blocking  the  deactivation  of  XOR  by  its  produced 
ROS. This would result in the continuation of the concomitant production of uric acid 
and its mediation of an unanticipated protective effect against that disease model (uric 
acid is known to have some beneficial as well as harmful effects, see later). 
 
1.4.2 Role of XOR-generated ROS in disease 
 
In studies relating to cardiovascular system, Zweier and co-workers (1994) showed that 
subjecting cultured human aortic endothelial cells to anoxia resulted in severe damage 
(after reoxygenation) and intense production of free radicals that was prevented in the 
presence  oxypurinol.  Although  in  their  study  XOR  level  did  not  change  during  the 
insult,  the  concentrations  of  its  substrate  (HX)  and  its  product  (uric  acid)  increased 
sharply after the anoxia. This sharp rise in HX was paralleled with a sharp decrease in 
ATP  concentration,  which  suggests  that  the  source  of  the  accumulated  HX  was  the 
breakdown  of  ATP  pathway.  This  can  be  considered  as  an  example  of  toxic 
augmentation between energy depletion and oxidative stress. Brown and co-workers 
(1988), using isolated rat heart, found that inhibiting XOR by either feeding rats (before 
isolating the heart) with tungsten or infusing the isolated heart with allopurinol led to 
the attenuation of ventricular dysfunction induced by ischemia-reperfusion injury. Phan 
and co-workers (1989) have shown that, in cultures of rat pulmonary artery endothelial 
cells, the use of any of three different inhibitors of XOR (allopurinol, oxypurinol, or   34 
lodoxamide)  attenuated  the  damage  induced  by  adding  activated  neutrophils,  an 
example of a toxic augmentation between oxidative stress and inflammatory mediators.  
 
In an in vivo study, Nakazono and co-workers (1991) showed that XOR has a role in 
increased blood pressure in spontaneously hypertensive rats (SHR), since oxypurinol (as 
well as a modified form of SOD) decreased the blood pressure in those rats. Although in 
that study the level of XOR was the same in SHR and normal rats, the levels of plasma 
uric acid was higher in SHR rats, suggesting that the enzyme substrate (HX and X) 
concentrations were higher in the SHR rats. In that study, oxypurinol did not decrease 
the blood pressure of normal rats. Another in vivo study showed that XOR played a role 
in a mouse model of atherosclerosis [Schröder et al., 2006]. In that model, inhibiting 
XOR  through  feeding  mice  with  tungsten  led  to  the  normalization  of  endothelial 
function and the decrease in free radical generation as well as the attenuation of plaque 
formation. However, as the authors mentioned, since oxypurinol or alloppurinol could 
not be used in that study, it can not be ruled out that this protective effect of tungsten 
treatment was due to inhibiting enzymes other than XOR that have a molybdenum atom 
at their active sites e.g.  aldehyde oxidase and sulfite oxidase.  
 
In a recent clinical study, oxypurinol was seen to improve myocardial contractility in 
patients  with  ischemic  cardiomyopathy  [Baldus  et  al.,  2006].  Another  clinical  study 
showed that allopurinol improved endothelial function in patients with chronic heart 
failure [George et al., 2006]. Doubling the allopurinol dose in that study resulted in more 
than  twice  the  improvement  in  endothelial  function,  and  based  on  this  finding,  the 
authors argued that allopurinol doses used in many previous clinical trials were sub-
optimal.  The other important finding of the study of George and co-workers was that 
merely decreasing uric acid (which can have either detrimental or beneficial effects, see 
later)  concentration  by  a  means  other  than  inhibiting  XOR  did  not  result  in  any 
improvement  in  endothelial  function.  The  implication  is  that  allopurinol  was  likely 
protective through inhibiting XOR-mediated ROS production (coupled to the oxidation 
of HX and X to uric acid) and not through merely decreasing the in vivo concentration 
of  uric  acid  per  se.  However,  it  should  be  kept  in  mind  that,  as  mentioned  earlier, 
allopurinol  (and  oxypurinol)  can  exert  some  other  beneficial  actions  unrelated  to 
inhibiting  XOR.  Another  clinical  study  showed  that  oxypurinol  improved  coronary 
endothelial function in patients with coronary artery disease [Baldus et al., 2005], whilst 
others observed that treatment with XOR inhibitors has beneficial cardiovascular effects   35 
in smokers and hypercholesterolemic patients [Guthikonda et al., 2003, Cardillo et al., 
1997].  However,  all  these  clinical  studies  are  limited  by  the  small  sample  size, 
demanding more validation with bigger clinical trials.  
 
Regarding neuronal/cerebral disease, using primary cultures of rat striatum, it was found 
that intracellular XOR, through a non clear mechanism, exacerbated the toxicity of an 
endogenous  neurotoxicant,  3-Hydroxykynurenine  (3-HK),  when  this  toxicant  was 
applied externally at concentrations of 1-10  M. The importance of this finding is that 
these  concentrations  are  comparable  to  3-HK  concentrations  found  in  some 
neurodegenerative diseases, implying that 3-HK as well as XOR might be important 
players in the development of some neurodegenerative diseases [Okuda et  al., 1996]. 
Using cortical neuronal cultures, Tagami and co-workers (1998) showed that allopurinol 
attenuated the damage induced by hypoxia-reoxygenation.  
 
Widmer and co-workers (2007) showed that inhibiting XOR with oxypurinol attenuated 
lipid peroxidation as well as cellular damage in cultures of microglia cell line (microglia 
are considered resident macrophages in the brain) induced by anoxia-reoxygenation. It 
is worth mentioning that, in that study, oxypurinol was protective at a low concentration 
(10  M) which rules out that its protection was due to directly scavenging hydroxyl 
radical  (not  inhibiting  XOR),  a  side  activity  that  might  occur  only  at  a  high 
concentration of oxypurinol (or allopurinol) (≥ 500  M). Actually, since oxypurinol 
(and allopurinol) was shown to scavenge hydroxyl radical at such a high concentration 
only  in  cell-free  experiments  in  the  presence  of  only  one  competing  detector  (i.e. 
scavenger), even if oxypurinol (or allopurinol) was used at such a high concentration in 
the above toxicity study (or other toxicity studies), its protective effect in a cellular 
milieu is unlikely to be due to its ability to directly scavenge hydroxyl radical. The 
reason is that, in a cellular milieu, oxypurinol needs to compete with many biological 
targets (i.e. scavengers) of hydroxyl radical, and thus a much higher concentration than 
500  M of oxypurinol might be needed for it to significantly scavenge hydroxyl radical. 
Abramov and co-workers (2007) showed that 20  M oxypurinol attenuated cell damage 
induced by oxygen-glucose deprivation in cultures of either cortical or hippocampal 
neurons. In other studies, XOR inhibitors attenuated the damage induced by kainate 
(which activates a subclass of glutamate receptors called AMPA/kainate receptors) in 
cortical, retinal, or cerebellar neurons [Dykens et al., 1987, Cheng and Sun, 1994, Dutrait et 
al., 1995].    36 
 
Takuma and co-workers (1999) showed that, in primary cultures of astrocytes (which 
are glial cells that exert usually protective/supportive roles in the brain), allopurinol 
(100  M) attenuated the damage induced by increasing intracellular Ca
2+ concentration. 
Allopurinol  attenuated  the  damage  induced  by  mechanical  trauma  in  cultured  brain 
endothelial cells [Gidday  et  al., 1999]; whilst oxypurinol was shown to  attenuate the 
damage  induced  by  anoxia-reoxygenation  in  similar  brain  endothelial  cell  cultures 
[Beetsch et al., 1998, Wu et al., 1997]. This damage to brain vascular endothelial cells is 
thought to be  an important traumatic event in acute neurodegenerative  diseases  e.g. 
stroke, and as mentioned before, cerebral (as it is the case with the cardiac) vascular 
endothelial cells contain significant amount of XOR [Betz, 1985, Harrison, 2002, Berry 
and Hare, 2004, Zweier et al., 1994, Terada et al., 1991a].  
 
MacGregor  and  co-workers  (1996)  showed  that  oxypurinol,  and  to  a  lesser  extent 
allopurinol, attenuated the neuronal membrane damage induced by a systemic in vivo 
administration of kainate in rats. Palmer and co-workers (1993), in an in vivo study, 
showed  that  a  high  dose  of  allopurinol,  although  administered  after  the  period  of 
ischemia,  attenuated  acute  and  chronic  brain  injuries  in  rats  subjected  to  cerebral 
ischemia-reperfusion. Phillis (1989) showed that in vivo administration of oxypurinol 
attenuated  hippocampal  damage  and  the  associated  neurological  deficits  in  gerbils 
subjected to ischemia. Thom (1992) showed that inhibiting XOR through either feeding 
rats  with  tungsten  for  a  month  or  pre-treatment  with  allopurinol  resulted  in  the 
attenuation  of  brain  lipid  peroxidation  induced  by  carbon  monoxide  poisoning 
(followed  by  reoxygenation).  Phillis  and  co-workers  (1995)  showed  that  oxypurinol 
restored  cerebral  cortical  ATP  content  (during  the  early  period  of  insult)  and  also 
improved physiological indices in rats subjected to ischemia-reperfusion injury. These 
authors suggested that oxypurinol may have been protective by inhibiting XOR, which 
would result in inhibition of ROS generation and would result also in the accumulation 
of HX which can in turn be converted (salvaged) to adenine nucleotides including ATP.  
 
Peeters-Scholte  and  co-workers  (2003)  observed  a  protective  effect  of  allopurinol, 
although given after the period of ischemia, against brain damage induced by ischemia-
reperfusion in newborn piglets. In a small sample size clinical trial, allopurinol was 
observed to decrease free radical generation and improve cerebral hemodynamics and   37 
electrical  activity  in  human  newborns  suffering,  during  birth,  from  severe  asphyxia 
followed by cerebral perfusion [Van Bel et al., 1998].   
 
A toxic role has been also observed for XOR in many other disease models of different 
organs of the body (in addition to the cardiovascular and cerebral systems). In cultures 
of the Kupffer cells of rat liver, it was shown that allopurinol significantly attenuated 
the  damage  induced  by  hypoxia-reoxygenation  [Wiezorek  et  al.,  1994].  In  cultures  of 
mouse retinal endothelial cells, it was shown that either DPI (which can inhibit XOR 
through blocking the FAD site, but can also inhibit some other enzymes) or oxypurinol 
attenuated the damage induced by glucose/oxygen deprivation followed by restoration 
to normal glucose and oxygen levels [Rieger et al., 2002].  
 
Terada and co-workers (1992b) showed that inducing intestinal ischemia-reperfusion 
resulted in injury to the lung tissue, suggesting that the damaged intestine released toxic 
circulating mediators that caused distal injury to the lung tissue, where inhibiting XOR 
by either feeding the rats with tungsten or pre-treatment with allopurinol attenuated the 
lung injury. These authors suggested that XOR released from the damaged intestine (in 
addition to XOR present in the lung tissue) played a role in the lung injury. Nielsen and 
co-workers (1996) showed that inducing ischemia-reperfusion of rabbit liver resulted in 
damage  to  both  of  the  liver  and  the  lungs,  where  feeding  the  rabbits  with  tungsten 
attenuated the damage observed in both of the organs. Ohta and co-workers (2007), in 
an in vivo study, showed that rat liver damage induced by D-galactosamine (a toxicity 
model resembles the liver damage observed in acute viral hepatitis in humans) was 
attenuated by allopurinol even though it was administered 6 hours after administering 
D-galactosamine.  Zeki  and  co-workers  (2002),  using  an  in  vivo  model  of  chronic 
pancreatitis, showed that feeding the animals with tungsten resulted in the attenuation of 
the observed injury.  
 
Kumagai and co-workers (2002) showed that in vivo inhibition of XOR with either 
BOF-4272 (a highly specific inhibitor of the Mo site on the enzyme) or allopurinol 
attenuated rat testicular damage induced by surgical cryptorchidism. Also, Lamarque 
and Whittle (1995) showed that in vivo pre-administration of allopurinol attenuated rat 
gastric mucosal damage induced by local intra-arterial infusion of nitric oxide donors. 
These authors attributed the allopurinol-inhibitable toxicity of the nitric oxide donors to   38 
the  reaction  between  superoxide  produced  by  XOR  and  nitric  oxide  to  produce 
peroxynitrite, which can be very toxic.  
 
In  all  disease  models  where  inhibiting  XOR-generated  ROS  appears  to  be  either 
beneficial or non beneficial, it is difficult to know where to put uric acid (whose level 
will be reduced by inhibiting XOR) in the equation. This is because that uric acid seems 
to have both beneficial and harmful effects [Feig et al., 2008, Dimitroula et al., 2008]. 
Thus, if inhibiting XOR shows protection, a question arises: is this protective effect of 
XOR inhibition is due to decreasing ROS levels or due to decreasing uric acid level 
(here we assume that uric acid is detrimental)? On the other hand, when inhibiting XOR 
does not show protection, another question arises, is this lack of protection of XOR 
inhibition  is  due  to  the  lack  of  a  role  of  XOR-generated  ROS,  or  is  it  due  to  the 
beneficial effects of decreasing ROS were antagonized by preventing beneficial effects 
of uric acid? A possible way to address these questions is through decreasing ROS 
levels by a means other than inhibiting XOR (e.g. direct scavenging of ROS) and/or 
decreasing uric acid levels by a means other than inhibiting XOR (e.g. direct scavenging 
of uric acid). 
 
Because of the above mentioned evidence for a toxic role of XOR in many pathologies, 
and  also  because  XOR  is  considered  one  of  very  few  convenient  tools  to  produce 
superoxide experimentally, a combination of XO and its substrate X (or other substrates 
that bind to the Mo site) is a widely used model to generate ROS and to study their 
effects in many cell culture studies [Rieger et al., 2002, Fatokun et al., 2007a, Matesanz et 
al., 2007, Van Grevenstein et al., 2007, Knorpp et al., 2006, Casalino-Matsuda et al., 2006, 
Mander et al., 2006, Wu et al., 2002, Lee et al., 2001, Atlante et al., 2000, Mitobe et al., 2000, 
Bellmann et al., 1995, Satoh et al., 1998, Link and Riley, 1988, Mohsen et al., 1995, Duell et al., 
1995, Simon et al., 1981, Hiraishi et al., 1987, Ito et al., 1992, Valencia and Morán, 2004, 
Michikawa et al., 1994]. However, there are not many cell culture studies which have 
studied the effect/toxicity of the combination of XO (or XDH) and the substrate NADH 
(which binds to the FAD site). A possible reason for this lack of interest is that, unlike 
X, NADH is oxidized by many enzymes other than XO and is involved in many cellular 
processes, which can obscure the mechanism of action of ROS generated by applying 
NADH / XO combination. Another reason for this lack of interest may be that NADH is 
known to be a much weaker substrate than X for the most studied form of the enzyme, 
the bovine milk XO [Gilbert, 1963, Liochev et al., 1989, Nakamura, 1991]. However, some   39 
other forms of the enzyme are much more potent than the bovine milk XO in oxidizing 
NADH. Actually, recent studies have shown that  XO (and especially XDH) isolated 
from certain human tissues have a potent NADH oxidase and ROS generating activity, 
while some of these human forms have, surprisingly, a low xanthine oxidase activity [ 
Sanders et al., 1997, Zhang et al., 1998, Maia et al., 2007]. Also, as mentioned earlier, in 
cell-free experiments, it was shown that blocking the site of X binding on the enzyme 
(the Mo site) does not significantly prevent NADH oxidation and the concomitant ROS 
generation [Nakamura, 1991, Berry and Hare, 2004, Harrison, 2002, Sanders et al., 1997, 
Olson  et  al.,  1974].  This  led  some  authors  to  warn  against  overlooking  the  NADH 
oxidase activity of XOR when interpreting results of studies that looked for a role for 
this enzyme in certain diseases. In particular, the failure of allopurinol (a blocker of the 
site of X binding, but not NADH binding) in preventing tissue damage in previous 
studies where XOR-mediated damage was proposed [Allen et al., 1990, Benders et al., 
2006, Mosler et al., 2005, Coetzee et al., 1996] could be theoretically explained by the 
inability of allopurinol to prevent NADH oxidation by XOR, and hence its inability to 
prevent the tissue damage [Berry and Hare, 2004, Harrison, 2002, Sanders et al., 1997, 
Zhang et al., 1998]. 
 
1.5 Cell culture technique 
 
Cell cultures derived from different organ systems are now widely used for different 
physiological, pathological, and pharmacological studies. They have several advantages 
over  the  in  vivo  studies:  they  allow  for  investigations  on  specific  cell  types;  test 
compounds  can  be  applied  in  defined  concentrations,  and  a  precise  control  of  the 
environment around cells can be achieved [Smith and Jiang, 1994, Freshny, 2004]. The 
ability of a test compound to penetrate the  membrane of the cell or the subcellular 
organelles  can  be  assessed;  specific  extracellular,  membrane,  or  intracellular 
targets/effects  of  the  test  compounds  can  be  identified;  interactions  between  two  or 
more types of cells can be studied (e.g. interaction between neurons and astrocytes); 
availability of multi-well plates allows for testing a large number of treatments at the 
same  time  and  under  the  same  conditions,  and  ethical  concerns  about  animal 
experimentation are avoided [Freshny, 2004]. A challenging aspect in studying oxidative 
stress is how to directly detect and measure ROS which are unstable, short lived, and 
present at very low levels? It is often done in vivo through indirect measurements e.g.   40 
(1) measuring the end products of oxidative stress attack on lipids, proteins, or DNA  
(2) measuring the alteration in the activity of the antioxidant enzymes [Halliwell and 
Whiteman, 2004]. Cell cultures, however, make it much easier to directly and indirectly 
measure ROS.  
 
Cell cultures, however, have their clear limitations e.g. lack of the complex biological 
environment  around  the  cells,  and  hence  the  lack  of  the  resemblance  to  the  actual 
physiological  and  pathological  states.  Regarding  oxidative  stress  in  particular,  it  is 
possible that the isolation of cells and the subsequent culturing ‘stress’ would force the 
cells, in order to survive in the new strange environment, to induce survival/protective 
pathways that would not be induced under normal in vivo conditions. This means that 
cells that survive in vitro might be more resistant to oxidative stress insults than cells in 
vivo. However, it can be argued for an opposite possibility, where in vivo tissues might 
be  better  equipped  with  protective  mechanisms  (e.g.  they  have  richer  antioxidant 
environment) to cope with insults than cells in vitro [Halliwell, 2003], and hence higher 
concentrations of toxic insults might be required to kill cells in vivo than if applied in 
vitro.  
 
Another important fact that should be considered when conducting cell culture studies is 
that cells in cultures are usually exposed to higher oxygen levels than its levels in most 
in vivo tissues [Halliwell, 2003]. However, there are some details that require discussion. 
Physiological oxygen levels in most in vivo tissues (with some exceptions e.g. some 
pulmonary cells) are estimated to be around 1-60 mmHg [Halliwell, 2003, de Groot and 
Littauer, 1989, Taylor and Camalier, 1982], where in vivo brain interstitial oxygen levels 
were reported to be around 30-40 mmHg [Liu et al., 2004]. In cell cultures plated under 
standard  conditions  (5%  CO2,  95%  air,  and  37˚C),  the  levels  of  dissolved  oxygen 
around cells (in the culture medium) were reported to be more than 100 mmHg after the 
first minutes/hours of plating (or renewing the medium) [Metzen et al., 1995, Wolff et al., 
1993, Hanson et al., Hanson et al., 2007, Taylor and Camalier, 1982]. What happens to the 
dissolved oxygen level around cells after that (i.e. after the first minutes/hours of plating 
(or renewing the medium)) is not clear, but seems to depend on (among other factors) 
the  oxygen  consumption  efficiency  of  the  cultures  when  maintained  in  a  static 
environment i.e. without shaking the plates [Metzen et al., 1995, Jensen, 1976, Bader et al., 
1999]. For example, Metzen and co-workers (1995) showed that although in rat renal 
mesangial primary cultures the dissolved oxygen level around cells was more than 100   41 
mmHg after 24 hours of renewing the medium, in some cell line cultures (renal LLC-
PK1 and LLC-MK2 or hepatic HepG2 and Hep3B epithelial cells) the dissolved oxygen 
level around cells dropped to less than 0.2 mmHg (the detection limit) after 24 hr of 
renewing the medium (i.e. the cells become very hypoxic despite the fact that the air in 
the incubator was maintained at 95%). These authors attributed the observed hypoxia in 
these cell lines to a high oxygen consumption efficiency of the cells that exceeded the 
ability of oxygen in the incubator air to dissolve in the culture medium and diffuse to 
the cells attached to the bottom of the plate wells (i.e. oxygen consumption far exceeded 
oxygen  supply).  Similar  findings  were  observed  by  others  [Holzer  and  Maier,  1987]. 
Therefore,  in  cultures  (under  static  environment  and  standard  conditions)  with  high 
oxygen consumption efficiency the cells might  be exposed to hyper-oxic conditions 
(initially) and then be exposed to either transient or sustained hypoxic conditions, where 
both cases are non-physiological. To overcome these problems, some researchers have 
tried culture plates with gas-permeable bottoms instead of the standard (polystyrene) 
culture plates (which are poorly permeable to gases) [Holzer and Maier, 1987, Wolff et al., 
1993, Bader et al., 1999, Jensen, 1976, Metzen et al., 1995]. On the other hand, in cultures 
with low oxygen consumption efficiency (many primary cultures might be under this 
category)  the  cells  might  be  under  hyper-oxic  (i.e.  oxidative  stress)  conditions  both 
initially and throughout their maintenance in culture, which is also non-physiological.  
 
With these limitations in mind, however, cell culture is an indispensible technique to 
investigate  many  biological/pathological  conditions  including  oxidative  stress.  Many 
important discoveries would have been difficult or at least delayed in the absence of the 
cell culture technique e.g. the demonstration that activating some glutamate receptors in 
cultured CNS neurons generates intracellular superoxide [Patel et al., 1996, Lafon-Cazal 
et al., 1993b].   
 
Oxidative  stress  in  cell  cultures  can  be  induced  in  different  ways.  ROS  can  be 
applied/generated  directly  e.g.  applying  hydrogen  peroxide  solution,  applying  XOR 
with its substrate, or applying nitric oxide donors. Also, oxidative stress can be induced 
indirectly  through  applying  specific  disease  model  inducers  e.g.  hypoxia,  glucose 
deprivation,  serum/growth  factors  deprivation,  or  (in  cultures  of  CNS  neurons) 
glutamate receptor activation. Also oxidative stress can be induced by inhibiting cellular 
antioxidant mechanisms e.g. inhibiting the activity or knocking out the gene of SOD or 
catalase.   42 
To  test  the  possible  involvement  of  ROS  in  some  pathological  conditions  in  cell 
cultures,  many  detection/measurement  methods  have  been  developed.  For  example, 
2′,7′-dichlorodihydrofluorescein diacetate (DCFDA) is used as a probe for general intra-
cellular oxidative stress. The principle of this assay is that DCFDA readily crosses the 
cell membrane and accumulates in the cytosol. Intracellularly, DCFDA is converted by 
esterases to a non-fluorescent species, 2′,7′-dichlorodihydrofluorescein (DCFH), where 
many  reactive  species  can  oxidize  DCFH  into  a  fluorescent  species,  2′,7′-
dichlorofluorescein (DCF), which can be measured [Halliwell and Whiteman, 2004].  
 
A  recently  developed  method  is  considered  one  of  the  most  available  specific 
intracellular detection methods of superoxide, which involves the oxidation of the probe 
hydroethidine by superoxide to yield a fluorescent species (2-hydroxyethidium) [Zhao et 
al., 2005]. This specific species (2-hydroxyethidium) was shown to be only produced by 
reaction  between  hydroethidine  and  superoxide,  but  not  by  reaction  between 
hydroethidine and any of the following reactive species: hydrogen peroxide, hydroxyl 
radical, peroxynitrite, or hypochlorous acid [Zhao  et  al.,  2005].  The involvement of 
oxidative stress in some pathological conditions in cell cultures can also be measured 
indirectly e.g. measuring the stable end products of the oxidative stress attack on lipids, 
proteins, or DNA.  
 
In  studying  oxidative  stress  or  other  damaging  events  in  cell  cultures,  the  overall 
damage to the cells is usually assessed using viability tests. One type of viability tests is 
measuring membrane integrity through examining the ability of the cells to uptake a dye 
that is normally excluded by cells e.g. trypan blue or naphthalan black, so dead cells 
will uptake the dye while viable cells will exclude it. This can also be done the other 
way around through applying a dye that is known to be excluded by dead cells while 
being  taken up by viable cells e.g. neutral red [Freshny, 2004]. The membrane integrity 
can also be assessed through observing the leak of some intracellular components into 
the  extracellular  medium  e.g.  lactate  dehydrogenase  [Lin  and  Maiese,  2001].  Another 
type of viability tests is measuring the enzymatic activity of cells. For example, 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl  tetrazolium  bromide  (MTT)  and  Alamar  blue  are 
dyes that can be reduced by some cellular enzymes, where the extent of their reduction 
reflects the viability status of the cultures [Hamid et al., 2004, Fatokun et al., 2007b].  
Since  cells  in  cultures  have  characteristic  morphology,  a  very  important  way  of 
assessing the culture viability is also through examining the morphological appearance   43 
of the cells under the microscope. For example, cultured neurons have a characteristic 
morphology, and when damaged, clear changes in their morphology are observed e.g. 
degenerated axons and also shrinking or even lysed cell bodies. To know whether the 
morphological  changes  are  reversible  or  irreversible,  the  morphology  can  be 
periodically checked for an extended period of time.  
 
In  this  project  cultured  neurons  were  chosen  to  investigate  the  toxicity  of  XOR. 
Although this thesis attempted to answer some relatively general questions regarding 
XOR toxicity (and hence any other type of cells might have been applicable for this 
study), neurons were selected for several reasons. As mentioned earlier, brain is thought 
to be particularly vulnerable to oxidative stress, and hence delicate oxidative stress-
related levels of toxicity/effects might be observed in neurons by applying relatively 
low concentrations of ROS. Also, since a toxic interplay in the CNS neurons between 
oxidative stress and glutamate-receptor activation was previously postulated, we were 
keeping in mind that we might want to do some experiments to have more analysis of 
this toxic interplay. Also, it was mentioned earlier that cellular XOR potentiated the 
toxicity  of  an  endogenous  neurotoxicant,  3-hydroxykynurenine  (3-HK),  in  cultured 
neurons through a non clear mechanism. So, we were also keeping in mind that we 
might want to do some experiment to investigate the mechanism of this interesting toxic 
augmentation.   
 
Using neuronal cultures derived from the brain of adult animals is preferable to younger 
ones,  since  the  oxidative  stress-related  neurondegenrative  diseases  (e.g.  stroke  and 
Parkinson’s disease) are age related. At each stage of body development, neurons and 
cells in general have characteristic genetic, structural, metabolic, and redox status e.g. 
the expression pattern of neuropeptide Y in the guinea-pig sympathetic neurons differs 
significantly between embryos and adults [Matsumoto, 1993]. Also neurons may switch 
their dependency from one growth factor to another at different stages of development. 
 
 However, neuronal cultures derived from adult animal brain are difficult to produce and 
sustain. The reasons for this difficulty might include that neurons in the adult brain 
tissue are embedded in a network of adhesive macromolecules that physically retard the 
neurons from dissociating from the tissue during the isolation procedure [Brewer, 1997]. 
Also,  some  molecules  in  the  adult  tissue  were  shown  to  specifically  inhibit  the 
attachment of neurons to the surface of culture plates e.g. phosphacan and neurocan are   44 
large proteoglycans present in the extracellular matrix in the nervous system which have 
been shown to impair the neurite outgrowth and the attachment to the culture plate of 
adult rat dorsal root ganglion neurons in a dose dependent manner [Sango et al., 2003]. 
Also, with increased age, there is an impairment of the fundamental properties of the 
cell membrane such as fluidity and elasticity [Horie et al., 1990]. 
 
Some  researchers  have  tried  different  approaches/techniques  to  improve  culturing 
conditions in order to produce and sustain a good yield of adult neuronal cultures e.g. 
using specialised media, adding specific growth factors, and/or using techniques such as 
density gradient fractionation technique [Brewer, 1997]. However, these approaches are 
relatively expensive and complex for a routine use. So, neuronal cultures derived from 
younger animals, embryos or neonates, are widely used instead in research. Among the 
different  types  of  brain-derived  cultures,  the  primary  cultures  of  neonatal  cerebellar 
granule neurons (CGNs) have a particular attraction [Contestabile, 2002, Smith et al., 2008, 
Fatokun et al., 2007b]. They contain a very homogeneous population of neurons. The 
cerebellum is anatomically distinct and easy to dissect. Also, these cultures seem to be 
very  vulnerable  to  at  least  some  types  of  oxidative  stress  e.g.  it  was  observed  that 
treatment with hydrogen peroxide (100  M) for just 15 minutes killed 75% of CGNs, 
while it was observed in another study that the same percent of death in cultured brain 
cortical neurons required 24 hours application of the same concentration of hydrogen 
peroxide [Klein and Ackerman, 2003].     
 
1.6 Aim/Objectives 
 
The aim of this project was to investigate some aspects of the in vitro toxicity of XOR, 
which might provide more insights into its in vivo toxicity. So we were interested to 
know the answer of the following questions: 
 
A:  
 Since there are not many cell culture studies which have investigated the toxicity of the 
NADH / XO combination (see before), what are the differences and similarities between 
X / XO and NADH / XO toxicities? In particular: 
1- What are the concentrations of NADH and X that produce the same toxicity level? 
2- What is the effect of blocking the different sites on XO on the two toxicity systems?   45 
3-  What  is  the  effect  of  deactivating  superoxide  or  hydrogen  peroxide  on  the  two 
toxicity systems? 
4- What is the effect of adding metal chelators on the two toxicity systems? 
5- What is the effect of adding hydroxyl radical scavengers on the two toxicity systems? 
 
B:  
We were also interested to clarify some secondary issues regarding X / XO toxicity. In 
particular: 
1-  Since  many  previous  studies  (one  of  them  was  conducted  previously  in  this 
laboratory  using  CGNs  [Fatokun  et  al,  2007a])  showed  that  catalase  was  protective 
against X / XO toxicity, while SOD had no effect, what is the reason for the lack of 
effect  of  SOD?  Is  it  because  superoxide  generated  from  this  combination  was  not 
involved in the toxicity?  
2- Since some previous studies, that used some tissues other than CGNs, showed that 
intracellularly generated superoxide mediated the X / XO toxicity (or similar models, 
where extracellular hydrogen peroxide was a main product) [Ito et al., 1992, Kyle et al., 
1988,  Hiraishi  et  al.,  1994],  is  this  also  the  case  with  CGNs  i.e.  does  intracellularly 
generated  superoxide  mediate  X  /  XO  toxicity  in  CGNs?  And  if  so,  is  the  lack  of 
protection of SOD, observed in CGNs and other tissues, due to its inability to cross the 
cell  membrane?  And  also  if  intracellular  superoxide  is  involved,  does  the  lack  of 
protection  by  SOD  mean  that  superoxide  generated  extracellularly  from  X  /  XO 
combination was unable to cross the cell membrane? 
3- Since some previous studies showed that some commercial preparations of XO are 
contaminated with iron [Britigan et al., 1990], is this also the case with our preparation of 
XO? And if so, is this iron active and does it contribute to the effects that we observe in 
X / XO toxicity?  
4- Since many previous studies suggested that intracellular hydroxyl radical is involved 
in X / XO toxicity [Satoh et al., 1998, Link and Riley, 1988, Mohsen et al., 1995, Duell et al., 
1995, Hiraishi et al., 1987, Zigler et al., 1985], can this also be demonstrated here? If so, 
can directly scavenging hydroxyl radical intracellularly provide protection? 
 
C:  
Since in the start of this project we found some difficulties with CGNs cultures, one aim 
was  to  establish  the  optimal  culturing  conditions  required  in  order  to  successfully   46 
perform our experiments with XO. In particular, we wanted to know why the neurons 
(including those in the control group) die at the experiments day by manipulating the 
cultures (i.e. aspirating the culture medium, adding treatment and control vehicles, and 
adding the restoration medium).   
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2  Materials and methods 
 
 2.1 Chemicals (ordered alphabetically) 
 
-  AlamarBlue®; Invitrogen (DAL1100) 
-  Albumin; Sigma (A2153) 
-  Allopurinol; Sigma (A8003) 
-  Catalase; Sigma (C1345) 
-  Cytochrome c; Sigma (C7752) 
-  Cytosine β-D-arabinofuranoside (Cytosine arabinoside); Sigma (C1768) 
-  Deferoxamine mesylate salt; Sigma (D9533) 
-  Diethyldithiocarbamate (DDC); Sigma (228680) 
-  Diphenyleneiodonium (DPI); Sigma (D2926) 
-  DNAse I ; Sigma (AMPD1) 
-  Dulbecco's Phosphate-Buffered Saline (DPBS); Invitrogen (14190) 
-  Ethylenediaminetetraacetate (EDTA); Sigma (D2SS) 
-  Fetal bovine serum (FBS); Sigma-Aldrich (F9665) 
-  Glutamic acid (glutamate); Acros Organics (156212500) 
-  Glutamic-Pyruvic Transaminase; Sigma (G8255) 
-  Hydrogen peroxide (H2O2) solution; Sigma (H1009) 
-  Manganese-superoxide dismutase (Mn-SOD); Sigma (S5639) 
-  Minimum Essential Medium (MEM); Invitrogen (32360-034) 
-  (+)-MK-801; Sigma (M107) 
-  NG-nitro-L-arginine methyl ester (L-NAME); Sigma (N5751) 
-  Poly-D-lysine hydrobromide ; Sigma (P0899) 
-  α-(4-Pyridyl N-oxide)-N-tert-butylnitrone (POBN); Sigma (215430) 
-  Reduced β-Nicotinamide adenine dinucleotide (NADH); Sigma-Aldrich (N4505) 
-  S-Nitroso-N-acetyl-DL-penicillamine (SNAP); Sigma (N3398) 
-  Superoxide  dismutase-1  (SOD-1)  (Copper,Zinc-superoxide  dismutase);  Sigma-
Aldrich (S5395). 
-  Tiron (4,5-Dihydroxy-1,3-benzenedisulfonic acid) disodium salt; Sigma (33724) 
-  Trypsin; Sigma (T-4799) 
-  Trypsin inhibitor; sigma (T6414)   48 
-  Xanthine; Sigma (X4002) 
-  Xanthine oxidase (from bovine milk); Sigma-Aldrich (X4376) 
-  XTT  (2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 
inner salt); Sigma (X4626) 
 
2.2 Equipments 
 
-  Laminar flow hood. 
-  Different sizes of automatic pipettes. 
-  96-well plates. 
-  Inverted contrast-field microscope (Olympus IX50) with Olympus DP50 software 
for image processing. 
-  Centrifuge (MSe; Harrier 18/80). 
-  CO2 incubator. 
-  Water bath. 
-  Plate reader (DYNEX TECHNOLOGIES; Opsys MR). 
 
2.3 Treatment solutions and media 
 
HEPES-sol:  Contains  (in  distilled  water):  Sodium  chloride  (140  mM),  potassium 
chloride  (5  mM),  calcium  chloride  (2mM),  N-(2-Hydroxyethyl)piperazine-N′-(2-
ethanesulfonic acid) (HEPES) (for buffering) (20 mM), magnesium chloride (0.8 mM), 
and  glucose  (3  mM).  pH=  7.2-7.6.  When  this  solution  was  used,  the  cultures  were 
moved to an incubator that contains zero% CO2. 
 
This solution was used as a vehicle for the test compounds in many viability studies that 
were  performed  after  solving  the  problem  of  fresh  culture  medium  toxicity.  This 
solution was also used in all cell-free experiments (except one cell-free experiment that 
will be indicated later on).  
 
MEM-HEPES-sol:  MEM  medium  (Invitrogen  (32360)),  which  already  contains: 
HEPES (for buffering) (25 mM) and sodium bicarbonate (NaHCO3) (also for buffering) 
(2.2 mg/ml). This solution was modified to contain: glutamine (2 mM), gentamicin (50   49 
 g/ml), and potassium chloride (25 mM) as final concentrations. When this solution was 
used, the cultures were maintained under 5% CO2. 
 
This solution was used as a vehicle for the test compounds in many viability studies that 
were performed after solving the problem of fresh culture medium toxicity. 
 
Fresh culture  medium: the same as MEM-HEPES-sol but also contains 10% fetal 
bovine serum (FBS). 
 
This was the solution that was used in the isolation and plating process of neurons at 
day zero. So, the neurons were maintained in this solution for 8-9 days until the time of 
experiments. A fresh culture medium was also used as a vehicle for the test compounds 
in  all  of  the  experiments  that  were  performed  before  solving  the  problem  of  fresh 
culture medium toxicity. This solution was also the solution to which the neurons were 
restored after the treatment period in all of the experiments that were performed before 
solving the problem of fresh culture medium toxicity. 
 
Conditioned  medium:  This  was  the  culture  medium  collected  from  plates  that 
contained neurons grown for 6-7 days. This medium will not contain significant (toxic) 
amount  of  glutamate  (that  is  already  present  in  the  fresh  culture  medium),  because 
glutamate gets taken up/degraded by neurons during the 6-7 days of plating [Aronica et 
al., 1993]. So, this solution was the solution to which the neurons were restored at the 
end of treatment period in all of the experiments that were performed after solving the 
problem of fresh culture medium toxicity. 
 
2.4 Test compounds stock solutions 
 
-Bovine  milk  XO  powder  was  dissolved  in  0.001  M  sodium  hydroxide  (NaOH) 
(prepared in normal saline) to a concentration of 0.5 Units/ml. Aliquots of this stock 
solution were stored at -20˚C until use (notice that the NaOH presence and freezing the 
enzyme might cause damage to the enzyme, and thus these should be avoided in future 
experiments. A better way is to dissolve the enzyme in a neutral buffer and then use it 
immediately).    50 
-SOD-1 powder was dissolved in normal saline to a concentration of 10000 Units/ml.  
Aliquots of this stock solution were stored at -20˚C until use (notice that freezing the 
enzyme might cause damage to the enzyme, and thus this should be avoided in future 
experiments. A better way is to dissolve the enzyme in a neutral buffer and then use it 
immediately).  
-Catalase (Cat.) powder was dissolved in phosphate buffer (pH= 7.4) to a concentration 
of 10000 Units/ml. This stock solution was stored at 4-8 C and used in the same day.  
-  NADH  powder  (100 mg)  was  dissolved  in  1 ml  of  0.01 M  NaOH  to  generate  a 
solution of 134.8 mM NADH, and this solution was then diluted by adding 5.74 ml of 
normal  saline  to  make  6.74 ml  of  20 mM  NADH  stock  solution.  Aliquots  of  this 
solution (pH = 10–11) were protected from light and stored at − 40 °C until use (notice 
that the high pH might cause damage to NADH, and thus should be avoided in future. A 
better way is to dissolve NADH in a neutral buffer and then use it immediately without 
freezing). 
-POBN powder was dissolved in normal saline to a concentration of 100 mM. Aliquots 
of this solution were protected from light and stored at -20˚C until use. 
-Deferoxamine powder was dissolved in distilled water to a concentration of 76 mM.  
Aliquots of this solution were stored at -20˚C until use. 
-Cytochrome c powder was dissolved in distilled water to a concentration of 2 mM. 
Aliquots of this solution were protected from light and stored at -20˚C until use (notice 
that freezing the protein might cause damage to it, and thus this should be avoided in 
future experiments. A better way is to dissolve the protein in a neutral buffer and then 
use it immediately). 
-XTT powder was dissolved in distilled water to a concentration of 2 mM. Aliquots of 
this solution were protected from light and stored at -20˚C until use. 
-Allopurinol  powder  was  dissolved  in  1  M  NaOH  to  a  concentration  of  100  mM. 
Aliquots of this solution were stored at -20˚C until use. 
-Xanthine powder was dissolved in 0.1 M NaOH to a concentration of 10 mM. Aliquots 
of this solution were stored at -20˚C until use. 
-EDTA powder was dissolved in distilled water to a concentration of 50 mM. Aliquots 
of this solution were stored at -20˚C until use. 
- Tiron powder was dissolved in distilled water to a concentration of 200 mM. Aliquots 
of this solution were stored at -20˚C until use.   51 
 -To  prepare  a  stock  solution  of  diphenyleneiodonium  (DPI),  an  initial  concentrated 
solution of 15.9 mM was prepared, and some of this solution was diluted in distilled 
water to 0.1 mM. Aliquots of this 0.1 mM solution were stored at -20˚C until use. 
Notice: It was missed to record the identity of the solvent that was used to prepare the 
initial concentrated solution (i.e. 15.9 mM) of DPI. Tracing our memory back could not 
reveal  the  identity  of  this  solvent.  However,  it  is  very  likely  that  this  solvent  was 
DMSO, for two reasons. First, we usually follow the supplier instructions to dissolve 
our compounds, and in this case, Sigma mentioned that although DPI can be dissolved 
in water or ethanol to generate low concentrations of stock solutions, the only solvent 
they mentioned that can dissolve DPI to generate concentrations of stock solutions as 
high as the one prepared here (i.e. 15.9 mM) was DMSO. Second, when we thawed this 
concentrated solution of DPI (15.9 mM) (which we were still keeping it) it gave the 
distinctive odour of DMSO. Assuming this was DMSO, this means that in the viability 
experiments  where  DPI  was  tried  (it  was  always  tried  at  100  nM)  the  DMSO 
concentration present in the treatment solution applied to cells was in the micromolar 
range. This is unlikely to have an effect, since DMSO used at 20 mM against the same 
toxicity insults that DPI was protective against them had no effect (Results section; Fig. 
3-66 and Fig. 3-67).  
Also, in a pilot experiment, new DPI powder was obtained from Sigma, and distilled 
water  was  used  to  dissolve  it.  In  agreement  to  the  supplier  instructions,  it  was  not 
possible to generate 15.9 mM, and a DPI stock solution of only 0.636 mM in distilled 
water was prepared. Using DPI diluted from this 0.636 mM stock solution in a pilot 
viability experiment at 100 nM produced substantial protection (in the morphological 
examination) against NADH / XO toxicity i.e. produced the same effect against NADH 
/ XO toxicity as DPI (100 nM) derived from the 15.9 mM concentrated solution. This 
substantial protection (observed in the morphological examination) in this pilot study 
was also observed when the experiment was repeated in the subsequent day (this is not 
n = 2, since n = 2 in the viability experiments in this project represents experiments 
repeated in two separate weeks) (no Alamar blue viability assay was performed for this 
pilot study).   
 
Notice: In viability experiments where NaOH was used in preparing the stock solutions 
of the test compounds, the levels of NaOH added to cultures (by adding the treatment 
solutions) do not exceed few hundreds micromolar concentrations in the majority of 
experiments. In few experiments, the level of NaOH added can be around 1 mM. In rare   52 
cases (only in two experiments:  Fig. 3-23 (the fourth treatment group) and Fig. 3-36 
(column  C))  there  will  be  around  2  mM  NaOH  added  in  the  treatment  solutions. 
However, adding MEM-HEPES-sol containing 2 mM NaOH to the cultures did not 
have any effect on the viability (data not shown).  
 
2.5 Using 96-well plates 
 
96-well plates allow for testing many treatment groups at the same time and under the 
same conditions (Fig. 2-1 shows a photo and a diagram of a 96-well plate). These plates 
were used for both of viability (cell-containing) and cell-free experiments. 
 
 
 
 
 
 
                       
                       
                       
                       
                       
                       
                       
                       
 
 
A 
B 
Figure 2-1: A photo and a diagram of a 96-well plate. A: A photo of a 96-well plate with its cover. 
B: A diagram of a 96-well plate. This diagram will be shown later in this thesis for many purposes. 
Notice that the surface of the wells is not square as it appears in the diagram, but it is actually round as 
it  appears  in  the  shown  photo,  but  will  be  shown  as  square  in  the  subsequent  diagrams  only  for 
convenience.    53 
2.6  Primary  cultures  of  cerebellar  granule  neurons 
(CGNs) 
 
Every set of cerebellar granule neurons (CGNs) cultures was prepared as follows: 
 
1-  Cerebella were isolated from 7- to 8-day old Sprague-Dawley rats (6-9 cerebella 
were used), cleared from meninges and blood vessels using forceps, chopped 
thoroughly by a blade to small pieces. 
2-  The chopped pieces were transferred to trypsin solution: 0.25 mg/ml in 20 ml of 
DPBS buffer solution (this buffer is a DPBS with the following added: albumin 
(3 mg/ml), glucose (2.5 mg/ml), and magnesium sulphate (0.382 mg/ml)), and 
incubated for 20 minutes at 37˚C.  
3-  To the same tube, an equal volume (20 ml) of a weak trypsin inhibitor solution 
(contains in the DPBS buffer solution: trypsin inhibitor (8 µg/ml) and DNAse I 
(8 Units/ml)) was added and the tube was centrifuged at 1200 RPM for two 
minutes. 
4-  The  supernatant  was  discarded  and  2  ml  of  a  concentrated  trypsin  inhibitor 
solution  (DPBS  buffer  solution  containing  trypsin  inhibitor  (50  µg/ml)  and 
DNAse I (50 Units/ml)) was added to the cell pellet. The cell suspension was 
triturated with three Pasteur glass pipettes with a decreasing pore size, 10 times 
each. 
5-  The  DPBS  buffer  solution  was  then  added  up  to  20  ml,  and  the  tube  was 
centrifuged again at 1200 RPM for two minutes. 
6-  The supernatant was discarded and 2 ml of fresh culture medium was added, and 
the same steps of trituration with Pasteur glass pipettes were repeated. 
7-  Fresh  culture  medium  was  then  added  up  to  20  ml.  This  dilution  of  cell 
suspension eases cell counting. 
8-  The cells in this suspension were counted under the microscope as follows: one 
drop of the suspension was added to a chamber of a haematocytometer slide and 
the slide was placed under the microscope. A 10x objective was selected, and 
the slide was moved so that the field seen is the central area of the grid. A large 
square will appear filling the field. This square contains 25 smaller squares, and 
each one of these 25 squares is bounded by three parallel lines. The number of 
cells was counted in 5 of these 25 squares. The number obtained was multiplied   54 
by 5 (to get the approximate number in the 25 squares). The number obtained is 
number of cells in a volume of 0.1 mm
3. This number was multiplied by 10000 
to give the number of cells in one cm
3 i.e. the number of cells in one ml.  
9-  The cell density in the cell suspension was adjusted (diluted) with fresh culture 
medium to give a cell density of 1 million cells / ml.  
10-  This adjusted cell suspension (which contains a density of 1 million cells / ml) 
was plated into 96-well plates (pre-coated with poly-D-lysine hydrobromide (50 
 g/ml)), where 100 µl of this cell suspension was added to each well (so each 
well contained 0.1 million cells).  
11-  The cultures were incubated at 37˚C and maintained in a humidified atmosphere 
under 5% CO2 / 95% air. 
12-  After 24 hours of plating, 10 µM of cytosine arabinoside was added to inhibit 
the growth of non-neuronal cells. 
13-  Viability experiments were performed at day 8 or 9 after plating. 
 
2.7 Experimental design of viability studies 
 
1- Experimental design of viability studies performed before solving the problem 
of fresh culture medium toxicity 
 
The exact experimental protocol will be stated for each experiment in the figures of the 
Results section. In general the design is as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The culture medium was replaced by treatment solution i.e. fresh culture 
medium that contains (test) or does not contain (control) the test compound(s) 
Neurons were maintained in the culture medium at day 8 or 9 
Neurons were restored (after aspirating the treatment solution) to fresh culture 
medium and left for 16-24 hr 
Alamar blue was added to the cultures at 10 % V/V in the medium and left for 4 
hr 
The optical density reading was taken on a plate reader   55 
2- Experimental design of viability studies performed after solving the problem of 
fresh culture medium toxicity 
 
The exact experimental protocol will be stated for each experiment in the figures of the 
Results section. In general the design is as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.8 Viability assay 
  
In each experiment, at the end of the treatment period, the cultures were restored to a 
culture medium and left for 16-24 hours. The viability status of the cultures was then 
assessed by measuring the reduction of the Alamar blue dye, added as 10 % V/V in the 
medium and left for 4 hr before taking the optical density (OD) reading on a plate 
reader.  The  principle  is  that  the  more  reduction  of  the  dye  is,  the  more  viable  the 
neurons are. The assay was performed according the instructions of the manufacturer. 
We will show here the steps of calculating the viability of the control and treatment 
groups. The steps will be shown using data obtained in a real experiment that will be 
shown later in the Results section (the experiment shown in Fig. 3-68 in the Results 
section):  
 
1-  The  optical  density  readings  for  the  culture  plate  wells  were  taken  at  two 
wavelengths, 540 and 595 nm. All included wells contained cells with Alamar 
The culture medium was replaced by treatment solution i.e. either HEPES-sol or 
MEM-HEPES-sol that contains (test) or does not contain (control) the test 
compound(s) 
Neurons were maintained in the culture medium at day 8 or 9 
Neurons were restored (after aspirating the treatment solution) to conditioned 
medium (not fresh culture medium) and left for 16-24 hr 
Alamar blue was added to the cultures at 10 % V/V in the medium and left for 4 
hr 
The optical density reading was taken on a plate reader   56 
blue added to them as 10% V/V in the culture medium, with the exception of 
two wells. One of these two wells contained only culture medium but did not 
contain either Alamar blue or cells (a blank well), and the other well contained 
culture medium that contained Alamar blue as 10% V/V but did not contain cells 
(see Fig. 2-2).  
2-  The reading taken at 540 nm of the well that contained only 10% Alamar blue 
(did not contain cells) was divided by the reading taken at 595 nm of the same 
well. The obtained number was called the factor. From Fig. 2-2, this factor was: 
0.191 / 0.479 = 0.399. 
3-  The following calculations were performed: the OD readings taken at 595 nm of 
the  wells  in  the  groups  were  averaged.  From  figure  2-2,  the  averaged  OD 
readings at 595 were: Control group = (0.285 + 0.276 + 0.267 + 0.273) ÷ 4 = 
0.275; First treatment group = (0.439 + 0.414 + 0.408 + 0.425) ÷ 4 = 0.422; 
Second treatment group = (0.353 + 0.356 + 0.338 + 0.362) ÷ 4 = 0.352. The 
average was also taken for OD readings taken at 540 nm for the wells in the 
groups. So, from Fig. 2-2, the averaged OD readings at 540 were: Control group 
= (0.342 + 0.338 + 0.34 + 0.347) ÷ 4 = 0.342; First treatment group = (0.251 + 
0.238 + 0.242 + 0.249) ÷ 4 = 0.245; Second treatment group = (0.294 + 0.282 + 
0.282 + 0.297) ÷ 4 = 0.289.  
4-  To obtain what is called the adjusted OD value for each group, the averaged OD 
reading taken at 595 nm for a group was multiplied by the factor obtained in step 
2. The obtained number was subtracted from the averaged OD reading taken at 
540 nm for the same group. The obtained number is the adjusted OD value for 
that group. So, the adjusted OD values for the groups were: Control group = 
0.342 - (0.275 × 0.399) = 0.232; First treatment group = 0.245 – (0.422 × 0.399) 
= 0.0766; Second treatment group = 0. 289 – (0.352 × 0.399) = 0.149.  
5-  By obtaining the adjusted OD values, the groups can now be compared with 
each other. Because we wanted to express the viability of each group as % of the 
control group, we considered the adjusted OD value of the control group to be 
100%, and we divided the adjusted OD of each treatment group by the adjusted 
OD value of the control group and then multiplied by 100 to get the viability 
value  expressed  as  %  of  the  control.  Therefore,  the  viabilities  of  the  groups 
were: Control = 100%, First treatment group = (0.0766 / 0.232) × 100 = 33%, 
Second treatment group = (0.149 / 0.232) × 100 = 64%.    57 
6-  The viability percents obtained in step 5 were those viabilities obtained in only 
one set of cultures (one week). Since we repeat each experiment using many sets 
of cultures (prepared in different weeks), we calculate the mean ± the standard 
error of mean (S.E.M) for the viabilities obtained in the different sets of cultures 
(i.e. obtained in the different weeks).  In the case of the experiment shown in the 
Figure 3-68 in the Results section, the legend of that figure indicated that n=5, 
which means that that experiment was repeated in 5 different weeks. The means 
± S.E.M of the viabilities obtained in the 5 different weeks for that experiment 
were: Control group = (100% + 100% + 100% + 100% +100%) ÷ 5 = 100% ± 
zero; First treatment group = (33% + 21% + 15% + 54% + 27%) ÷ 5 = 30%  ± 
6.7; Second treatment group = (64% + 40% + 40% + 89% + 44%) ÷ 5 = 55.4% 
± 9.5. Notice that the means ± S.E.M. obtained in this step are those shown in 
Figure 3-68 in the Results section. 
 
In addition to the Alamar blue assay, the viability status of the cultures was checked by 
observing the morphology of the neurons under the microscope (see the Results and 
Discussion sections for comments on the Alamar blue assay and references therein).  
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Figure 2-2: Diagram shows the Alamar blue OD readings at 540 and 595 nm for one set of an actual 
viability experiment. This is the reading in one of the 5 weeks in which we repeated the experiment shown in 
Figure 3-68 (see the Results section). The upper diagram of the plate shows the reading at 540 nm. The lower 
diagram is for the same plate but with the reading taken at 595 nm.    59 
2.9 Cell-free assays 
 
2.9.1 Cell-free detection of superoxide production 
 
Since superoxide is known to be directly produced by the X / XO and NADH / XO 
combinations  (see  Introduction),  it  was  of  interest  to  confirm  this  in  cell-free 
experiments.  These  cell-free  experiments  of  detecting  superoxide  production  also 
helped us answer many questions we faced during the progress of this project (please 
see the Results and Discussion sections). Two different cell-free detection methods of 
superoxide production were performed: 
 
1- Cytochrome c reduction 
 
The principle of this assay is that superoxide reduces the oxidized Cytochrome c in a 
SOD-inhibitable manner, where this reduction can be detected calorimetrically through 
observing the increase of Cytochrome c absorbance at 550 nm [McCord and Fridovich, 
1969]. Since hydrogen peroxide (which will be directly generated from XO and will also 
be produced by the spontaneous dismutation of superoxide) interferes with this method, 
catalase has to be present in the reaction mixture. Also, EDTA is usually added in the 
reaction  mixture  to  prevent  the  interference  of  metals  that  might  be  present  as 
contaminants.  In  this  assay,  the  blank  was  the  assay  solution  (HEPES-sol)  free  of 
reagents.   
 
Experiments in Fig. 3-46 and Fig. 3-47 were performed as follows: test cell-free wells 
contained the indicated treatment groups in HEPES-sol and left for 1 hr. After that, the 
optical density at 550 nm was recorded on a plate reader. Experiment in Fig. 3-51 was 
was performed as follows: test cell-free wells contained the indicated treatment groups 
and the optical density at 550 nm was recorded on a plate reader at the indicated time 
points. 
 
2- XTT reduction 
 
This is similar to Cytochrome c reduction method. Superoxide reduces XTT in a SOD-
inhibitable manner, where this reduction results in the release of an orange product   60 
(water soluble formazan) that can be detected calorimetrically through observing the 
increase of its absorbance at 450 nm (maximum absorption at 570 nm) [Ukeda et al., 
1997, Benov and Fridovich, 2002]. The advantage of this method is that, since hydrogen 
peroxide is unlikely to interfere with this method, catalase does not need to be added to 
the reaction mixture. In this assay, the blank was the reaction solution (HEPES-sol) free 
of reagents. 
 
Experiment in Fig. 3-48 was performed as follows: test cell-free wells contained the 
indicated treatment groups in HEPES-sol and left for 1 hr. After that, the optical density 
at 450 nm was recorded on a plate reader. Experiment in Fig. 3-50 was was performed 
as follows: test cell-free wells contained the indicated treatment groups and the optical 
density at 450 nm was recorded on a plate reader at the indicated time points. 
 
 
2.9.2 Cell-free detection of hydrogen peroxide production 
 
Since hydrogen peroxide is known to be directly produced by the X / XO and NADH / 
XO  combinations,  and  will  also  be  produced  by  the  spontaneous  dismutation  of 
superoxide  (see  Introduction),  we  were  interested  to  confirm  that  in  cell-free 
experiments.  These  cell-free  experiments  of  detecting  hydrogen  peroxide  production 
also helped us answer important questions we faced during the progress of this project 
(please see the Results and Discussion sections). 
 
It  is  observed  that  assay  for  hydrogen  peroxide  is  difficult  in  systems  that  contain 
NADH,  because  NADH  interferes  with  some  components  of  some  commonly  used 
assays  for  hydrogen  peroxide  [Rapoport  et  al.,  1994,  Votyakova  and  Reynolds,  2004]. 
Therefore, we used one of the few suitable detection methods [Rapoport et al., 1994], 
which is principled as follows: 
Catalase  converts  hydrogen  peroxide  to  water,  where  catalase  is  converted  in  this 
process to the so-called compound-1. Compound-1 can convert another molecule of 
hydrogen  peroxide  intro  water  plus  oxygen,  and  compound-1  in  this  process  is 
converted back to catalase. Alternatively, in the presence of a suitable substrate e.g. 
methanol,  compound-1  can  convert  (oxidize)  methanol  to  formaldehyde,  and 
compound-1 in this process is also converted back to catalase. So, catalase can work as   61 
a  peroxidase  i.e.  uses  hydrogen  peroxide  to  oxidize  some  molecules  e.g.  methanol. 
Hence, the production of formaldehyde from methanol is dependent on the presence of 
hydrogen peroxide. Formaldehyde can by detected calorimetrically by reacting it with 
Nash’s  reagent  [Nash,  1953],  producing  a  yellow  product  that  can  be  detected  by 
observing the increase of its absorbance over a wide spectrum range (400-450 nm) (we 
used 405 nm) (Fig. 2-3 shows a diagram for the principle of this assay). In this assay, 
the blank was the reaction solution (HEPES-sol) free of reagents plus an equal volume 
of Nash’s reagent.  
 
The experiments were performed as follows: test cell-free tubes contained the indicated 
treatment compounds in HEPES-sol and left for 1 hr. After that methanol (to get 5% 
V/V) and catalase (to get 100 Units/ml) were added to each of these tubes and left for 
10 minutes. After that an equal volume of Nash’s reagent (which contains the following 
(in distilled water): ammonium acetate (150 mg/ml), acetic acid (0.3% V/V), acetyl 
acetone (0.2% V/V)) was added to each of these tubes and left for 40 minutes. After 
that, the mixture solutions in the test tubes were aliquoted into a 96-well plate with each 
mixture  solution  (i.e.  treatment  group)  aliquoted  into  4  wells,  and  then  the  optical 
density at 405 nm were taken on a plate reader. The readings of the 4 well for each 
group were averaged, and this average was considered n=1. Each experiment is repeated 
in 3 different days, and hence the figures legends of these experiments state that n=3.  
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2.10 Statistical analysis 
 
-  Figures in the Results section show the mean values, where the error bars represent 
standard error of mean (S.E.M).  
-  If comparing one test group to the control group, a one sample t test was performed, 
where the mean of the test group was compared to a hypothetical mean of either 
100  or  zero  depending  on  the  expression  of  the  treatment  group.  So  when  we 
wanted to express the value of the test group as viability relative to group A (i.e. 
control)  (%),  then  the  hypothetical  mean  was  100.  On  the  other  hand,  when 
expressing the value of the test group as improvement in viability relative to group 
A (%), then the hypothetical mean was zero.  
-  If comparing more than one test group to the control group, a one-way ANOVA 
followed by Dunnette’s multiple comparisons was performed.  
Catalase 
Hydrogen 
peroxide 
Compound-1 
H2O  
methanol  formaldehyde 
Nash’s 
reagent 
Colour product 
Read optical 
density at 405 nm 
Figure 2-3: A diagram shows the principle of detecting hydrogen peroxide using 
catalase.   63 
-  To determine the differences among more than two groups including the control 
group, a one-way ANOVA followed by Tukey’s comparisons was performed.  
-  In the one experiment where only selected pairs of treatment groups were compared 
(Results  section,  Fig.  3-29),  a  one-way  ANOVA  followed  by  Bonferroni’s 
comparisons was performed. 
-  In  all  tests,  the  difference  between  two  groups  was  considered  significant  at  p 
≤0.05.  
-  The n number that will be shown later in the figures of the Results section differs 
depending on whether the experiment is a viability (cell-containing) or a cell-free 
experiment. In viability experiments, the n number is the number of sets of cultures 
in which the experiment was repeated. Since every set of cultures is prepared in a 
separate week, this means that n=5 for example means that the experiment was 
repeated 5 times using 5 sets of cultures prepared in 5 different weeks. In cell-free 
experiments, the n number is the number of times in which the experiment was 
repeated using reagents diluted from the thawed aliquots of the stock solutions at 
each time. Since each experiment is performed in a different day, this means that 
n=3 for example is the number of the different days in which the experiment was 
repeated using reagents diluted from the thawed aliquots of the stock solutions at 
each day.  
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3  Results 
 
3.1 Culturing and experimental conditions 
 
3.1.1 Morphology of the cultures 
 
The culturing process produced viable CGNs. Immediately after plating, the cells were 
round with no processes (Fig. 3-1). After 24 hours of plating, the cells showed extended 
processes, and tended to migrate and group with each other (Fig. 3-2). Also at this time, 
many cells appeared to be dead, even before addition of the cytosine arabinoside. After 
8 days in cultures, the cells showed the known characteristic morphology of cultured 
CGNs (Fig. 3-3).  
 
 
 
 
 
 
 
 
Figure 3-1: Morphology of the cultures immediately after plating. The cells look round with no 
processes. Scale bar = 50  m.    65 
 
 
 
 
 
 
 
 
 
Figure  3-2:  Morphology  of  the  cultures  24  hr  after  plating.    The  cells  began  to  show  extend 
processes (white arrows), and tended to group with each other. Also, many dead cells were evident 
(black arrows). This photo was taken before adding cytosine arabinoside. Scale bar = 50  m.    66 
  
 
 
 
 
3.1.2 Effect of the position in the plate on the viability of cultures 
 
In the initial stages of this project the neurons were plated into all wells in a 96-well 
plate (apart from the top left well and the well below it). After 8 days of plating, the 
neurons in the wells located at the edge of the plate (edge wells) (see Fig. 3-4) looked 
much stressed. The cultures in those wells did not look healthy and they contained a lot 
of debris. So, from the start of this project, the cultures in the edge wells were not 
included in the viability studies.  
 
 
 
 
 
 
Figure 3-3: Morphology of the cultures after 8 days of plating. Black large arrows = cell bodies. White 
large arrows = processes. Also notice that most of those cells that died in the first 24 hours of plating 
(shown in Fig. 3-2) seemed to have disappeared, though some are still remaining (white dashed small 
arrows).   Scale bar = 50  m. 
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In addition, since the cultures in the edge wells appeared much stressed, there was a 
possibility that the cultures in the wells located next to the edge wells (next-edge wells) 
(see Figures 3-4 and 3-5) were being affected by this effect, even though they did not 
appear to be stressed. So, an experiment was performed to compare the viability of the 
neurons in the next-edge wells with the viability of the neurons in the wells located 
inside the plate (inside wells) (see Figures 3-4 and 3-5). The result of this experiment is 
shown in Fig. 3-5.  
 
From the upper diagram in Fig. 3-5 it is clear that the wells in both of group A and 
group F are next-edge wells, whereas the wells in groups B, C, D, and E are inside 
wells. This experiment was designed in a way that all treatment groups (A-F) were 
manipulated exactly the same way, leaving the only difference between them is their 
position in the plate (see Fig. 3-5 for the exact treatment procedure).   
 
The  result  shows  that,  interestingly,  although  there  was  no  statistically  significant 
difference in the viability between group A and group F (the wells in these two groups 
are  next-edge  wells),  there  was  statistically  significant  difference  in  the  viability 
between any of the groups B, C, D, or E (the wells in these groups are inside wells) and 
group A (Fig. 3-5).  
 
 
 
 
Figure 3-4: Diagram of a 96-well plate showing edge, next-edge, and inside wells. 1) edge wells 
dotted with red = 36 wells; 2) next-edge wells dotted with blue = 28 wells; 3) inside wells dotted with 
green = 32 wells.    68 
 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
A B  C D E F
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
g
r
o
u
p
 
A
 
(
%
)
*
ns
*
**
*
 
 
 
 
 
 
 
                       
                       
                       
                       
                       
                       
                       
                       
Figure 3-5: The effect of the position in the plate on the viability of neurons. The upper diagram shows the 
position  of  each  group  (where  each  group  contained  4  wells)  in  the  96-well  plate.  The  experiment  was 
performed as follows: at day 8 or 9 after plating, culture medium was replaced by fresh culture medium and 
left for 1 hour (this was done to all groups) → the neurons were restored (after aspirating the fresh culture 
medium) to also fresh culture medium and left for 16-24 hours until the viability assay (this was done to all 
groups). So, the only difference between the groups was their position in the plate. This shows that neurons in 
next-edge wells (A & F) give slightly higher viability values than neurons in inside wells (B,C,D, and E). 
*p<0.05, **p<0.01, ns: not significant. (n=5). 
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Also  when  the  groups  in  the  plate  were  aligned  vertically,  there  was  a  statistically 
significant difference in the viability between any of the inside groups and the next-edge 
group (Fig. 3-6).  Importantly, there was no statistically significant difference when the 
viability of the inside groups were compared with each other (Fig. 3-6, see the note in 
the figure legend). 
 
Therefore, the results in Figures 3-5 and 3-6 show that the cultures in the next-edge 
wells give consistently slightly (around 10-15 %) higher viability values (measured by 
Alamar blue assay) compared to the cultures in the inside wells. Also, it was noticed 
that  this  was  reflected  in  the  morphology  of  neurons  seen  under  the  microscope. 
However, it was not possible to rely on the morphological examination in this case i.e. it 
was not possible to judge that, based on the morphological examination, the neurons in 
the next-edge group looked undoubtedly more viable than the neurons in the inside 
groups.  The  reason  is  that,  as  noticed  throughout  this  project,  the  morphological 
examination can be very helpful, and also very objective, only if the difference in the 
Alamar blue viability readings between two groups is high (≥ 20 %), in which case there 
will be observed in correlation a clear difference in the morphology of the neurons. On 
the  other  hand,  if  the  difference  in  the  Alamar  blue  readings  is  small  (as  in  this 
experiment) there will be no completely clear (although it can be noticed) difference in 
the morphology, and the examination under the microscope may result in a subjective 
judgment. So, in this case, it was not possible to decisively confirm the Alamar blue 
viability readings by the morphological examination. 
 
It should be noticed that this experiment was conducted before solving the problem of 
fresh  culture  medium  toxicity,  and  since  fresh  culture  medium  was  used  in  this 
experiment, the neurons were likely affected by glutamate (already present in the fresh 
culture medium) excitotoxicity (see Discussion for the implication of this fact).  
 
Since the difference in the viability reading between the next-edge group and any of the 
inside groups was statistically significant, and also since the difference in the viability 
of  the  inside  groups  (aligned  vertically)  when  compared  with  each  other  was  not 
statistically significant (Fig. 3-6), it was decided not to include cultures in the next-edge 
wells in the experiments conducted in the rest of this project, and only cultures in inside 
wells were included. Therefore, in the experiments conducted afterwards, the neurons 
were plated into only the inside wells, and a cell-free medium was added to both of the   70 
edge wells and next-edge wells. Also in the experiments conducted afterwards, it was 
decided to align the treatment groups vertically, where each group contained 4 wells, 
which means that it was possible to use maximum of 8 treatment groups with each 
group containing 4 wells (Fig. 3-7). 
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Figure 3-6: The effect of the position in the plate on the viability of neurons with the groups aligned 
vertically in the 96-well plate. The upper diagram shows the position of each group (where each group 
contained 4 wells) in the 96-well plate. The experiment was performed as follows: at day 8 or 9 after 
plating, the culture medium was replaced by fresh culture medium and left for 1 hour (this was done to all 
groups) → the neurons were restored (after aspirating the fresh culture medium) to also fresh culture 
medium and left for 16-24 hours until the viability assay (this was done to all groups). So, the only 
difference between the groups was their position in the plate. Note: there was no statistically significant 
difference when the viabilities of the inside groups (i.e. B, C, D, and E) were compared with each other. 
**p<0.01, ***p<0.001. (n=5).  
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3.1.3 Toxicity of fresh culture medium 
 
The biggest problem encountered with CGNs cultures in the early stage of this project 
was the severe and immediate damage to the neurons (including those in the control 
groups)  induced,  during  the  experimental  day  i.e.  day  8  or  9,  by  manipulating  the 
cultures (i.e. aspirating the culture medium, adding treatment and control vehicles, and 
adding restoration medium). Several months were spent before solving this problem, 
and it turned out that it was due to glutamate excitotoxicity (through activating its N-
methyl-D-aspartate (NMDA) receptors). The source of glutamate was the fresh serum 
(which we were unaware of its content of glutamate) which is present at 10% V/V in the 
fresh culture medium that is added to the cultures at that day.  Fresh culture medium 
addition occurred at the experimental day for two purposes; (i) as a vehicle that contains 
(treatment) or does not contain (control) the test compounds, and (ii) after that it is used 
as  the  restoration  medium  following  treatment.  Immediately  after  performing  the 
experiment in which we discovered the role of NMDA receptors, we found an early 
report in the literature which showed that an NMDA receptor-mediated action, likely 
through  the  activation  of  these  receptors  by  glutamate  already  present  in  the  fresh 
serum, is responsible for fresh serum toxicity in CGNs cultures [Schramm et al., 1990]. 
We had, therefore, reached the same conclusion independently. In this section, there 
Figure  3-7:  alignment  of  treatment  groups  in  the  viability  studies  that  were  performed  after 
finding  that  next-edge  group  gives  higher  viability  values  than  inside  groups.  So,  in  the 
experiments conducted afterwards, the neurons were being plated into only the inside wells (dotted in 
green), and cell-free medium was being added to both of the edge wells and next-edge wells (dotted in 
red). Also the treatment groups were being aligned vertically, as shown, where each group contained 4 
wells. Notice that both of the well at the left upper corner of the plate and the well below it were always 
left empty at the plating day (i.e. day zero) because they were needed for the viability assay at day 9 or 
10 (see Materials and Methods).   72 
will  be  shown  some  of  the  observations/experiments  that  either  led  eventually  to 
discovering the reason of fresh culture medium toxicity or were explained only after 
discovering that reason. After that, there will be shown another set of experiments that 
were conducted in order to add more proof to the conclusion that we and others reached. 
Notice that the experiments whose results are shown in this section (i.e. Section 3.1.3) 
were  performed  after  finding  that  the  neurons  in  next-edge  wells  give  consistently 
higher viability reading than neurons in inside wells, so in these experiments only inside 
wells were used, which gives more validity to their results.   
 
 
3.1.3.1 Was fresh culture medium responsible for the death? 
 
The culture medium did not seem to kill the neurons when they were maintained in it 
before the intervention day. Although there were many cells that died in the first 24 hr 
of plating, fresh culture medium used to plate the cultures at day zero was not suspected 
to cause this death for two reasons. Firstly, this culture medium is universally used to 
culture many types of cells including neurons, and there was no reason to suspect that it 
might be toxic. Secondly, it indeed did not kill the viable neurons when they were 
maintained in it from day 1 until the intervention day. 
 
This  was  the  reason  that  in  the  beginning  a  toxic  effect  of  the  added  fresh  culture 
medium was not suspected to cause the damage observed at the intervention day, where 
alternative explanations were explored at that time. One of the explanations explored 
was that, from day zero to the experiments day, the neurons release growth factors that 
in turn maintain their viability, where the neurons become dependent on those factors, 
and when the medium that the neurons are maintained in is aspirated at the experiments 
day, the neurons die due to growth factor withdrawal. However, it was not feasible to 
test this explanation in the context of this project. 
 
3.1.3.2 Previous projects 
 
A  strange  observation  was  that  the  damage  induced  to  the  cultures  at  the 
experiments/intervention day was severe in this project but not severe in two previous 
projects undertaken in this laboratory [Fatokun, 2006, Smith, 2008]. This turned out to be 
related to the cell density obtained after plating at day zero (higher in this project than in 
these previous two projects, see Discussion).     73 
3.1.3.3 Effect of pH 
 
 A reason for suspecting the fresh culture medium added at the experimental day as the 
reason for the seen cell death was the consistent observation that the damage tends to be 
more severe if this fresh culture medium was looking more pinkish i.e. more alkaline. 
The reason for the fresh culture medium getting alkaline is that this medium bottle was 
being opened many times (to take out the needed amount at each time), which was 
likely causing release of CO2 from the medium, and since bicarbonate (HCO3-) does not 
get released like CO2, this will result in the presence of more bicarbonate that is not 
balanced by CO2, which will result in the increase of the medium pH.  
  
To overcome this problem, a modification was performed by keeping the fresh culture 
medium in a vented cap flask i.e. permeable to gases (not a closed cap bottle as before) 
and keeping it in the incubator (not in the water bath as before). This meant that any 
CO2 that is released from medium by taking the flask out of the incubator (and opening 
the flask cap to take out the needed amount of medium) gets quickly replenished when 
the  flask  is  returned  to  the  incubator.  This  was  evident  by  the  observation  that  the 
medium  colour  (i.e.  Phenol  red  colour)  was  kept  constant  all  the  time  under  this 
modification. This resulted in considerable improvement in the viability of cultures and 
made it possible to conduct reproducible experiments. 
 
Despite the considerable improvement in the viability by the close adjustment of pH, 
the  problem  of  the  fresh  culture  medium  toxicity  added  at  the  experimental  day 
remained, and the damage was still severe. Also, there was an observation that was not 
possible to explain, which was that when a plate containing the cultures was placed 
outside the incubator for more than an hour, although this made the culture medium that 
the neurons were maintained in very pinkish (i.e. very alkaline) and although this also 
likely reduced the temperature of the cultures to the room temperature, this did not 
damage the neurons (at least there was no immediate damage observed). So, it seemed 
that although the increase in the pH per se (at day 8 or 9) of the culture medium that the 
neurons are maintained in does not kill the neurons, the increase in pH of the fresh 
culture medium added at that day potentiates its toxicity.  
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3.1.3.4 Effect of Ethanol and Dimethyl Sulfoxide (DMSO) 
 
 In parallel to the efforts to know the reason of cell death induced at the experimental 
day, there were also some experiments set out to study oxidative stress models that 
involved addition of different test compounds. Ethanol and dimethyl sulfoxide (DMSO) 
were used at some stage as hydroxyl radical scavengers, but it was necessary to check 
the effect of applying them alone to CGNs before testing them against any hydroxyl 
radical-producing insult. So the following experiments with ethanol and DMSO were 
not intentionally designed to investigate fresh culture medium toxicity. Surprisingly, 
instead  of  decreasing  the  viability  of  the  neurons  or  having  no  effects,  increasing 
concentrations of ethanol or DMSO tried alone (both added as V/V in fresh culture 
medium)  resulted  in  increased  improvement  in  cell  viability  i.e.  these  compounds 
attenuated the toxicity of the fresh culture medium. 
 
Ethanol at 1.5 % V/V attenuated the toxicity of fresh culture medium (Fig. 3-8). Notice 
that in this figure (and some other subsequent figures), the y axis is not the viability 
relative to group A (%), but is rather the improvement in viability relative to group A 
(%).  Since  there  will  be  no  improvement  in  viability  of  group  A  relative  to  itself, 
column A gives zero value, as shown (so, zero does not mean that the cultures in group 
A are completely dead). Although DMSO at 0.1 or 1% V/V had no effect on the toxicity 
of fresh culture medium (data not shown), DMSO at 5 or 10% V/V greatly attenuated 
the toxicity of fresh culture medium (Fig. 3-9).  
 
It  is  very  likely  that  the  attenuation  of  fresh  culture  medium  toxicity  by  these  two 
compounds was real and was not due to an artefact in the Alamar blue viability assay, 
for  many  reasons.  The  attenuation  of  the  toxicity  by  these  two  compounds  was 
undoubtedly  clear  in  the  morphological  examination  e.g.  when  Alamar  blue  assay 
indicated that ethanol protected at 1.5% V/V more than at 0.3% V/V, it was observed in 
correlation under the microscope that there was undoubtedly very little damage in the 
1.5% V/V group compared to the 0.3% V/V group, and that there was less damage in 
the 0.3% V/V group compared to the group where no ethanol was added (i.e. group A).  
Also, it is unlikely that Alamar blue was reacting with these compounds, since at the 
end of treatment period, the treatment medium that contained these compounds was 
aspirated and the neurons were restored to fresh culture medium for at least 16 hr of   75 
restoration period before adding Alamar blue.  It is even unlikely that Alamar blue was 
interfering  indirectly  with  these  compounds  through  interfering  with  their  delayed 
effects since the neuronal damage/morphology  seen under the microscope stabilized 
within 8 hr of the restoration period (and cells did not deteriorate or recover after that) 
i.e. the damage/morphology stabilized at least 8 hr before adding the Alamar blue.  
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Figure 3-8: Effect of ethanol on fresh culture medium toxicity. It shows that ethanol, probably 
through  blocking  NMDA  receptors,  protects  against  fresh  culture  medium  toxicity  in  a  dose 
dependent manner.  **p<0.01, ns: not significant.  (n=5).    76 
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3.1.3.5 NMDA receptors 
 
Because it was very likely that the serendipitously discovered protection of ethanol and 
DMSO against fresh culture medium toxicity was real and not due to an artefact in the 
Alamar blue assay, it was expected that if the reason(s) of their protective effect is 
revealed, this may lead to identifying and solving the problem of fresh culture medium 
toxicity. After searching out the literature, it was found that ethanol can block NMDA 
receptors in CGNs and some other types of neurons [Lin et al., 2003, Dildy and Leslie, 
1989, Lovinger et al., 1989, Cebere and Liljequist, 2003]. This effect of ethanol was shown 
Figure 3-9: Effect of DMSO on fresh culture medium toxicity. It shows that DMSO, probably through 
blocking NMDA receptors, protects substantially against fresh culture medium toxicity. **p<0.01. (n=3).  
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to inhibit the toxicity of NMDA [Danysz et al., 1992, Cebere and Liljequist, 2003].  It was 
also found in the literature that DMSO prevents both the action and excitotoxicity of 
glutamate  in  hippocampal  neuronal  cultures  in  a  dose  dependent  manner  [Lu  and 
Mattson, 2001]. Therefore, a specific NMDA receptor blocker, MK-801 (20  M), was 
tried and found to provide substantial protection against fresh culture medium toxicity 
(Fig. 3-10), which was  also reflected in the morphological examination (Fig. 3-11). 
Also  MK-801  at  a  very  low  concentration  (20  nM)  provided  large  and  statistically 
significant protection (improvement in viability relative to the viability in the absence of 
MK-801 was 59.4% ±10.1, p<0.05, n = 4).  
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Figure 3-10: Effect of MK-801 on fresh culture medium toxicity. It shows that MK-801, a 
specific NMDA receptor blocker, blocks fresh culture medium toxicity. **p<0.01. (n=5).    78 
 
 
 
 
 
Figure 3-11: Photos of CGNs showing protection by MK-801 against fresh culture medium toxicity. A: CGNs 
culture not subjected to any intervention (i.e. were not touched). All areas in wells in this group were as healthy as 
the shown area. B: CGNs cultures exposed to fresh culture medium at day 8 after plating: severe damage to the cell 
bodies and processes is evident. Notice that there were still some viable cell bodies. There were some areas in the 
wells (not shown) (around 20-30 % of the areas) in this group that were healthy (not damaged like the shown area). 
C: CGNs cultures exposed to fresh culture medium at day 8 after plating but with MK-801 (20  M) added. All 
areas in wells in this group were as healthy as the shown area. Scale bar = 50  m. For the experimental design, see 
Fig. 3-10. 
 
A 
B 
C   79 
As  mentioned  at  the  beginning  of  this  section,  this  role  of  NMDA  receptors  was 
discovered  before  finding  that  Schramm  and  co-workers  (1990)  reached  a  similar 
conclusion. In the following series of experiments, more proof is added. 
 
3.1.3.6 Kynurenic acid 
 
In addition to MK-801, another blocker of NMDA receptors, kynurenic acid, was tried. 
Kynurenic acid is an endogenous metabolite known to block NMDA receptors [Perkins 
and Stone, 1982, Fatokun et al., 2008b], and although this effect is relatively weak in cell 
cultures [Hilmas et al., 2001], the mechanism of blocking NMDA receptors by kynurenic 
acid is somewhat different from that of MK-801 [Fatokun et al., 2008b]. Thus it was 
useful to try it to see if protection against fresh culture medium toxicity can be provided 
by two different ways of blocking NMDA receptors. When tried, it provided protection 
in a dose dependent manner (Fig. 3-12). 
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Figure 3-12: Effect of kynurenic acid (KA) on fresh culture medium toxicity. It shows that KA, a 
blocker of the NMDA receptors, protects against fresh culture medium toxicity in a dose dependent 
manner. **p<0.01, ns: not significant. (n=4). 
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3.1.3.7 Glutamic-pyruvic transaminase 
 
It  was  thought  that  if  glutamate  already  present  in  the  fresh  culture  medium  was 
responsible for its toxicity, then degrading glutamate should prevent the toxicity. When 
tried, a glutamate degrading enzyme, glutamic-pyruvic transaminase [Matthews et al., 
2000], provided substantial protection (Fig. 3-13). Likely because this enzyme requires 
its other substrate, pyruvate, the enzyme alone (or pyruvate alone) was not protective, 
and  the  protection  was  provided  only  in  the  presence  of  both  of  the  enzyme  and 
pyruvate (Fig. 3-13). In this experiment, the treatment period (24 hr) was immediately 
followed by the viability assay i.e. there was no restoration period. This was done to 
avoid, after degrading  glutamate, exposing the  neurons before the viability assay to 
fresh culture medium (which contains glutamate). Since Alamar blue is always added to 
the medium around neurons, this experimental design (it does not apply to the other 
experiments) means that Alamar blue was present together with the test compounds (the 
enzyme and pyruvate). However, it is unlikely that the protection by this enzyme was 
due to an artefact due to interaction between Alamar blue and the enzyme (or pyruvate), 
for  two  reasons.  First,  the  substantial  protection  by  the  enzyme  was  undoubtedly 
reflected in the morphological examination of the neurons (long before adding Alamar 
blue). Secondly, the enzyme alone or pyruvate alone did not show significant difference 
in the Alamar blue reading compared to its reading in their absence (Fig. 3-13).   
   81 
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3.1.3.8 Protection by pre-treatment with reduced amount of fresh culture medium 
 
Since acute pre-treatment (minutes/hours) with a subtoxic concentration of glutamate in 
CGNs  is  known  to  protect  against  a  subsequent  lethal  exposure  to  glutamate  itself 
[Marini  and  Paul,  1992]  (acute  preconditioning  effect),  and  since  the  fresh  culture 
medium used here contains glutamate, it was sought to see if pre-treatment with reduced 
amount  of  fresh  culture  medium  protects  against  a  subsequent  exposure  to  a  lethal 
amount (full amount) of fresh culture medium itself, which can add more proof to the 
Figure 3-13: Effect of glutamic-pyruvic transaminase on fresh culture medium toxicity. It shows 
that degrading glutamate by this enzyme substantially protects against fresh culture medium toxicity. 
It also shows that pyruvate is a required co-substrate for the enzyme to degrade glutamate. **p<0.01, 
ns: not significant. (n=5). 
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conclusion that glutamate already present in fresh culture medium is responsible for its 
toxicity. Interestingly, this was found to be the case (Fig. 3-14).  
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Figure 3-14: Effect of pre-treatment with reduced amount of fresh culture medium on the toxicity 
of a full amount of fresh culture medium itself.  It shows that as the amount of fresh culture medium 
added as pre-treatment is reduced  more and  more, the protection against a subsequent lethal (full) 
mount of fresh culture medium increases.  **p<0.01, ns: not significant. (n=5).  
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3.1.3.9 Further investigation 
 
The experiment shown below in Fig. 3-15 shows many things at once (notice that the y 
axis in this figure shows the viability relative to group A (%) (and not the improvement 
in  viability  relative  to  group  A  (%)).  It  shows  that  physical  intervention  (through 
aspirating and replacing solutions) per se does  not kill the neurons, evident by that 
groups B and C which were subjected to physical interventions (but did not contain 
fresh  culture  medium)  gave  the  same  viability  values  as  group  A  which  was  not 
subjected to any physical intervention (i.e. was not touched). Therefore, fresh culture 
medium  (in  particular  glutamate  already  present  in  it)  seems  to  be  required  for  the 
neurons to die (group D). This figure also shows that 1 hr as an exposure time is enough 
for the fresh culture medium to cause significant toxicity (group D, notice that after 1 hr 
exposure, the fresh culture medium was replaced by conditioned medium). Also, it is 
clear  from  groups  B  and  C  that  restoring  the  neurons  to  conditioned  medium  (see 
Materials and Methods) does not cause toxicity. This was an important finding, and in 
all the subsequent viability experiments in this project, the neurons were restored to 
conditioned medium at the end of the treatment period.  
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3.1.3.10 Externally added glutamate 
 
Taking together, all the above experiments (in section 3.1.3) build strong evidence that 
glutamate already present in fresh culture medium was responsible, through activating 
NMDA receptors, for this medium toxicity at the intervention day. The last experiment 
performed  in  order  to  add  more  proof  to  this  conclusion  was  externally  applying 
glutamate to the neurons, which was also a necessary experiment to show that these 
CGNs are indeed susceptible to glutamate excitotoxicity.  When glutamate (300  M) 
was applied in a glutamate-free solution (MEM-HEPES-sol) for only 1 hr, it caused 
significant toxicity to the neurons (Fig. 3-16). Notice that MEM-HEPES-sol does not 
contain serum, which means that glutamate does not require co-application of serum for 
Figure 3-15: Further investigation of fresh culture medium toxicity. See explanation in the text. 
**p<0.01, ns: not significant. (n=5). 
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its toxicity (although serum can potentiate its toxicity as was shown in a previous report 
[Eimerl and Schramm, 1991]). There was also toxicity when the experiment was repeated 
but with glutamate applied at 10 times lower concentration i.e. 30  M (Mean viability 
was 70.8% ± 5 of the viability in the absence of glutamate. p<0.05, n = 4).  
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Figure 3-16: Toxicity of externally added glutamate. It shows that glutamate when applied in 
glutamate-free  and  serum-free  medium  for  only  1  hr  can  cause  significant  toxicity  to  CGNs. 
***p<0.001. ( n=5).  
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3.2  Oxidative  stress  experiments  performed  before 
solving the problem of fresh culture medium toxicity 
 
The experiments that will be shown in this section were performed before solving the 
problem  of  fresh  culture  medium  toxicity,  which  means  that  the  cultures  (including 
those in the control groups) were under the influence of glutamate excitotoxicity. Also, 
some of these experiments were performed before finding that the neurons in next-edge 
wells  give  consistently  slightly  higher  viability  readings  than  the  neurons  in  inside 
wells, so some of the treatment groups in these experiments contained next-edge wells. 
For  these  two  reasons,  it  will  be  hard  to  interpret  the  results  of  these  experiments. 
However, it was appropriate to show some of those experiments (performed in that 
period) that were consistent and provided some valuable information.  
 
3.2.1 Examining the susceptibility of CGNs to oxidative stress insults 
 
 In the beginning it was appropriate to examine the susceptibility of CGNs to different 
types of oxidative stress insults. 
 
3.2.1.1 Dose response curve of hydrogen peroxide toxicity 
 
When externally applied to CGNs, hydrogen peroxide showed a dose dependent toxicity 
(Figure 3-17). 
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3.2.1.2 Toxicity of the combination of xanthine and xanthine oxidase (X / XO) 
 
The  X  /  XO  combination  is  known  to  directly  generate  superoxide  and  hydrogen 
peroxide, and this type of insult is known to cause damage to many types of cells (see 
Introduction). An experiment was performed to determine the best combination of X 
and  XO  that  gives  consistent  and  significant  toxicity  levels,  which  can  be  used  in 
subsequent  experiments  that  use  X  /  XO  as  a  toxicity  model.  It  was  found  that  a 
combination of X (100  M) and XO (0.02 Units/ml) was the best (Fig. 3-18).  
 
 
 
Figure 3-17: Dose response curve of hydrogen peroxide toxicity. The experiment was performed as 
follows: at day 8 or 9 after plating, the culture medium was replaced by fresh culture medium that does 
not contain (control) or contains hydrogen peroxide at the indicated concentrations, and left for 1 hour 
→ the neurons in all groups (including control) were restored to fresh culture medium and left for 16-24 
hours until the viability assay. Notice: all treatment groups showed statistically significant difference 
when compared to the control group. (n=5). 
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3.2.1.3 Toxicity of S-Nitroso-N-acetyl-DL-penicillamine (SNAP) 
 
Nitric oxide is a free radical that can exert damaging effects under some conditions. 
Therefore, in this experiment a nitric oxide donor, SNAP, was tried to see if CGNs are 
susceptible to this type of oxidative stress insult. SNAP treated for 24 hr showed a dose 
dependent toxicity (Fig. 3-19).  However, it may be that this effect of SNAP was not 
due to providing nitric oxide. The reason is that the SNAP powder was dissolved in 
distilled water and the aliquots of the solution kept in a freezer until the experiment day. 
If  SNAP  in  solution  instantly  generates  nitric  oxide  (as  expected),  this  raises  the 
possibility that the nitric oxide, which is a short lived free radical, generated would have 
been  long  degraded  before  the  experiment  day.  A  better  way  would  have  been  to 
dissolve SNAP powder and then add it to the cultures instantly (see Discussion for 
possible explanations for the toxicity observed with SNAP).  
 
 
 
 
 
Figure 3-18: Toxicity of X / XO combinations. The experiment was performed as follows: at day 8 
or 9 after plating, the culture medium was replaced by fresh culture medium that does not contain 
(control) or contains X / XO combinations at the indicated concentrations, and left for 1 hour → the 
neurons in all groups (including control) were restored to fresh culture medium and left for 16-24 
hours until the viability assay.  *p<0.05 compared to control, **p<0.01 compared to control. (n=4). 
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3.2.2 Effect of different antioxidants on the toxicity of oxidative stress 
insults 
 
After establishing the susceptibility of the CGNs culture to different types of oxidative 
stress insults, it was appropriate to examine the effect of different antioxidants on these 
insults. 
 
 
 
 
Figure 3-19: Dose response curve of SNAP toxicity. *p<0.05, **p<0.01, ns: not significant. (n=3).  
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3.2.2.1 Antioxidants against hydrogen peroxide 
 
Since  hydrogen  peroxide  can  exert  its  toxicity  through  its  conversion  to  the  very 
reactive and toxic hydroxyl radical, and since this conversion can be mediated by a 
metal  (usually  iron  or  copper)  (see  Introduction),  the  effect  of  an  iron  chelator  on 
hydrogen  peroxide  toxicity  was  examined.  Deferoxamine  (deferox.)  (also  called 
desferrioxamine) is an iron chelator with high affinity for the oxidized form of iron i.e. 
Fe
3+ [Keberle, 1964]. Deferoxamine alone had no statistically significant effect on cell 
viability  (Fig.  3-20),  but  showed  substantial  protection  against  hydrogen  peroxide 
toxicity (Fig. 3-21). In this experiment, deferoxamine was present one hour before and 
also during the one hour treatment with hydrogen peroxide.   
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Figure 3-20: Effect of deferoxamine (deferox.) alone on cell viability. It shows that this iron 
chelator added alone has no significant effect on the neuronal viability. ns: not significant. (n=3).    91 
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This  result  of  deferoxamine  suggests  that,  without  excluding  other  possibilities,  the 
toxicity of hydrogen peroxide was due to its interaction with an iron ion to produce the 
toxic hydroxyl radical. To test the possibility of hydroxyl radical involvement, one of its 
known  scavengers,  mannitol [Babbs  and  Griffin,  1989],  was  tried.  Although  mannitol 
alone at 1 and 10 mM has no effect on cell viability, mannitol alone at 100 mM showed 
slight but statistically significant toxicity to CGNs cultures (data not shown). When 
mannitol was tried at 1 or 10 mM, it did not protect against hydrogen peroxide toxicity 
(Fig. 3-22). Although the failure of mannitol to protect can be explained by the lack of a 
role  of  hydroxyl  radical  in  hydrogen  peroxide  toxicity,  there  are  many  alternative 
explanations (see Discussion).  
Figure 3-21: Effect of deferoxamine (deferox.) on the toxicity of hydrogen peroxide. It shows 
that  this  iron  chelator  substantially  protects  against  hydrogen  peroxide  toxicity.  Notice  that 
deferoxamine was present 1 hr before and also during the 1 hr application of hydrogen peroxide. 
***p<0.001. (n=5).  
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3.2.2.2 Antioxidants against X / XO toxicity 
 
Since,  as  mentioned  earlier,  X  /  XO  can  directly  generate  hydrogen  peroxide  and 
superoxide, catalase (Cat.) and SOD-1 were tried against this type of toxicity. Catalase 
showed almost complete protection, but SOD-1 failed to show statistically significant 
protection. Also, since as mentioned in the Introduction that blocking either the site of 
X binding or the site of NADH binding on XO prevents the oxidation of X by XO, 
allopurinol (a blocker of the X binding site, the Mo site) and DPI (a blocker of the 
NADH binding site, the FAD site) were tried against X / XO toxicity, but they failed to 
show statistically significant protection. The effects of catalase, SOD, allopurinol, and 
DPI against X / XO toxicity are shown in Fig. 3-23. Catalase, SOD, allopurinol, and 
Figure 3-22: Effect of mannitol on the toxicity of hydrogen peroxide.  It shows that this hydroxyl 
radical scavenger could not protect against hydrogen peroxide toxicity. ns: not significant. (n=3).  
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DPI had no effect on cell viability when tested alone at the used concentrations and time 
interval (data not shown).  
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Since catalase showed almost complete protection, this suggests that hydrogen peroxide 
is a main toxic molecule responsible for X / XO toxicity, which makes this toxicity 
model somehow similar to the toxicity model of externally applying hydrogen peroxide. 
Since deferoxamine was protective against externally applied hydrogen peroxide, it was 
tried against X / XO toxicity. Deferoxamine at the concentration (and incubation time) 
that was very  protective against  externally  applied hydrogen peroxide did not show 
protection against X (100  M) / XO toxicity (Fig. 3-24). However, when X was used at 
30  M instead of 100  M, deferoxamine showed a statistically significant protection 
against X / XO toxicity (Fig. 3-25), suggesting that deferoxamine did not protect in the 
experiment shown in Fig. 3-24 because the toxic insult was too severe for it to provide 
significant protection.  
Figure 3-23: Effect of different antioxidants on X / XO toxicity. It shows that catalase, likely 
through  deactivating  hydrogen  peroxide,  protects  almost  completely  against  X  /  XO  toxicity.  
Although SOD-1 (deactivator of superoxide), allopurinol (blocker of the Mo site on XO), and DPI 
(blocker  of  the  FAD  site  on  XO)  seemed  to  protect  against  this  toxicity,  their  effects  were  not 
statistically significant. The experiment was performed as follows: at day 8 or 9 after plating, the 
culture medium was replaced by fresh culture medium that does not contain (control) or contains the 
indicated test compounds, and left for 1 hour → the neurons in all groups (including control) were 
restored to fresh culture medium and left for 16-24 hours until the viability assay. ***p<0.001, ns: 
not significant. (n=5). 
   94 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
A B C
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
 
(
%
)
Neurons maintained in 
culture medium at day 8 or 9
Half of culture medium 
replaced by fresh culture 
medium
Above solution 
replaced by fresh 
culture medium 
Same as in A
Same as in A 
Same as in A but fresh 
culture medium 
contains: X (100 µM) / XO 
(0.02 Units/ml)
Same as in A
1 hr
16-24
hr 
(restorati-
on period)
ns
Above solution replaced by 
fresh culture medium
Same as in A Same as in A
4 
hr
Same as in A but the fresh 
culture medium contains: 
deferox. (2 mM) (so the 
final concentration in the 
wells will be 1 mM)
1 hr
Viability assay Same as in A Same as in A
(Control)
Same as in A but fresh 
culture medium contains: X 
(100 µM) / XO (0.02 Units/ml) 
+ deferox. (1 mM) 
 
 
 
 
 
Figure 3-24: Effect of deferoxamine (deferox., 1mM) on the toxicity of X (100  M) / XO. It 
shows that deferoxamine, at the concentration and incubation time that was very protective against 
externally  applied  hydrogen  peroxide,  could  not  protect  against  this  toxicity  level  of  X  /  XO 
combination. ns: not significant. (n=5).  
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Because deferoxamine is thought to be slow in getting inside the cells [Porter et al., 
1988], the time of its pre-treatment (that was 1 hr in the experiments shown in Figures 3-
24 and 3-25) was increased to see if more protection can be obtained with prolonged 
pre-treatment. A side experiment showed that although deferoxamine at 300  M applied 
alone to the neurons for 6 hr had no effect on the neurons, deferoxamine at 1 mM 
applied  the  same  way  showed  slight  but  statistically  significant  toxicity  to  CGNs 
cultures (Fig. 3-26).  Therefore, it was decided not to try prolonged pre-treatment with 1 
mM deferoxamine against X / XO toxicity, and a prolonged pre-treatment with 300  M 
deferoxamine against this toxicity was tried instead. With 6 hr pre-treatment (in addition 
to the 1 hr co-treatment), deferoxamine at 300  M protected against X (100  M) / XO 
Figure 3-25: Effect of deferoxamine (deferox., 1 mM) on the toxicity of X (30  M) / XO. It shows 
that when the toxicity level of X / XO (that was shown in Fig. 3-24) was reduced i.e. X was used at 
30 instead of 100  M, deferoxamine was able to protect against this toxicity. *p<0.05. (n=5).  
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(0.02 Units/ml) toxicity (Fig. 3-27). Notice that with only 1 hr pre-treatment (in addition 
to 1 hr co-treatment), deferoxamine at even 1 mM could not protect significantly against 
X (100  M) / XO (0.02 Units/ml) toxicity (see again Fig. 3-24). This suggests that 
prolonged pre-treatment may bring more protection with deferoxamine, and this also 
suggests that the site of deferoxamine action is intracellular. Moreover, with 6 hr pre-
treatment (in addition to 1 hr co-treatment), deferoxamine at 300  M protected even 
more against X / XO toxicity when the toxic insult concentration was reduced i.e. when 
X concentration was reduced from 100  M to 30  M (Fig. 3-28).  
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Figure 3-26: Effect of prolonged application of deferoxamine (deferox.) alone on cell viability. 
*p<0.05, ns: not significant. (n=3).  
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Figure  3-27:  Effect  of  prolonged  pre-treatment  (in  addition  to  the  1  hr  co-treatment)  of 
deferoxamine (deferox., 300  M) on the toxicity of X (100  M) / XO. It shows that by increasing 
its pre-treatment time up to 6 hr, deferoxamine at 300  M was able to attenuate a toxicity level of X / 
XO that was not significantly attenuated by only 1 hr pre-treatment with deferoxamine at even 1 mM 
(see again Fig. 3-24).  **p<0.01. (n=5).  
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Figure  3-28:  Effect  of  prolonged  pre-treatment  (in  addition  to  the  1  hr  co-treatment)  of 
deferoxamine (300  M) on the toxicity of X (30  M) / XO. It shows that with both increasing  
the pre-treatment time up to 6 hr and reducing the toxic insult from X (100  M) / XO to X (30  M) 
/ XO, deferoxamine brings even more and more protection. ***p<0.001. ( n=5).  
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3.3  Oxidative  stress  experiments  performed  after 
solving the problem of fresh culture medium toxicity 
 
After solving the problem of fresh culture medium toxicity, it was possible to conduct 
reliable experiments. In this stage of the project, it was possible to answer many of the 
questions stated earlier in the section on the Aim/Objectives in the Introduction. This 
section is divided into two main sections, the first is a comparison between X / XO and 
NADH / XO toxicities, and the second is a further investigation of X / XO toxicity. 
  
In this stage, the solution used as a vehicle to add the compounds is (instead of fresh 
culture  medium)  a  serum-free  solution:  either  HEPES-sol  or  MEM-HEPES-sol.,  in 
order to avoid the excitotoxicity of fresh culture medium. There were two main reasons 
for trying two rather than only one serum-free solution as the treatment solution. First, 
obtaining the same effect of a compound by using two different treatment solutions adds 
more  validity  to  the  result  (there  were  some  cases  where  this  was  necessary,  see 
Discussion). Second, since NADH alone at 2 mM was toxic in MEM-HEPES-sol (see 
later), this solution was not suitable for experiments in which there was investigation of 
the toxicity of XO / NADH (2 mM) combination. On the other hand, HEPES-sol was 
suitable for such experiments, since NADH alone at 2 mM was not toxic in this solution 
(see later).  
 
Notice also that in this stage of the project, the medium to which the neurons were 
restored  at  the  end  of  the  treatment  period  was  conditioned  medium  and  not  fresh 
culture medium, and this was also done to avoid the excitotoxicity of the latter.  
 
3.3.1 Experimental check on the Alamar blue assay 
 
As mentioned earlier, there was  good correlation between the Alamar  blue viability 
assay readings and the morphological examination under the microscope. Actually, this 
good correlation was the reason for believing that the protection of ethanol and DMSO 
against fresh culture medium toxicity was real and not due to an artefact in the Alamar 
blue viability assay, which led eventually to discovering the reason of fresh culture 
medium toxicity. Alamar blue was used previously in CGNs with an incubation time 
between 4-6 hr, where the viability results based on this incubation time were expected   100 
to accurately reflect the viability of the cells [White et al., 1996, Fatokun, 2006, Fatokun et 
al.,  2007b].    To  add  more  validity  to  the  assay,  4  and  6  hr  incubation  times  were 
compared, to see if there is a difference between them, and if so, which one is more 
suitable to be used. In this experiment, there were three groups: control group, insult 
group, and insult with a protective compound group. The result shows that there was no 
statistically significant difference between the viabilities calculated at 4 hr and 6 hr 
Alamar blue incubation times (Fig. 3-29).  
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3.3.2 Comparison between X / XO and NADH / XO toxicities 
 
Since,  as  mentioned  in  the  Introduction,  NADH  /  XO  toxicity  has  rarely  been 
investigated  previously  compared  to  X  /  XO  toxicity,  a  series  of  experiments  were 
conducted to compare these two toxicity models.  
 
Figure  3-29:  Comparison  between  viabilities  calculated  with  4  hr  and  6  hr  Alamar  blue 
incubation times. The experiment was performed as follows: at day 8 or 9 after plating, the culture 
medium was replaced by HEPES-sol that does not contain (control) or contains the test compounds 
(either an insult compound or an insult compound with a protective compound), and left for 1 hour → 
the neurons in all groups (including control) were restored to conditioned medium and left for 16-24 
hours → Alamar blue was added at 10% (V/V) and left for 4 hr → The Alamar blue readings were 
taken  on  a  plate  reader  and  the  cultures  were  immediately  returned  to  the  incubator  and  left  for 
additional  two  hours  →  The  Alamar  blue  readings  were  taken  again  on  the  plate  reader.  ns:  not 
significant.  (n=3). 
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3.3.2.1 Establishing the toxicities of the X / XO and NADH / XO combinations 
 
X was not toxic when tried alone in MEM-HEPES-sol at 30 or 100  M, and it was also 
not toxic when tried alone in HEPES-sol at 15 or 30  M (data not shown). NADH alone 
was not toxic when tried alone at 2 mM in HEPES-sol (see later on in Fig. 3-49). When 
tried in MEM-HEPES-sol, NADH alone was not toxic at 1 mM but was toxic at 2 mM 
(Fig. 3-30). XO was not toxic when tried alone at 0.02 Units/ml either in HEPES-sol 
(data not shown) or MEM-HEPES-sol (Fig. 3-31). 
 
The Combination of XO and NADH tried in MEM-HEPES-sol was toxic only when the 
concentration  of  NADH  was  raised  up  to  1  mM  (Fig.  3-31).    Also,  when  tried  in 
HEPES-sol, the combination of XO and NADH was toxic when NADH was used at 1 
mM (see for example Fig. 3-33), 1.5 mM (see later on in Fig. 3-62), or 2 mM (see later 
on  in  Fig.  3-43  and  Fig.  3-54).  It  is  noticed  that  the  toxicity  of  the  NADH  /  XO 
combination tends to be more severe in HEPES-sol compared to MEM-HEPES-sol, 
though (as mentioned) NADH alone at 2 mM was toxic in MEM-HEPES-sol but was 
not toxic in HEPES-sol.   102 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
A B C
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
 
(
%
)
Neurons maintained in 
culture medium at day 8 or 9
Culture medium 
replaced by MEM-
HEPES-sol
Nuerons restored 
to conditioned 
medium
Same as in A
Same as in A but the 
MEM-HEPES-sol contains: 
NADH (1 mM)
Same as in A Same as in A
Same as in A
1 hr
16-24
hr 
ns
*
Same as in A but the 
MEM-HEPES-sol 
contains: NADH (2 mM)
Viability assay Same as in A Same as in A 4 
hr
(Control)
 
 
 
 
In MEM-HEPES-sol, the combinations of XO and X were toxic at X concentrations 
much lower than NADH, which is in agreement with previous cell-free experiments that 
showed that NADH is a much weaker substrate than X for bovine milk XO [Gilbert, 
1963, Liochev et al., 1989, Nakamura, 1991].  The X / XO combinations were toxic when 
X was used at either 30 or 100  M. Although these results were consistent throughout 
the months, there were some variations. For example, in some cases the toxicity of X 
(100  M) / XO (0.02 Units/ml) gave a lower toxicity level (see for example Fig. 3-36) 
than the toxicity level of X (30  M) / XO (0.02 Units/ml) combination (see for example 
Fig.  3-42)  despite  the  fact  that  all  treatment  conditions  (apart  from  the  lower  X 
concentration  in  the  latter)  were  the  same  in  the  two  experiments.  However,  this 
observed variation was usually between experiments, not within them, so it should not 
Figure 3-30: Effect of NADH alone on cell viability when applied in MEM-HEPES-sol. *p<0.05, 
ns: not significant. (n=5).  
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affect the validity of the comparisons between groups within an experiment. Also this 
observed variation between experiments was usually between those experiments where 
one experiment was conducted several months after completing the other (i.e. separated 
by wide intervals during the year).  
 
On  the  other  hand,  when  tried  in  HEPES-sol,  two  things  were  noticed  about  the 
toxicities of X / XO combinations. First, these toxicities were more consistent than the 
toxicities  of  X  /  XO  combinations  tried  in  MEM-HEPES-sol  e.g.  in  HEPES-sol,  a 
combination of X (15  M) / XO (0.02 Units/ml) always produced a consistent toxicity 
level between 50 and 75% cell damage (see all figures where this combination was used 
at this concentration in HEPES-sol). Second, the toxicity of these combinations tended 
always to be more severe than when tried in MEM-HEPES-sol e.g. as mentioned above, 
the  cell  damage  induced  by  only  X  (15   M)  /  XO  (0.02  Units/ml)  combination  in 
HEPES-sol was never less than 50%. 
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Figure  3-31:  Dose  response  of  NADH  /  XO  toxicity  in  MEM-HEPES-sol.  The  experiment  was 
performed as follows: at day 8 or 9 after plating, the culture medium was replaced by MEM-HEPES-sol 
that does not contain (control) or contains the indicated test compounds, and left for 1 hour → the 
neurons in all groups (including control) were restored to conditioned medium and left for 16-24 hours 
until the viability assay. **p<0.01, ns: not significant. (n=5). 
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3.3.2.2 Effects of using XO inhibitors on X / XO and NADH / XO toxicities 
 
There are two blockable sites on XO, the X binding site (the Mo site) and the NADH 
binding  site  (the  FAD  site)  (see  Introduction).  The  main  point  behind  trying  XO 
inhibitors was, using viability studies, to reproduce previous cell-free experiments that 
showed that blocking the Mo site does not prevent NADH oxidation, which may have 
important implications in interpreting the results of studies that sought a role of XOR in 
some diseases. The other point behind using the enzyme inhibitors was to prove that the 
toxicity of X / XO and NADH / XO combinations was indeed due to the enzymatic 
oxidation of the substrates and not merely due to non-specific interactions between the 
substrates and the enzyme.  
 
Allopurinol (100  M), a blocker of the Mo site on XO, when tried in MEM-HEPES-sol, 
failed to prevent NADH / XO toxicity (Fig. 3-32). This failure of allopurinol was also 
obtained when the experiment was repeated using HEPES-sol instead of MEM-HEPES-
sol (Fig. 3-33). Allopurinol alone was not toxic either in MEM-HEPES-sol or HEPES-
sol (data not shown). 
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Figure 3-32: Effect of allopurinol on the toxicity of NADH / XO combination in MEM-HEPES-
sol.  It  shows  that  blocking  the  Mo  site  on  XO  does  not  prevent  NADH  /  XO  toxicity.  ns:  not 
significant. (n=5).  
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On the other hand, DPI (100 nM), a blocker of the FAD site on XO, when tried in 
MEM-HEPES-sol, prevented the toxicity of the NADH / XO combination (Fig. 3-34), 
which is expected since blocking this site does indeed prevent NADH oxidation by XO 
(see Introduction). This protective effect of DPI was also obtained when the experiment 
was repeated using HEPES-sol instead of MEM-HEPES-sol (Fig. 3-35). DPI alone was 
not toxic either in MEM-HEPES-sol or HEPES-sol (data not shown).  
 
 
Figure 3-33: Effect of allopurinol on the toxicity of NADH / XO combination in HEPES-sol. It 
shows  that  also  when  the  experiment  was  carried  out  in  HEPES-sol  instead  of  MEM-HEPES-sol, 
allopurinol could not protect against NADH / XO toxicity. ns: not significant. (n=5).  
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Figure 3-34: Effect of DPI on the toxicity of NADH / XO combination in MEM-HEPES-sol.  It 
shows that blocking the FAD site on XO with DPI prevents NADH / XO toxicity. *p<0.05. (n=5).  
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The failure of allopurinol to prevent NADH / XO toxicity was not due to the failure of 
this compound to block the Mo site, since it was able to prevent the toxicity of the X / 
XO combination applied in either MEM-HEPES-sol (Fig. 3-36) or HEPES-sol (Fig. 3-
37).  
 
DPI when tried in MEM-HEPES-sol, failed to show statistically significant protection 
against X / XO toxicity (Fig. 3-38). However, when the experiment was repeated using 
HEPES-sol instead of MEM-HEPES-sol, DPI showed clear, substantial, and statistically 
significant protection against X / XO toxicity (Fig. 3-39).  
Figure 3-35: Effect of DPI on NADH / XO toxicity in HEPES-sol. It shows that also when the 
experiment was carried out in HEPES-sol instead of MEM-HEPES-sol, DPI protected against NADH 
/ XO toxicity. ***p<0.001. ( n=5).  
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Figure 3-36: Effect of allopurinol on X / XO toxicity in MEM-HEPES-sol.  It shows that blocking 
the Mo site on XO with allopurinol prevents X / XO toxicity. (n=5).  
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Figure 3-37: Effect of allopurinol on X / XO toxicity in HEPES-sol.  It shows that also when the 
experiment was carried out in HEPES-sol instead of MEM-HEPES-sol, allopurinol prevented X / XO 
toxicity. ***p<0.001. (n=5).  
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Figure 3-38: Effect of DPI on X / XO toxicity in MEM-HEPES-sol. It shows that blocking the 
FAD site on XO with DPI, although tended to produce protection against the toxicity of X / XO 
combination applied in this treatment solution, could not produce statistically significant protection. 
ns: not significant.  (n=5).  
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3.3.2.3 Effects of SOD against X / XO and NADH / XO toxicities 
 
Since superoxide is known to be directly generated from X / XO and NADH / XO 
combinations (see Introduction), these two systems of toxicity were compared in their 
responses to treatment with SOD-1 (Copper,Zinc-SOD) (which deactivates superoxide 
by  converting  two  molecules  of  it  into  one  molecule  of  hydrogen  peroxide  plus 
oxygen). SOD-1 alone at 300 Units/ml was not toxic either in HEPES-sol or MEM-
HEPES-sol (data not shown). 
 
Figure 3-39: Effect of DPI on X / XO toxicity in HEPES-sol. It shows that when the experiment was 
performed  in  HEPES-sol  instead  of  MEM-HEPES-sol,  DPI  produced  substantial  and  statistically 
significant protection against X / XO toxicity.  ***p<0.001. (n=5).  
   113 
When  tried  in  HEPES-sol,  SOD-1  (300  Units/ml)  failed  to  protect  against  X  /  XO 
toxicity  (Fig.  3-40).  Also,  when  tried  in  HEPES-sol,  Tiron,  a  known  superoxide 
scavenger [Greenstock and Miller, 1975, Hassan et al., 1980], failed to protect against X / 
XO toxicity (Fig. 3-41). Tiron alone was not toxic (data not shown). The failure of 
SOD-1 was also obtained when the experiment was performed in MEM-HEPES-sol 
instead of HEPES-sol (Fig. 3-42).  
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Figure 3-40: Effect of SOD-1 on X / XO toxicity in HEPES-sol. ns: not significant. (n=5).  
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Figure 3-41: Effect of Tiron on X / XO toxicity in HEPES-sol. It shows that like SOD-1, the 
superoxide scavenger, Tiron, has no effect on X / XO toxicity. ns: not significant. (n=3).  
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When tried in HEPES-sol, SOD-1 at either 300 (data not shown) or only 3 Units/ml 
(Fig.  3-43)  was  substantially  protective  against  NADH  /  XO  toxicity.  This  was 
interesting because, as mentioned above, most previous cell cultures studies found no 
protection with SOD-1 co-treatment against X / XO toxicity. Also when tried in MEM-
HEPES-sol instead of HEPES-sol, SOD-1 at 300 Units/ml (it was not tried at 3 Units/ml 
in this solution) was protective against NADH / XO toxicity (Fig. 3-44). 
 
 
Figure 3-42: Effect of SOD-1 on X / XO toxicity in MEM-HEPES-sol.  It shows that also when the 
experiment was performed in MEM-HEPES-sol instead of HEPES-sol, SOD-1 had no effect on X / 
XO toxicity. ns: not significant. (n=5).  
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  Figure 3-43: Effect of SOD-1 on NADH / XO toxicity in HEPES-sol.  It shows that, although 
failed to protect against X / XO toxicity, SOD-1 substantially protected against NADH / XO toxicity. 
**p<0.01. (n=5).  
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To make sure that the protection with SOD-1 against NADH / XO toxicity was due to 
its  elimination  (dismutation)  of  superoxide  and  not  due  to  any  of  the  known  non-
specific actions of SOD-1 (see Discussion), two additional experiments were conducted. 
In the first experiment, Mn-SOD, which is known to be free of at least some of the 
known  non-specific  actions  of  SOD-1  [Sankarapandi  and  Zweier,  1999,  Liochev  and 
Fridovich, 2000], was tried at 3 Units/ml against NADH / XO toxicity, where it was as 
protective as SOD-1 (data not shown). In the second experiment, Tiron, which is (as 
mentioned above) a known superoxide scavenger, was tried in HEPES-sol, and showed 
substantial protection against NADH / XO toxicity (Fig. 3-45) (though Tiron is also 
known to be (among other actions) an effective chelator of some metals including iron 
Figure 3-44: Effect of SOD-1 on NADH / XO toxicity in MEM-HEPES-sol. It shows that also when 
the  experiment  was  performed  in  MEM-HEPES-sol  instead  of  HEPES-sol,  SOD-1  protected  against 
NADH / XO toxicity. ***p<0.001. (n=5).  
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and molybdenum [Fridovich and Handler, 1962], an activity that can not be ruled out as 
the reason for its protection). 
.  
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The failure of SOD-1 and Tiron to protect against X / XO toxicity is unlikely to be 
because  superoxide  was  not  generated  from  the  X  /  XO  combination,  since  (as 
mentioned  before)  this  radical  is  known  to  be  directly  generated  from  the  X  /  XO 
combination.  Also,  in  a  cell-free  experiment  where  Cytochrome  c  was  used  as  a 
detection  molecule  (see  Materials  and  Methods),  X  /  XO  combination  generated 
superoxide, whereas this radical was barely detected in the presence of SOD-1 (Fig. 3-
Figure 3-45: Effect of Tiron on NADH / XO toxicity in HEPES-sol. It shows that like SOD-1, 
although failed to protect against X / XO toxicity, Tiron substantially protected against NADH / XO 
toxicity. **p<0.01. (n=3).  
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46) (also see later on in Fig. 3-50 and Fig. 3-51 where the time course of superoxide 
generation is shown).  
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The protection of SOD-1, Mn-SOD, and Tiron against NADH / XO toxicity suggests 
that superoxide generated from this combination plays a role in the toxicity. Superoxide, 
as  mentioned  above,  does  indeed  get  generated  directly  from  the  NADH  /  XO 
combination. Unfortunately, it was not possible to confirm this generation in cell-free 
experiments, because NADH added alone interfered with the two cell-free detection 
assays of superoxide that were tried here. So, NADH added alone (without XO) caused 
increase in Cytochrome c signal. This reduction of Cytochrome c was partially inhibited 
by SOD-1 (Fig. 3-47). This suggests either that superoxide was generated spontaneously 
from  NADH  in  the  HEPES-sol  and  was  then  detected  by  Cytochrome  c  or  that 
Figure 3-46: Cell-free detection (using Cytochrome c reduction method) of superoxide generation 
by the X / XO combination in the HEPES-sol. It shows that, as expected, the X / XO combination 
generates  superoxide.  The  experiment  was  performed  as  follows:  test  cell-free  wells  contained  the 
treatment groups in HEPES-sol and left for 1 hr. After that, the optical density at 550 nm was recorded 
on a plate reader. Deferoxamine and EDTA were included in the mixture to suppress any unwanted 
reactions of possibly contaminating traces of metals. Catalase is included because hydrogen peroxide, 
which will be produced in the system, interferes with the assay.  The signal observed in the first group 
(the mixture only group) is expected, since oxidized Cytochrome c should give such a signal.  (n=3).   120 
Cytochrome c was interacting with NADH where superoxide was generated from such 
interaction, which was then detected by Cytochrome c.  
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Also, when another cell-free detection method of superoxide was tried, the reduction of 
XTT (see Materials and Methods), NADH added alone (without XO) caused substantial 
reduction of XTT. This reduction of XTT was completely prevented in the presence of 
SOD-1  (Fig.  3-48).  Again,  this  suggests  either  that  superoxide  was  generated 
spontaneously from NADH in the HEPES-sol and was then detected by XTT or that 
XTT  was  interacting  with  NADH  where  superoxide  was  generated  from  such 
interaction, which was then detected by XTT. One way to test for that was to see the 
effect of adding XTT and NADH to cells. In a viability experiment, it was clear that 
XTT  was  not  acting  as  just  an  innocent  detector  of  superoxide,  but  rather  was 
interacting with NADH to cause substantial damage, likely through generating ROS, to 
the neurons (Fig. 3-49) (notice that in this viability experiment, XTT or NADH were 
Figure  3-47:  Cell-free  experiment  showing  the  effect  of  NADH  alone  (without  XO)  on 
Cytochrome c (Cyt c) signal in the HEPES-sol. The experiment was performed as follows: test 
cell-free wells contained the treatment groups in HEPES-sol and left for 1 hr. After that, the optical 
density at 550 nm was recorded on a plate reader. (n=3). 
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not toxic when added alone, but when added together, they caused severe damage to the 
neurons).  
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Figure 3-48: Cell-free experiment showing the reduction of XTT by NADH alone (without XO) in 
HEPES-sol. The experiment was performed as follows: test cell-free wells contained the treatment 
groups in HEPES-sol and left for 1 hr. After that, the optical density at 450 nm was recorded on a plate 
reader. (n=3). 
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3.3.2.4 Effects of catalase against X / XO and NADH / XO toxicities 
 
Since hydrogen peroxide is known to be directly generated from X / XO and NADH / 
XO combinations (see Introduction), these two systems of toxicity were compared in 
their  responses  to  treatment  with  catalase  (which  deactivates  hydrogen  peroxide  by 
converting it into water and oxygen). Catalase alone at 300 Units/ml was not toxic to 
neurons either in HEPES-sol or MEM-HEPES-sol (data not shown). 
 
In the early viability experiments with catalase, it was used at 300 Units/ml. however, 
some reports in the literature showed that some commercial preparations of catalase are 
Figure 3-49: Effect of NADH and XTT applied alone or in combination in HEPES-sol on the 
cell viability. It shows that the superoxide detector, XTT, interacts with NADH to cause, probably 
through generating ROS, severe damage to the neurons. **p<0.01. (n=5). 
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contaminated with significant amount of SOD [Halliwell, 1973, Liochev and Fridovich, 
1989],  so  it  was  necessary  to  check  if  the  preparation  of  catalase  used  here  is  also 
contaminated  with  SOD  activity.  Using  the  cell-free  XTT  reduction  as  a  detection 
method of superoxide generation in X / XO system, catalase at 3 Units/ml did not seem 
to contain significant contamination of SOD activity. However, catalase at 300 or 1000 
Units/ml seemed to contain significant contamination of SOD activity (Fig. 3-50). The 
contamination of catalase (1000 Units/ml) by SOD activity was also confirmed by the 
other detection method of superoxide, the Cytochrome c reduction method (Fig. 3-51) 
(notice that contamination of catalase at 300 Units/ml by SOD activity could not be 
verified  in  this  Cytochrome  c  experiment  because  catalase  at  300  Units/ml  was  an 
essential component of the reaction mixture used to prevent interference of hydrogen 
peroxide with the assay (see Materials and Methods)). Therefore, only those viability 
experiments where catalase was used at no more than 3 Units/ml will be presented in 
this section. 
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Figure 3-50: Cell-free XTT reduction assay showing the time course of superoxide production by 
the  X  /  XO  combination  in  HEPES-sol.  It  shows  the  contamination  of  catalase  with  some  SOD 
activity. The experiment was performed as follows: test cell-free wells contained the treatment groups 
and the optical density was recorded on a plate reader at the indicated time points. Notice that by 10 
minutes after starting the reactions, superoxide generation ceased. The readings are the averages of two 
repeats of the experiment (every repeat conducted in a different day), where both of the repeats gave 
very  similar  readings.  Notice  that  (unfortunately)  the  first  readings  were  taken  after  7  minutes  of 
starting the reaction, by which the superoxide production was approaching its completion. This delay 
was  due  to  the  time  required  (after  starting  the  reactions  in  test  tubes)  for  aliqouting  the  mixture 
solutions into a 96-well plate, and then taking the readings on the plate reader. To observe the initial 
enzyme kinetics, the groups can be measured individually in a spectrophotometer with a single cuvette. 
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In  viability  experiments,  when  tried  in  HEPES-sol,  catalase  (3  Units/ml)  offered 
complete protection against X / XO toxicity (Fig. 3-52). Also, when tried in MEM-
HEPES-sol, catalase (up to 3 Units/ml) showed protection against X / XO toxicity in a 
dose dependent manner (Fig. 3-53). When tried in HEPES-sol, catalase (3 Units/ml) 
offered complete protection against NADH / XO toxicity (Fig. 3-54) (catalase was not 
tried in MEM-HEPES-sol against NADH / XO toxicity).  
Figure 3-51: Cell-free Cytochrome c reduction assay showing the time course of superoxide 
production by the X / XO combination in HEPES-sol. It shows the contamination of catalase 
(1000 Units/ml) with some SOD activity. The experiment was performed as follows: test cell-free 
wells contained the treatment groups and the optical density was recorded on a plate reader at the 
indicated time points. The signal at trace 1 is expected, since oxidized Cytochrome c should give such 
a signal. Notice that by 10 minutes after starting the reactions, as it was the case in the XTT reduction 
assay shown in Fig. 3-50, superoxide generation ceased.  The readings are the averages of two repeats 
of the experiment (every repeat conducted in a different day), where both of the repeats gave very 
similar readings. For the explanation for why the first readings were not taken until 7 minuters of 
starting the reactions, please see Fig. 3-50.  
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Figure 3-52: Effect of catalase on X / XO toxicity in HEPES-sol. ***p<0.01. (n=4).  
 
   127 
 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
Control X(100 µM)/ XO (0.02
Units/ml)
X(100 µM)/ XO (0.02
Units/ml) + catalase
(0.03 Units/ml)
X(100 µM)/ XO (0.02
Units/ml) + catalase
(0.3 Units/ml)
X(100 µM)/ XO (0.02
Units/ml) + catalase (3
Units/ml)
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
 
(
%
)
***
  ns
ns
 
 
   
 
 
 
 
 
 
 
Figure 3-53: Effect of catalase on X / XO toxicity in MEM-HEPES-sol. The experiment was 
performed as follows: at day 8 or 9 after plating, the culture medium was replaced by MEM-HEPES-
sol that does not contain (control) or contains the indicated test compounds, and left for 1 hour → the 
neurons in all groups (including control) were restored to conditioned medium and left for 16-24 
hours until the viability assay. ***p<0.001, ns: not significant.  (n=5). 
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As  seen,  the  viability  experiments  with  catalase  show  its  ability  to  offer  complete 
protection against both of the toxicity systems i.e. X / XO and NADH / XO toxicities. 
This suggests that hydrogen peroxide plays a central role in both of the toxicity systems. 
Hydrogen peroxide does indeed get generated directly from X / XO and NADH / XO 
combinations,  and  should  also  be  produced  from  the  spontaneous  dismutation  of 
superoxide which is directly generated from these combinations (see Introduction).  
 
To  confirm  the  production  of  hydrogen  peroxide,  some  cell-free  experiments  were 
conducted.  There  was  also  another  reason  for  measuring  hydrogen  peroxide 
production/accumulation  in  the  systems.  In  the  case  of  NADH  /  XO  toxicity,  since 
Figure 3-54: Effect of catalase on NADH / XO toxicity in HEPES-sol.  ***p<0.001. (n=3).  
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catalase, likely  through deactivating hydrogen peroxide, provided complete protection 
against  the  toxicity,  it  was  expected  that  SOD-1  and  Mn-SOD  (which  convert 
superoxide to hydrogen peroxide) should potentiate the toxicity (or at least have no 
effect) rather than preventing it as observed. A possible explanation for this paradox is 
that the NADH / XO toxicity was due to a superoxide-dependent hydrogen peroxide-
accumulating free radical chain  reaction where adding SOD to such a reaction can, 
although by converting superoxide to hydrogen peroxide, block the hydrogen peroxide-
accumulating chain reaction from the start, and hence prevent much larger and toxic 
production/accumulation of hydrogen peroxide in the system (see Discussion). In a cell-
free experiment conducted to detect hydrogen peroxide production/accumulation in the 
NADH / XO system, adding SOD-1 (3 Units/ml) seemed to potently inhibit hydrogen 
peroxide production/accumulation in the system (Fig. 3-55), which gives support to the 
proposed explanation for the above mentioned paradox. Using the same assay, SOD-1 
at  either  3  or  300  Units/ml  did  not  seem  to  influence  hydrogen  peroxide 
production/accumulation in X / XO system, whereas allopurinol (used to confirm the 
enzymatic oxidation of X) potently inhibited this production/accumulation (Fig. 3-56). 
Almost  exactly  the  same  degree  of  inhibition  of  hydrogen  peroxide 
production/accumulation in the NADH / XO system by SOD-1 was also observed when 
the reaction was carried out in a HEPES-free solution (Dulbecco's Phosphate-Buffered 
Saline (DPBS)) instead of HEPES-sol (data not shown).   
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Figure 3-55: Cell-free catalase-based assay of hydrogen peroxide production/accumulation from 
the NADH / XO combination. It shows that SOD-1 decreases hydrogen peroxide accumulation in 
NADH / XO system. The reactions were carried in HEPES-sol. (n=3). 
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3.3.2.5 Role of metals in X / XO and NADH / XO toxicities 
 
Since the viability experiments indicated the involvement of hydrogen peroxide in X / 
XO and NADH / XO toxicities and indicated the involvement of superoxide in NADH / 
XO toxicity, and since hydrogen peroxide and superoxide can exert their toxic effects 
through interacting with some metals (see Introduction), a series of experiments were 
conducted  in  order  to  investigate  the  involvement  of  metals  in  the  studied  toxicity 
systems.  
 
Figure 3-56: Cell-free catalase-based assay of hydrogen peroxide production/accumulation from 
the  X  /  XO  combination.  It  shows  that  SOD-1  does  not  influence  hydrogen  peroxide 
production/accumulation  in  X  /  XO  system,  whereas  allopurinol  (used  to  confirm  the  enzymatic 
oxidation of X) potently inhibited this production/accumulation of hydrogen peroxide. The reactions 
were carried in HEPES-sol. (n=3). 
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Deferoxamine at 300  M was not toxic to CGNs when applied alone in MEM-HEPES-
sol as a 3 hr pre-treatment (data not shown). In MEM-HEPES-sol, when deferoxamine 
was applied to CGNs as pre-treatment  for 3 hr, removed, and replaced by  X / XO 
combination, it provided protection against the toxicity of this combination (Fig. 3-57). 
When  the  experiment  was  repeated  but  with  only  15  minutes  deferoxamine  pre-
treatment  instead  of  3  hr,  it  failed  to  protect  (data  not  shown).  This  suggests  that 
deferoxamine was exerting its protective effect intracellularly and also suggests that this 
chelator, as expected, needs relatively long pre-treatment time to get inside the cells.  
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Figure 3-57: Effect of deferoxamine pre-treatment on X / XO toxicity in MEM-HEPES-sol. Notice 
that deferoxamine was removed before applying the toxic insult. ***p<0.001. (n=5). 
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Although the above experiment with deferoxamine involved pre-treating neurons for 3 
hr and then treating for 1 hr in a serum-free medium, it is unlikely that withdrawing the 
serum from the neurons for 4 hr per se was causing damage because the neurons in the 
control group were looking healthy. Also, in a separate experiment, serum withdrawal 
for 4 hr did not cause statistically significant damage to the neurons (the viability of 
neurons withdrawn from serum for 4 hr was 93.5% ± 3 of the control neurons (i.e. not 
withdrawn from serum), p>0.05, n = 4). When serum was withdrawn for 24 hr, there 
was a small but statistically significant damage to the neurons (the viability of neurons 
withdrawn  from  serum  for  24  hr  was  84.4%  ±  4.3  of  the  control  neurons  (i.e.  not 
withdrawn from serum), p<0.05, n = 5). 
 
When the experiment with deferoxamine pre-treatment for 3 hr was repeated but with 
the toxic insult applied in HEPES-sol instead of MEM-HEPES-sol, deferoxamine also 
protected  against  X  /  XO  toxicity  (Fig.  3-58).  Notice  that  in  this  experiment, 
deferoxamine was applied in MEM-HEPES-sol as pre-treatment before removing it and 
replacing  it  by  the  toxic  insult  applied  in  HEPES-sol.  The  reason  for  using  MEM-
HEPES-sol  as  the  pre-treatment  solution  is  that  HEPES-sol  contains  low  potassium 
concentration, and low potassium solutions might cause damage to the cells if applied to 
them for a relatively prolonged time as for the pre-treatment time in this experiment. 
MEM-HEPES-sol was therefore preferred as the pre-treatment solution in this and other 
experiments.  
 
When the neurons were pre-treated for 3 hr with deferoxamine at 300  M, it failed to 
protect against NADH / XO toxicity (data not shown). However, when the neurons were 
pre-treated  for  3  hr  with  deferoxamine  at  1  mM,  it  protected  against  NADH  /  XO 
toxicity (Fig. 3-59).  
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The  foregoing  results  show  that  deferoxamine,  if  applied  as  pre-treatment  at  the 
appropriate concentration and time interval, can protect against X / XO toxicity and also 
against NADH / XO toxicity, which suggests that intracellular iron ion plays a role in 
the damage observed in these two systems.  Alternatively, deferoxamine pre-treatment 
may  have  been  protective  by  blocking  intracellular  peroxynitrite-mediated  effects 
[Bartesaghi et al., 2004], where peroxynitrite can be produced from reaction between 
superoxide (produced by XO or other sources) and nitric oxide produced by endogenous 
nitric oxide synthase. To test this possibility, L-NAME (1 mM), a nitric oxide synthase 
inhibitor [Patel et al., 1996, Gunasekar et al., 1995], was used as pre-treatment for 1 hr to 
inhibit intracellular nitric oxide-mediated peroxynitrite production, but it failed to offer 
Figure 3-58: Effect of deferoxamine pre-treatment (in MEM-HEPES-sol) on the toxicity of X / 
XO combination applied in HEPES-sol. Notice that deferoxamine was removed before applying the 
toxic insult. **p<0.01. ( n=5). 
   135 
protection against either NADH / XO or X / XO toxicities. So, in NADH / XO toxicity, 
the viability of neurons insulted by NADH (1 mM) / XO (0.02 Units/ml) was 39.7% ± 
3.8 of the control neurons, and the viability of neurons pre-treated with L-NAME (1 
mM) before applying the insult was 41% ± 1.2 of the control neurons; the P value for 
the difference between the insult and the insult with L-NAME pre-treatment was > 0.05; 
n = 3. In X / XO toxicity, the viability of neurons insulted by X (15  M) / XO (0.02 
Units/ml) was 36.3% ± 9.3 of the control neurons, and the viability of neurons pre-
treated with L-NAME (1 mM) before applying the insult was 32.3% ± 6.1 of the control 
neurons; the P value for the difference between the insult and the insult with L-NAME 
pre-treatment  was  >  0.05;  n  =  3.  L-NAME  alone  was  not  toxic  (data  not  shown). 
Therefore, the failure of L-NAME pre-treatment to protect against either NADH / XO 
or X / XO toxicities argues against the blockade of peroxynitrite-mediated effects as the 
mechanism of protection by deferoxamine pre-treatment. 
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Figure 3-59: Effect of deferoxamine pre-treatment (in MEM-HEPES-sol) on the toxicity of the 
NADH / XO combination applied in HEPES-sol. Notice that deferoxamine was removed before 
applying the toxic insult. **p<0.01. (n=5). 
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It is commonly observed that traces of metals do often contaminate solutions used in 
cell  culture  studies.  Also,  some  commercial  preparations  of  XO  are  known  to  be 
contaminated with iron ion (which is different from iron that is an integral part of XO) 
[Britigan et al., 1990, Vile and Winterbourn, 1986]. Thus, a series of experiments were 
conducted  in  order  to  investigate  the  involvement  of  metal  contaminants  in  the 
extracellular solutions (or contaminating XO) in the toxicity of X / XO and NADH / XO 
combinations.  In the case of NADH / XO toxicity in particular, there was another 
reason  for  suspecting  the  involvement  of  an  extracellular  metal  contaminant  in  the 
toxicity, which was the observed protection by SOD. Since SOD-1 and Mn-SOD were 
likely  producing  their  protective  effects  through  an  extracellular  action,  and  since 
superoxide  can  exert  its  toxicity  through  some  sort  of  a  reaction  with  metals  (see 
Introduction),  an  extracellular  toxic  interaction  between  superoxide  (generated 
extracellularly from NADH / XO combination) and an extracellular metal contaminant 
was suspected. Two metal chelators were tried, ethylenediaminetetraacetate (EDTA, a 
non specific cation chelator [Hutcheson et al., 2004]) and deferoxamine.  
 
Deferoxamine (300  M) was pre-incubated with XO for 3 hr in HEPES-sol in a test 
tube (this pre-incubation time was without any contact with CGNs). After the 3 hr, 
NADH was added to the solution in the test tube (to start the reaction) and the whole 
mixture  (which  contains  NADH,  XO,  and  deferoxamine)  was  applied  to  CGNs. 
Deferoxamine, when tried this way, failed to protect against NADH / XO toxicity (Fig. 
3-60) (notice that the volume of HEPES-sol containing deferoxamine and XO before 
adding NADH was 95% of its volume after adding NADH). 
 
When the experiment was repeated exactly but with using EDTA (at 2  M (Fig. 3-61), 
20  M (Fig. 3-62), or 200  M (data not shown)) instead of deferoxamine, it protected 
against NADH / XO toxicity. Interestingly, EDTA lost its protective effect when XO 
was omitted from the solution that was pre-incubated for 3 hr with EDTA. In other 
words, EDTA (20  M) was pre-incubated for 3 hr in HEPES-sol (without XO) in a test 
tube (again, this pre-incubation time was without any contact with CGNs). After the 3 
hr, both XO and NADH were added to the solution in the test tube (to start the reaction) 
and the whole mixture (which contains NADH, XO, and EDTA) was applied to CGNs. 
With this protocol, EDTA no longer protected against NADH / XO toxicity (Fig. 3-63) 
(notice  that  the  volume  of  the  EDTA-containing  HEPES-sol  before  adding  XO  and 
NADH was more than 90% of its volume after adding XO and NADH).    137 
 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
A B C
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
 
(
%
)
Neurons maintained in 
culture medium at day 8 or 9
Culture medium 
replaced by HEPES-
sol
Nuerons restored 
to conditioned 
medium
Same as in A
Same as in A but the 
HEPES-sol contains: 
NADH (1 mM) / XO (0.02 
Units/ml)
Same as in A Same as in A
Same as in A
1 hr
16-24
hr 
ns
Same as in A but the 
HEPES-sol contains: 
NADH (1 mM) / XO (0.02 
Units/ml) + 
deferoxamine (300 µM)
Viability assay Same as in A Same as in A 4 
hr
(Control)
 
 
 
 
 
 
 
 
Figure 3-60: Effect of deferoxamine co-treatment on NADH / XO toxicity. Notice: in column C, 
HEPES-sol including XO was pre-incubated with deferoxamine for 3 hr (notice that this 3 hr pre-
incubation was in a test tube without any contact with the CGNs cultures) and then NADH was added 
to the solution (to initiate the reaction), and then the mixture (including deferoxamine, NADH, and XO) 
was applied to the neurons as shown in the figure (notice that the volume of HEPES-sol containing 
deferoxamine and XO before adding NADH was 95% of its volume after adding NADH). The same 
was done to column B but without deferoxamine, and the same was done to column A but without 
either deferoxamine or the toxic insult. ns: not significant. (n=5).   138 
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Figure 3-61: Effect of EDTA (2  M) co-treatment on NADH / XO toxicity. Notice: in column C, 
HEPES-sol including XO was pre-incubated with EDTA for 3 hr (notice that this 3 hr pre-incubation 
was in a test tube without any contact with the CGNs cultures) and then NADH was added to the 
solution (to initiate the reaction), and then the  mixture (including EDTA, NADH, and XO)  was 
applied to the neurons as shown in the figure. The same was done to column B but without EDTA, 
and the same was done to column A but without either EDTA or the toxic insult. ***p<0.001. (n=5). 
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Figure 3-62: Effect of EDTA (20  M) co-treatment on NADH / XO toxicity. NADH was used 
here at 1.5 mM just to show that even at higher toxicity level EDTA is still able to provide substantial 
protection against NADH / XO toxicity. Notice: in column C, HEPES-sol including XO was pre-
incubated with EDTA for 3 hr (notice that this 3 hr pre-incubation was in a test tube without any 
contact with the CGNs cultures) and then NADH was added to the solution (to initiate the reaction), 
and then the mixture (including EDTA, NADH, and XO) was applied to the neurons as shown in the 
figure. The same was done to column B but without EDTA, and the same was done to column A but 
without either EDTA or the toxic insult. ***p<0.001. (n=5).   140 
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The effects of deferoxamine and EDTA co-treatments were also investigated against the 
toxicity of the X / XO combination. Deferoxamine at 300  M (Fig. 3-64) or EDTA at 2, 
20, or 200  M (Fig. 3-65) was pre-incubated with XO for 3 hr in HEPES-sol in a test 
tube (again, this pre-incubation time was without any contact with CGNs). After the 3 
hr, X was added to the solution in the test tube (to start the reaction) and the whole 
mixture (which contains X, XO, and the chelating agent) was applied to CGNs. Neither 
deferoxamine  nor  EDTA,  when  tried  this  way,  was  able  to  protect  against  X  /  XO 
Figure 3-63: Effect of EDTA (20  M) co-treatment when it was not pre-incubated with XO on 
the toxicity of NADH / XO combination. Notice: in column C, HEPES-sol (not including XO) was 
pre-incubated with EDTA for 3 hr (notice that this 3 hr pre-incubation was in a test tube without any 
contact with the CGNs cultures) and then both XO and NADH were added to the solution (to initiate 
the reaction), and then the mixture (including EDTA, NADH, and XO) was applied to the neurons as 
shown in the figure (notice that the volume of the EDTA-containing HEPES-sol before adding XO 
and NADH was more than 90% of its volume after adding XO and NADH). The same was done to 
column B but without EDTA, and the same was done to column A but without either EDTA or the 
toxic insult. ns: not significant. (n=5). 
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toxicity. Notice that neither deferoxamine (300  M) nor EDTA (200  M), when tried 
alone this way, was toxic to CGNs (data not shown).  
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Figure  3-64:  Effect  of  deferoxamine  co-treatment  on  X  /  XO  toxicity.  Notice:  in  column  C, 
HEPES-sol including XO was pre-incubated with deferoxamine for 3 hr (notice that this 3 hr pre-
incubation was in a test tube without any contact with the CGNs cultures) and then X was added to 
the solution (to initiate the reaction), and then the mixture (including deferoxamine, X, and XO) was 
applied  to  the  neurons  as  shown  in  the  figure.  The  same  was  done  to  column  B  but  without 
deferoxamine, and the same was done to column A but without either deferoxamine or the toxic 
insult. ns: not significant. (n=5). 
   142 
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
A B C D E
V
i
a
b
i
l
i
t
y
 
r
e
l
a
t
i
v
e
 
t
o
 
c
o
n
t
r
o
l
 
(
%
)
Neurons 
maintained in 
culture medium 
at day 8 or 9
   
Culture 
medium 
replaced by 
HEPES-sol
Neurons restored 
to conditioned 
medium 
Same as in A
Same as in A 
but the HEPES-
sol contains: X 
(10 µM) / XO 
(0.02 Units/ml)
Same as in A Same as in A
Same as in A but 
the HEPES-sol 
contains : X (10 
µM) / XO (0.02 
Units/ml) + EDTA 
(2 µM)
Same as in A
 
  Viability assay
1 hr
16-24
hr
(control)
 
Same as in A
Same as in A but 
the HEPES-sol 
contains : X (10 
µM) / XO (0.02 
Units/ml) + EDTA 
(20 µM)
Same as in A but 
the HEPES-sol 
contains : X (10 
µM) / XO (0.02 
Units/ml) + EDTA 
(200 µM)
Same as in A
Same as in A Same as in A
ns
ns
ns
Same as in A Same as in A Same as in A Same as in A 4 hr
 
 
 
 
   
 
 
 
 
 
 
 
3.3.2.6 Role of extracellular hydroxyl radical in NADH / XO and X / XO toxicities 
 
Since  SOD-1  (and  Mn-SOD),  catalase,  and  EDTA  co-treatments  protected  against 
NADH / XO toxicity, there is a possibility that the toxicity was due to a Fenton reaction 
where hydrogen peroxide generated extracellularly was interacting with an extracellular 
contaminating metal (where this reaction can be mediated by superoxide) to produce the 
Figure 3-65: Effect of EDTA co-treatment on X / XO toxicity. X was used here at 10 instead of 15 
 M just to show that even at lower toxicity level EDTA was not able to provide any protection 
against X / XO toxicity (also when X was used at 15  M, EDTA (200  M) could not protect (data not 
shown)) . Notice: in columns E, D, and C, HEPES-sol including XO was pre-incubated with EDTA 
at the shown concentrations for 3 hr (notice that this 3 hr pre-incubation was in a test tube without 
any contact with the CGNs cultures) and then X was added to the solution (to initiate the reaction), 
and then the mixture (including EDTA, X, and XO) was applied to the neurons as shown in the 
figure. The same was done to column B but without EDTA, and the same was done to column A but 
without either EDTA or the toxic insult. ns: not significant. (n=5). 
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very reactive and toxic hydroxyl radical.  However, the treatment solutions used i.e. 
HEPES-sol  and  MEM-HEPES-sol  contain  at  least  two  hydroxyl  radical  scavengers: 
HEPES (at 20 mM in HEPES-sol and 25 mM in MEM-HEPES-sol) and glucose (at 3 
mM  in  HEPES-sol  and  5  mM  in  MEM-HEPES-sol).  This  argues  against  the 
involvement of extracellular hydroxyl radical in the toxicity of either NADH / XO or X 
/  XO  combinations.  To  confirm  or  refute  this,  three  additional  hydroxyl  radical 
scavengers were tried: mannitol, ethanol, and DMSO. None of these three compounds 
was toxic to CGNs when tried alone at 20 mM (data not shown). However, none of 
these three compounds was able to provide protection against NADH / XO (Fig. 3-66) 
or X / XO (Fig. 3-67) toxicity.  
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  Figure 3-66: Effect of co-treatment with hydroxyl radical scavengers on NADH / XO toxicity. 
ns: not significant. (n=3).  
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3.3.3 Further investigation of X / XO toxicity 
 
In addition to investigating the toxicity of the NADH / XO combination (which was 
rarely investigated in previous studies) and comparing it to the well investigated toxicity 
of the X / XO combination, another aim of this project was to address specific questions 
regarding those aspects of X / XO toxicity where there is uncertainties about them (see 
the  section  on  Aim/Objectives  in  the  Introduction).  Some  of  these  questions  were 
addressed in the previous section (e.g. the possibility that XO is contaminated with 
iron/metal). 
 
Figure 3-67: Effect of co-treatment with hydroxyl radical scavengers on X / XO toxicity. ns: not 
significant. (n=3).  
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Another aspect of further investigation was the role of superoxide in X / XO toxicity. It 
was shown in the previous section that SOD-1 and Tiron failed to protect against X / 
XO toxicity despite the fact that the cell-free experiments showed that superoxide does 
indeed get generated from X / XO combination. The complete protection found with 
catalase indicates that hydrogen peroxide was a main toxic molecule in X / XO toxicity. 
Also,  intracellular  superoxide  was  shown  previously  to  mediate  the  toxicity  of 
extracellularly generated/applied hydrogen peroxide, though this was shown in tissue 
cultures other than CGNs [Ito et al., 1992, Kyle et al., 1988, Hiraishi et al., 1994]. For these 
reasons, there is a possibility that intracellular superoxide is involved in the X / XO 
toxicity in CGNs cultures used here, and that the failure of SOD-1 and Tiron to protect 
was due to both the failure of SOD-1 (and Tiron at the used concentration and study 
design) to enter the cells and also the failure of superoxide generated from X / XO 
combination to enter the cells.  
 
Tiron, although it failed to protect against X / XO toxicity when it was applied as co-
treatment at 50  M (see earlier), was tried here as pre-treatment for 3 hr at 2 mM, 
aiming to give it a chance to get inside the neurons in high amount. When tried alone 
this way, Tiron was not toxic (data not shown). When tried this way, Tiron provided 
protection against X (15  M) / XO toxicity (Fig. 3-68) or X (10  M) / XO toxicity (Fig. 
3-69). This suggests that, as suspected, intracellular superoxide might be involved in the 
toxicity of X / XO combination. However, it is not possible to rely heavily on the Tiron 
result  alone,  because  there  is  a  possibility  that  this  compound  was  producing  its 
protective  effect  through  a  mechanism  different  from  scavenging  intracellular 
superoxide  e.g.  chelating  some  intracellular  metals  [Fridovich  and  Handler,  1962]. 
Another way to test the involvement of intracellular superoxide in X / XO toxicity was 
through inhibiting intracellular SOD-1, where this inhibition should potentiate the X / 
XO  toxicity  if  intracellular  superoxide  was  mediating  this  toxicity. 
Diethyldithiocarbamate (DDC) was tried, which is a known and cell permeable inhibitor 
of SOD-1 (but of low specificity) [Ito et al., 1992, Hiraishi et al., 1994, Blum and Fridovich, 
1983, Benov and Fridovich, 1996]. DDC pre-treated alone was not toxic (data not shown). 
The neurons were pre-treated with DDC at 50  M for 1 hr before removing it and 
replacing it with X / XO combination, but DDC failed to show statistically significant 
potentiation of the toxicity (Fig. 3-70).   
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Figure 3-68: Effect of Tiron pre-treatment on the toxicity of X (15  M) / XO (0.02 Units/ml) 
combination. Notice that Tiron was removed before applying the toxic insult. *p<0.05. (n=5). 
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Figure 3-69: Effect of Tiron pre-treatment on the toxicity of X (10  M) / XO (0.02 Units/ml) 
combination. Notice that Tiron was removed before applying the toxic insult. *p<0.05. (n=4). 
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 The  results  with  Tiron  pre-treatment,  deferoxamine  pre-treatment,  and  catalase  co-
treatment (and also the results of many previous studies [Satoh et al., 1998, Link and Riley, 
1988, Mohsen et al., 1995, Duell et al., 1995, Hiraishi et al., 1987, Zigler et al., 1985]) suggest 
that the toxicity of X / XO combination was due to hydrogen peroxide generated in the 
extracellular space and then entering the neurons and participating in a Fenton reaction 
with  an  intracellular  iron  (where  this  reaction  was  likely  mediated  by  intracellular 
superoxide)  to  produce  the  very  reactive  and  toxic  hydroxyl  radical  (or  a  similar 
species).  The failure of co-treatment with the hydroxyl radical scavengers tried in the 
previous  section  (mannitol,  ethanol,  and  DMSO),  although  might  argue  against  the 
involvement of extracellular hydroxyl radical in X / XO toxicity, does not necessarily 
Figure 3-70: Effect of diethyldithiocarbamate (DDC) pre-treatment on X / XO toxicity. Notice 
that DDC was removed before applying the toxic insult. ns: not significant. (n=3). 
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mean that intracellular hydroxyl radical was not involved.  Therefore it was decided to 
use different hydroxyl radical scavengers (mannitol, ethanol, DMSO, and others) as pre-
treatment (to give them a chance to accumulate inside the cells) before applying the X / 
XO  combination.  As  a  start,  a  compound  called  α-(4-Pyridyl  N-oxide)-N-tert-
butylnitrone (POBN) was tried, which has the ability to scavenge hydroxyl radical (but 
also many other free radicals) [Mottley et al., 1986, Pérez and Cederbaum, 2001, Reinke et 
al., 1994].  POBN is a member of a large group of compounds called spin traps, which 
are used essentially as detectors of free radicals, where a spin trap can react with a free 
radical  (e.g.  hydroxyl  radical)  to  produce  a  new  species  (a  more  stable  secondary 
radical)  that  can  be  detected  by  a  method  called  electron  paramagnetic  resonance 
spectroscopy [Reinke et al., 1994, Tarpey and Fridovich, 2001]. In theory (which was also 
shown in some viability studies), since these detect free radicals by scavenging them, 
they might protect tissues from insults that involve generation of toxic free radicals. 
When POBN was applied alone as pre-treatment, it was not toxic to CGNs (data not 
shown).  When  the  neurons  were  pre-treated  with  POBN  at  20  mM  for  1hr  before 
removing  it  and  replacing  it  by  the  X  /  XO  combination,  instead  of  protecting,  it 
potentiated  the  toxicity  (Fig.  3-71).  Surprisingly,  when  POBN  was  applied  as  co-
treatment rather than pre-treatment, it produced the opposite effect, showing significant 
protection against X / XO toxicity (Fig. 3-72) (see Discussion for possible explanations 
for these opposite effects).  
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Figure 3-71: Effect of POBN pre-treatment on the toxicity of X  / XO combination in MEM-
HEPES-sol. Notice that POBN was removed before applying the toxic insult. *p<0.05. (n=5). 
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Figure 3-72: Effect of POBN co-treatment on the toxicity of X  / XO combination in MEM-
HEPES-sol. ***p<0.001. (n=5).  
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4 Discussion 
 
4.1 Culturing and experimental conditions 
 
Please notice that some detailed discussion of the justification of using neurons and 
CGNs in particular was mentioned in the Introduction (section 1.5, pages 43 & 44). 
 
4.1.1 Neuronal morphology 
 
The  culturing  process  produced  viable  CGNs.  The  cells  appeared  immediately  after 
plating as round cells. In the first 24 hr of plating, the neurons started to grow processes, 
and also started to migrate and group with each other. On the other hand, many cells 
died in the first 24 hr of plating, even before adding the cytosine arabinoside. There is 
more than one possibility for this death. First, it is possible that these cells died as a 
result of physical damage in the isolation process i.e. the death was due to: chopping 
with the blade, trypsin treatment, trituration, etc. An attempt was undertaken here to 
assess the viability of the neurons immediately after isolation (and before plating) by 
using the Trypan blue exclusion test (see Introduction for the principle of this test), and 
it was found that most of the cells were viable (data were not shown). However, this test 
was not clear at all when tried. Neither the dead cells were clearly obtaining the dye, nor 
were the viable cells clearly excluding it. The presence of serum and/or some debris 
might have caused this obscurity in observing the uptake/exclusion of Trypan blue by 
cells. Therefore, it was not possible to prove or rule out this possibility as the reason for 
the neuronal death, though it might be at least partially responsible.  
 
The second explanation for the death is that, since the fresh culture medium used in the 
culturing process contains glutamate, it might have been due to glutamate excitotoxicity 
after  exposure  to  this  medium.  However,  this  is  unlikely,  since  it  was  shown  that 
glutamate does not cause toxicity to CGNs at this early stage [Frandsen and Schousboe, 
1990] (also see later). The third explanation, which might contribute (at least partially), 
is  that  the  majority  of  dead  cells  may  did  not  necessarily  die  immediately  after 
dissociation from brain, but rather they may have died gradually in the first 24 hr of 
plating, where the cells (neurons and non-neuronal cells) that died are those ones which   153 
could not stand the culturing shock/stress induced by placing them in a new and strange 
environment drastically different from their normal in vivo environment. 
 
After 8 days in culture, the neurons exhibited a normal phenotype, and showed the 
known characteristic morphology of cultured CGNs [Peng et al., 1991, Parks et al., 1991], 
where most of those cells that died in the first 24 hr of plating disappeared. The cytosine 
arabinoside added after  24 hr of plating should have ensured that most of the cells 
present after 8 days in culture are neurons. Also, the neuronal nature of these CGNs 
cultures, as well as the absence of a significant number of glial cells, was confirmed by 
immunocytochemistry in a previous project undertaken in this laboratory [Smith, 2008].  
 
4.1.2 Morphological examination in viability experiments 
 
It was a constant observation under the microscope that, after applying a toxic insult and 
then restoring neurons to the restoration medium, the neurons continue to deteriorate for 
up to 4-8 hr with no deterioration/recovery afterwards. Therefore, the restoration period 
(at least 16 hr) seemed to be enough for the damage to stabilize at a certain level after 
which the neurons were unlikely to recover/deteriorate. 
 
Morphological  examination  is  a  very  objective  way  of  assessing  the  viability  of 
neurons. However, taking images of the neurons can be less objective. The reason is 
that an insult-mediated damage to the neurons observed under the microscope in a well 
is, in many cases, not homogenous. Therefore, choosing the area in a well to take a 
photo can result in contrasting photos. For example, if a toxic insult caused moderate 
toxicity to neurons, it is possible to take the photos for the control group (from any area 
in a well) and the toxic insult group (from an area in a well that is not damaged) that 
make the toxic compound appears as if it was not toxic. That non-homogeneity in the 
damage  observed  under  the  microscope  in  neuronal  cultures  can  occur  was  noticed 
previously [Leahy et al., 1994].  
 
If so, why it is said above that morphological examination is a very objective technique? 
The reason is that, to take the above example, although a well in the insult group will 
contain some viable areas (not damaged), it is possible to move around the well to see 
all of its field, which will make it possible to see that other areas in the well are indeed   154 
damaged. On the other hand, in the control group, no damage is seen whatever the area 
in a well is looked at. This applies to many experiments performed in this project. 
 
There are some cases where taking photos can be as objective as observing the damage 
under the microscope. This happens when the toxic insult is so severe to the degree that 
the whole culture in wells is totally collapsed/damaged, and hence there will be severe 
damage observed whatever the area is chosen in a well to take a photo. This applies to 
some experiments performed in this project. 
 
4.1.3 Alamar blue assay 
 
The  viability  assay  used,  the  Alamar  blue  reduction  assay,  although  not  free  of 
drawbacks,  is  a  reliable  and  very  convenient  measure  of  cell  viability.  It  has  been 
validated previously on its own and against other assays (e.g. Trypan blue exclusion 
method,  3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl  tetrazolium  bromide  (MTT-assay), 
or lactate dehydrogenase (LDH) release) in different types of cell cultures including 
CGNs, and using a variety of toxicity models including oxidative stress [White et al., 
1996, Nakayama et al., 1997, Back et al., 1999, O'Brien et al., 2000, Gonzalez and Tarloff, 
2001,  Hamid  et  al.,  2004].  Although  it  is  generally  thought  that  Alamar  blue  is 
exclusively reduced by mitochondrial enzymes, other enzymes are known to reduce it 
also (e.g. the cytosol is as efficient as the mitochondria in reducing it) [O'Brien et al., 
2000, Gonzalez and Tarloff, 2001, Hamid et al., 2004]. Regardless of the site of its action, 
Alamar blue is recognized to be reduced mainly by living cells: its active ingredient, 
resazurin, was introduced more than 70 years ago to the food industry to detect and 
measure the presence of contaminating living microorganisms [John, 1939, Nixon and 
Lamb, 1945, Straka and Stokes, 1957]. The extent of its reduction is expected to reflect the 
viability status of the cultures.  
 
In this project, when the difference in viability between two groups based on Alamar 
blue assay results is ≥ 20%, there is found a good (but not necessarily exact) correlation 
between the Alamar blue viability assay results and the morphological appearance of the 
neurons under the microscope. There was not even a single case where the neuronal 
appearance  under  the  microscope  was  suggesting  that  Alamar  blue  was  giving 
misleading false results. Actually, this good correlation between Alamar blue assay and 
the  morphological  examination  was  the  reason  for  believing  that  the  protection  of   155 
ethanol and DMSO against fresh culture medium toxicity was real and not due to an 
artefact  in  the  Alamar  blue  viability  assay,  which  led  eventually  to  discovering  the 
reason of fresh culture medium toxicity. 
Moreover, it is unlikely that Alamar blue was  interfering with any of  the treatment 
compounds or even interfering with their delayed effects, since the end of the treatment 
period (when the treatment solutions that contain the test compounds are removed) and 
the addition of Alamar blue are separated by at least 16 hr of restoration period and also 
since, as mentioned above, the cell damage/morphology seemed under the microscope 
to stabilize within 8 hr of the restoration period (i.e. at least 8 hr before adding Alamar 
blue) and the cells do not deteriorate or recover after that. 
 
As mentioned above, the good correlation between Alamar blue viability results and the 
morphological examination is only seen if the difference between two groups based on 
Alamar blue results is ≥ 20%. As this difference decreases more and more below 20 %, 
although the correlation between Alamar blue results and morphological examination 
can be noticed, it will start to be less and less clear. It is possible that Alamar blue has 
the ability to detect small changes in the viability of cells, where these small changes are 
not large enough to cause very clear changes in the morphology. 
 
Also as mentioned above, the Alamar blue viability assay, like any other assay, is not 
free of drawbacks. For example, if an experiment contains two groups, a control group 
and a moderate insult group, then although the Alamar blue will be reduced more by the 
control group, if the dye is left in the cultures for too long a period, then the moderate 
insult group (and the control group) may reduce the remaining Alamar blue molecules 
that were not reduced initially, resulting in full reduction of the Alamar blue in the two 
groups, and hence equal viability values in the two groups. For this reason, an optimal 
incubation  period  and  optimal  concentration  of  Alamar  blue  have  to  be  applied. 
Previous studies have applied an incubation time between 2 and 6 hr (4-6 hr if using 
CGNs  cultures)  [White  et  al.,  1996,  Fatokun,  2006,  Fatokun  et  al.,  2007b],  where  the 
Alamar  blue  viability  results  based  on  this  incubation  time  accurately  reflect  the 
viability status of the cultures. In an experimental check performed in this project, there 
was no statistically significant difference between the viability result based on 4 and 6 
hr Alamar blue incubation times, which suggests that both of the incubation times are 
appropriate (4 hr was used throughout this project) .  
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4.1.4 Effect of position in the plate on the viability of cultures 
 
It was observed that neurons located in the edge wells look much stressed after 8 days 
in culture, which was likely due to a massive evaporation of liquids from these wells. 
This was evident from the observation that the medium volume was much reduced in 
those wells and was also looking very pinkish. Therefore, neurons in these wells were 
never used in this project. 
 
Importantly,  the  results  show  that  neurons  located  in  the  next-edge  wells  give 
consistently slightly (10-15%) higher viability values in the Alamar blue assay than 
neurons located in the inside wells. May be because these differences were small, it was 
not possible to decisively confirm them by the morphological examination under the 
microscope,  though  they  were  noticeable.    If  these  differences  were  real,  they  are 
somehow unexpected. It is expected that, because the neurons in the edge wells were 
looking much stressed under the microscope, the viability of neurons should decrease 
rather than increase as the location of cultures gets closer to the edge of the plate. A 
speculative explanation is that, because the neurons in those experiments were under the 
influence of fresh culture medium toxicity (i.e. glutamate excitotoxicity, see later), the 
neurons in the next-edge wells (being under the stress of the edge effect, although much 
less than the stress of the neurons in the edge wells) were able to activate compensatory 
mechanisms during the 8 days in culture that made them more resistant than neurons in 
inside wells when they were challenged at day 8 or 9 by fresh culture medium (i.e. 
glutamate) excitotoxicity.  
 
Regardless of whether these relatively small differences in the viability between next-
edge wells and inside wells were real or were artefacts in the Alamar blue assay, it was 
clear  that  such  differences  could  lead  to  significant  misleading  conclusions.  For 
example, if the real difference in viability between two treatment groups, one with a 
toxic insult and the other with this toxic insult plus a protective agent, was around 5% in 
favour  of  the  latter  group  (which  might  not  be  statistically  significant),  placing  the 
former  group  in  inside  wells  and  the  latter  group  in  next-edge  wells  will  give  a 
difference, in the Alamar blue assay, of around 15-20% in favour of latter group, which 
can be statistically significant, but misleading. For this reason, next-edge wells were 
never used after this finding.  
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4.1.5 Fresh culture medium toxicity 
 
It turned out that the immediate damage seen in the neurons (including those in the 
control group) when they are manipulated at the experiments/intervention day (i.e. day 8 
or 9) was due to glutamate excitotoxicity (through activating NMDA receptors). The 
source of glutamate was the fresh serum (which we were unaware of its content of 
glutamate) which is present at 10% V/V in the fresh culture medium that is added to the 
cultures  at  that  day.  The  discovery  in  this  project  of  the  involvement  of  NMDA 
receptors in the fresh culture medium toxicity was serendipitous. This occurred when 
ethanol and DMSO, which were tried for another purpose (they were tried as hydroxyl 
radical scavengers), prevented this toxicity, and it was found in the literature that they 
can block NMDA receptors in neurons and can prevent glutamate toxicity [Lin et al., 
2003, Dildy and Leslie, 1989, Lovinger et al., 1989, Cebere and Liljequist, 2003, Danysz et al., 
1992, Wegelius and Korpi, 1995, Lu and Mattson, 2001]. When MK-801 [Fatokun et al., 
2008b & c], a specific NMDA receptor blocker was tried here, it blocked the toxicity. 
After  this  finding,  an  early  report  was  found  [Schramm  et  al.,  1990]  that  clearly 
demonstrated the role of NMDA receptors in fresh serum toxicity (likely through the 
activation of these  receptors by  glutamate already present in fresh serum) in CGNs 
cultures. Therefore, we kind of reached the same conclusion independently, which gives 
it  more  support.  The  very  low  concentration  at  which  MK-801  was  found  to  be 
protective here (20 nM) is in accord with this report of Schramm and co-workers (1990) 
which found a similar potency with MK-801.  
 
A series of experiments was conducted to substantiate this conclusion. The first was 
using  another  blocker  of  NMDA  receptors,  kynurenic  acid  [Perkins  and  Stone,  1982, 
Fatokun et al., 2008b]. Since the mechanism of blocking NMDA receptors by MK-801 
(blocks the ion channel in the receptor) is somewhat different from that of kynurenic 
acid (blocks the glycine binding site on the receptor) [Fatokun et al., 2008b], it was useful 
to try the latter to see if fresh culture medium toxicity can be prevented by two different 
ways  of  blocking  NMDA  receptors,  which  was  the  case.  The  relatively  high 
concentration of kynurenic acid needed to block the toxicity (1 mM) is in accord with a 
previous study that showed that this activity is relatively weak in cell cultures [Hilmas et 
al., 2001]. Kynurenic acid possesses other known activities e.g. blocking some nicotinic 
receptors and blocking non-NMDA glutamate receptors [Hilmas et al., 2001, Fatokun et 
al., 2008b]. However, it is unlikely that non-NMDA glutamate receptors were involved in   158 
fresh  culture  medium  toxicity,  since  the  specific  NMDA  receptor  blocker  MK-801 
provided  almost  complete  protection,  and  also  since  previous  studies  found  that 
blocking non-NMDA glutamate receptors does not prevent glutamate toxicity in CGNs 
[Eimerl and Schramm, 1991,Fatokun et al., 2008c, Resink et al., 1994].  
 
Further  evidence  for  the  role  of  glutamate  and  NMDA  receptors  in  fresh  culture 
medium toxicity came from an experiment in which fresh culture medium was behaving 
like glutamate in producing the so-called preconditioning effect. Marini and Paul (1992) 
have observed that acute pre-treatment (minutes/hours) with a subtoxic concentration of 
glutamate in CGNs can protect against a subsequent lethal exposure to glutamate itself 
(acute preconditioning effect). The same was found here with fresh culture medium, 
where acute pre-treatment with a reduced amount of fresh culture medium protected 
against a subsequent exposure to a lethal full amount of fresh culture medium itself. The 
protective mechanism of pre-treatment with subtoxic glutamate in CGNs was shown to 
be mediated by a subtle (subtoxic) activation of NMDA receptors [Marini  and  Paul, 
1992]. The experiment performed here with pre-treatment with reduced amount of fresh 
culture  medium  shows  that  as  the  volume  of  fresh  culture  medium  applied  as  pre-
treatment is reduced, the protection increased, suggesting that with reducing the volume 
in the pre-treatment (assuming that glutamate concentration is reduced in parallel) the 
effect of fresh culture medium (i.e. glutamate) moves away from a toxic effect towards 
a  preconditioning  protective  effect  against  a  subsequent  exposure  to  full  and  lethal 
amount of fresh culture medium (i.e. glutamate) itself.  
 
The experiments with ethanol, DMSO, MK-801, kynurenic acid, and pre-treatment with 
reduced amount of fresh culture medium showed that protection in these experiments 
against  fresh  culture  medium  toxicity  was  sustained  even  after  these  protective 
interventions were terminated and followed by addition of fresh culture medium (which 
contains glutamate) for 16-24 hr before the viability assay. Although it is possible that 
the  mechanism  of  the  sustaining  of  protection  of  ethanol,  DMSO,  MK-801,  and 
kynurenic acid is similar in these experiments (since they work by blocking NMDA 
receptors),  this  may  not  necessarily  be  the  same  mechanism  responsible  for  the 
sustaining of protection of pre-treatment with reduced amount of fresh culture medium 
(where this protection was likely mediated by subtle activation of NMDA receptors).  
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When a glutamate degrading enzyme, glutamic-pyruvic transaminase [Matthews et al., 
2000],  was  used  here  it  provided  almost  complete  protection  against  fresh  culture 
medium toxicity. Since glutamate is present in fresh serum-containing culture medium 
(like  the  one  used  here)  at  concentrations  more  than  50   M  [Aronica  et  al.,  1993, 
Schramm  et  al.,  1990],  this  effect  of  glutamic-pyruvic  transminase  confirms  that  the 
glutamate molecule itself (and not a similar NMDA receptor agonist) was responsible 
for fresh culture medium toxicity. This adds a direct proof to the study of Schramm and 
co-workers (1990) where they suggested glutamate to be responsible for fresh serum 
toxicity based on the presence of  glutamate in  fresh serum  and based  also on their 
finding of protection by blocking NMDA receptors. Therefore, the combined results of 
these two independent investigations makes it very likely that the toxicity of glutamate 
already  present  in  fresh  culture  medium  was  exerted  through  activating  NMDA 
receptors. This does not rule out that the toxicity of glutamate was potentiated by other 
factors in the fresh culture medium. It was shown previously that glutamate toxicity can 
be potentiated by serum, where serum albumin was likely the component responsible 
for this potentiation [Schramm et al., 1990, Eimerl and Schramm, 1991].  
 
When  glutamate  was  applied  here  to  CGNs  in  a  glutamate-free  and  a  serum-free 
solution at concentrations of 300 or 30  M for only one hour, it caused significant 
toxicity. This shows that CGNs are indeed susceptible to glutamate excitotoxicity, and 
also shows that serum is not required for this toxicity (although it can potentiate it). It is 
worth mentioning that the solution used here as a vehicle to externally add glutamate 
(MEM-HEPES-sol)  does  not  contain  added  glycine.  However,  it  is  very  likely  that 
glycine was still required for glutamate toxicity, since it is known to be required as a co-
substrate in NMDA receptor-mediated glutamate excitotoxicity in CGNs [Beaman-Hall 
et al., 1998, Fatokun et al., 2008b & c]. Since the concentration of glycine needed for such 
an action can be quite low (in nM concentrations) this amount could easily have been 
provided  by  the  cells  themselves,  as  suggested  previously  [Beaman-Hall  et  al.,  1998, 
Parks et al., 1991]. Also, since kynurenic acid provided substantial protection (likely 
through blocking the glycine binding site), this suggests that glycine was present and 
was  activating  its  kynurenic  acid-inhibitable  binding  site.  Another  point  worth 
mentioning is that, although MEM-HEPES-sol contains magnesium at nearly 0.8 mM 
which  is  known  to  be  a  physiological  blocker  of  NMDA  receptors,  it  was  shown 
previously  that  under  depolarizing  conditions,  as  applied  here  (25  mM  potassium   160 
chloride), NMDA receptors can be activated even in the presence of magnesium [Marini 
and Paul, 1992, Eimerl and Schramm, 1991]. 
 
By  discovering  that  glutamate  already  present  in  the  fresh  culture  medium  was 
responsible (through activating NMDA receptors) for the immediate damage induced by 
manipulating  the  neurons  at  the  intervention  day,  many  previously  unexplained 
observations in this project seemed to be explainable at once. One observation was that 
the damage induced to the neurons at the intervention day was severe in this project but 
not severe in two previous projects undertaken in this laboratory [Fatokun, 2006, Smith, 
2008]. The cell density observed under the microscope immediately after plating tended 
always to be much higher in this project compared to the previous two projects, which 
was likely due to a small difference in the culturing procedure undertaken at the plating 
day  (i.e.  day  zero).  It  seems  now  that  the  higher  cell  density  in  this    project  was 
responsible  for  the  severe  damage  observed  by  adding  fresh  culture  medium  (i.e. 
glutamate) at the intervention day, since glutamate excitotoxicity was shown previously 
to be highly dependent on the neurons density in CGNs cultures [Ciotti et al., 1996].  
 
Another observation was that the toxicity of the added fresh culture medium tended 
always to be more severe if this medium was looking more pinkish (i.e. more alkaline). 
Although  close  adjustment  of  this  fresh  medium  pH  resulted  in  a  considerable 
improvement in cell viability, the damage by adding this fresh medium was still severe. 
Also, when a plate containing the cultures was placed outside the incubator for more 
than an hour, although this made the culture medium that the neurons were maintained 
in very pinkish (i.e. very alkaline) and although this also likely reduced the temperature 
of the cultures to the room temperature, this did not damage the neurons (at least no 
immediate damage was observed). It seemed at that time that although increasing the 
pH per se (at day 8 or 9) of the culture medium that the neurons are maintained in does 
not kill the neurons, increasing the pH of the fresh culture medium that is added at day 8 
or 9 potentiates its toxicity. The increase in damage by increasing fresh culture medium 
pH can now be explained by the fact that NMDA receptor-mediated glutamate toxicity 
in CGNs is greatly potentiated by the increase in pH [Eimerl and Schramm, 1991], which 
is  because  increasing  the  pH  relieves  a  proton-mediated  block  of  NMDA  receptors 
[Traynelis and Cull-Candy, 1990]. However, because NMDA receptor-mediated glutamate 
toxicity does indeed operate at pH 7.4 [Eimerl and Schramm, 1991], this also explains the 
damage observed here by adding fresh culture medium (i.e. glutamate) even with close   161 
adjustment of pH (though this adjustment improved the viability). Also, the fact that 
NMDA receptors require the ligand (i.e. glutamate) to cause toxicity may also explain 
the observation that the increase in the pH per se (at day 8 or 9) of the culture medium 
that  the  neurons  are  maintained  in  (which  does  not  contain  significant  amount  of 
glutamate) does not kill the neurons. 
 
A third observation that was not explained previously was that the culture medium does 
not  kill  the  neurons  when  they  are  maintained  in  it  before  the  intervention  day. 
Although there were many neurons dying in the first 24 hr of plating, fresh culture 
medium  was  not  suspected  to  cause  this  death  for  two  reasons.  Firstly,  this  culture 
medium is universally used to culture many types of cells including neurons, and there 
was  no  reason  to  suspect  that  this  medium  might  be  toxic.  Secondly,  if  it  was 
responsible for the death observed at the plating day (i.e. day zero), why did it not kill 
the viable neurons when they were maintained in it from day 1 until the intervention 
day? Actually this was the reason that in the beginning a toxic effect of the added fresh 
culture  medium  was  not  suspected  as  the  reason  for  the  damage  observed  at  the 
intervention day, where alternative explanations were explored at that time. However, 
this can now be explained by the following scenario of events. In the first few days, 
glutamate can not cause damage to neonatal CGNs as was shown previously [Frandsen 
and  Schousboe,  1990,  Resink  et  al.,  1994],  and  this  is  likely  because  the  glutamate 
receptors subunits that can mediate the toxicity are not matured/functioning at this early 
stage [Frandsen and Schousboe, 1990, Resink et al., 1994, Schramm et al., 1990, Leist et al., 
1997]. Since the brain quickly clears any glutamate that is present extracellularly, the 
glutamate present in the fresh culture medium is quickly removed by CGNs as was 
shown  previously  where  glutamate  concentration  drops  in  fresh  serum-containing 
culture medium in CGNs cultures from more than 50  M to only 5  M in the first 24 hr, 
and then drops further in the next two days to around 2  M and is maintained at this low 
level in the subsequent days [Aronica et al., 1993]. By the time that glutamate receptors 
subunits that can mediate toxicity are matured (likely after 5-6 days of plating [Resink et 
al., 1994]) there will be no significant amount of glutamate left in the culture medium to 
cause  toxicity,  but  when  fresh  culture  medium  (which  contains  more  than  50   M 
glutamate) is added to the neurons at the intervention day (i.e. day 8 or 9), glutamate 
binds to the matured NMDA receptors to induce severe toxicity to the CGNs.  
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Schramm  and  co-workers  (1990)  have  discussed  the  pathological  relevance  of  the 
presence of glutamate in serum (i.e. circulation), and the potentiation of its toxicity by 
some  serum  components.  They  proposed  that  in  some  pathological  conditions  e.g. 
hemorrhagic  stroke  or  brain  trauma,  circulating  glutamate  might  contribute  to  cell 
damage. This is a valid proposal and this might be a unique mechanism of in vivo 
toxicity, since the exposure of neurons to circulating glutamate in such pathological 
conditions might initiate toxicity without the pre-request of the depolarization/damage-
induced glutamate release from the neurons. The same authors also speculated that such 
a circulating glutamate might cause chronic toxic effects by leaking through the blood 
brain barrier (BBB) in elderly people where this barrier is expected to be fragile.  
 
Given the central excitatory role played by glutamate in the brain, the wide diversity of 
its receptor sub-classes, its presence in the circulation, and its ability to cause neuronal 
damage  in  many  situations,  it  is  not  surprising  that  every  time  a  new  role  is 
postulated/discovered  for  the  glutamate  system  in  neuronal  pathological  conditions 
(studied in vivo or in vitro) that were not shown/suspected initially to be related to this 
system. Therefore, in studying neuronal pathologic conditions thought not to be related 
to  glutamate  system,  it  should  be  considered  that  the  master,  highly  diverged,  and 
widely  distributed  glutamate  system  might  be  interfering  with  the  condition  under 
investigation, and that checking for this involvement may resolve some unexplained 
observations. 
 
4.2 Oxidative stress experiments performed before solving the 
problem of fresh culture medium toxicity 
 
The  interpretation  of  the  results  of  the  experiments  discussed  in  this  section  is 
complicated  by  two  facts.  These  experiments  were  performed  before  solving  the 
problem  of  fresh  culture  medium  toxicity,  which  means  that  the  cultures  (including 
those in the control groups) were under the influence of glutamate excitotoxicity. Also, 
some of these experiments were performed before finding that the neurons in next-edge 
wells give consistently higher viability readings than the neurons in inside wells, so 
some of the treatment  groups in these experiments were containing next-edge wells 
(which  may  result  in  misleading  conclusions  as  discussed  before).  However,  it  was 
appropriate to discuss some of those experiments (performed in that period) that were   163 
consistent and provided some valuable information. Due to the uncertainties mentioned 
above, there will be only a brief discussion of the results in this short section, without 
detailed discussion on  why  a compound produced  an unexpected effect or failed to 
produce an expected effect. 
 
The idea was to test the susceptibility of CGNs to different types of oxidative stress 
insults,  which  can  lay  the  foundation  for  detailed  investigation  of  XO  toxicity. 
Hydrogen peroxide externally applied showed toxicity to CGNs in a dose dependent 
manner, which is in agreement with previous studies that externally applied this toxic 
insult to CGNs [Fatokun et al., 2007b, Götz et al., 1999]. Due to the relatively modest 
reactivity of hydrogen peroxide, it usually exerts its toxic effects through its conversion 
to more reactive species, usually hydroxyl radical. This conversion to hydroxyl radical, 
called Fenton reaction, requires a metal, usually iron or copper (see Introduction). When 
deferoxamine, an iron chelator with high affinity for the oxidized form of iron (i.e. Fe
3+) 
[Keberle, 1964], was tried, it provided protection, raising the possibility that hydrogen 
peroxide toxicity was due to Fenton reaction. To confirm this mechanism of toxicity, a 
hydroxyl  radical  scavenger,  mannitol,  was  tried,  but  failed  to  show  any  protection. 
Although the failure of mannitol to protect can be explained by the lack of a role of 
Fenton  reaction  and  hydroxyl  radical  in  the  toxicity,  there  are  many  alternative 
explanations (see later in section 4.3).  
 
Another toxic insult, the X / XO combination, was tried and it showed significant and 
consistent toxicity to CGNs when applied at X (100  M) / XO (0.02 Units/ml). The 
toxicity of this combination is expected since it is known to produce toxicity in different 
types of cell cultures [Fatokun et al., 2007a, Satoh et al., 1998, Link and Riley, 1988, Mohsen 
et al., 1995, Duell et al., 1995, Simon et al., 1981, Hiraishi et al., 1987, Zigler etal., 1985, 
Valencia  and  Morán,  2004].  Since  this  combination  is  known  to  directly  produce 
hydrogen peroxide and superoxide (hydrogen peroxide should also be produced by the 
spontaneous dismutation of superoxide that is directly produced), catalase and SOD-1 
were  tried  against  the  toxicity  of  this  combination.  Catalase  produced  complete 
protection, but SOD-1 failed to produce protection.. Most previous studies in cultures 
found that  catalase protects whereas SOD does not protect against X / XO toxicity 
[Fatokun et al., 2007a, Satoh et al., 1998, Link and Riley, 1988, Mohsen et al., 1995, Duell et 
al., 1995, Simon et al., 1981, Hiraishi et al., 1987, Zigler etal., 1985].  
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In the same experiment, in addition to testing the effects of catalase and SOD-1, two 
XO inhibitors were tried against X / XO toxicity: allopurinol (a blocker of the X binding 
site, the Mo site) and DPI (a blocker of the NADH binding site, the FAD site) (see 
Introduction).  Both  of  allopurinol  and  DPI  failed  to  provide  statistically  significant 
protection,  which  was  unexpected  since  both  (especially  allopurinol)  are  known  to 
block  X  oxidation  by  XO  (but  see  next  section  4.3  for  detailed  discussion  of 
experiments  performed  after  solving  the  problem  of  fresh  culture  medium  toxicity 
where these two compounds were tried against X / XO toxicity).  
 
Since catalase provided complete protection against X / XO toxicity, this suggests that 
hydrogen peroxide is a main toxic molecule, which makes this toxicity model somehow 
similar  to  the  toxicity  model  of  externally  applying  hydrogen  peroxide.  Since 
deferoxamine provided protection against externally applied hydrogen peroxide, it was 
also tried against X / XO toxicity. Although deferoxamine at the concentration (and 
incubation time) that was protective against externally applied hydrogen peroxide did 
not show protection against X (100  M) / XO toxicity, it was protective when the toxic 
insult was reduced to X (30  M) / XO, which suggests that it did not protect in the first 
experiment  because  the  toxic  insult  was  too  severe  for  it  to  provide  significant 
protection. Also the protection with deferoxamine against X / XO toxicity was increased 
when its pre-treatment time was increased, and since this chelator is expected to be slow 
in  entering  the  cells  [Porter  et  al.,  1988],  this  suggests  that  its  site  of  action  is 
intracellular (see section 4.3 for more discussion on deferoxamine). 
 
A third type of oxidative stress insults, a nitric oxide donor, SNAP, was also applied to 
CGNs cultures to see if they are also susceptible to this type of toxicity. Nitric oxide is a 
free  radical  that  can  cause  damaging  effects  (probably  indirectly)  under  some 
conditions, which was demonstrated previously in CGNs cultures [Leist et al., 1997]. 
SNAP treated here for 24 hr showed a dose dependent toxicity. However, it may be that 
this effect of SNAP was not due to providing nitric oxide. The reason is that the SNAP 
powder  was  dissolved  and  the  aliquots  of  the  solution  kept  in  a  freezer  until  the 
experiment day. If SNAP in solution instantly generates nitric oxide (as expected), this 
raises the possibility that the nitric oxide, which is a short lived free radical, generated 
would have been long degraded before the experiment day. A better way would have 
been to dissolve SNAP powder and then add it to the cultures instantly.  
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There  is  more  than  one  explanation  for  the  observed  toxicity  with  SNAP.  One 
possibility is that it was still due to, at least partially, nitric oxide spontaneously released 
by SNAP at the time of treatment. This is because, based on the published data on 
SNAP stability in solutions under different conditions (where SNAP t1/2 can be up to 
hours) [Megson et al., 1997, Ioannidis et al., 1996, Singh et al., 1996, Mathews and Kerr, 1993, 
Arnelle  and  Stamler  1995],  there  is  still  a  possibility  that  the  SNAP  stock  solution 
prepared  under  our  conditions  (the  powder  was  dissolved  in  distilled  water  to  a 
concentration of 10 mM at room temperature and ambient oxygen, aliquoted, protected 
from light, and then immediately kept in freezer until the experiments day) was still 
containing a significant amount of intact SNAP when the frozen aliquots were thawed 
and SNAP was applied to CGNs. A second possibility, also assuming the presence of a 
significant amount of intact SNAP at the time of addition to cultures, is that the toxicity 
was not due to nitric oxide spontaneously released by SNAP, but rather was due to other 
actions of SNAP itself that may or may not involve production of nitric oxide (but not 
spontanously  released from it). This is consistent with some previous studies which 
showed that some biological actions of SNAP, although might be due to production of 
nitric oxide, are not due to nitric oxide that is spontanously released from it [Kowaluk 
and Fung, 1990, Singh et al., 1996, Mathews and Kerr, 1993, Arnelle and Stamler, 1995]. A 
third possibility, assuming that SNAP was long degraded before the experiments time, 
is that the toxicity was not due to nitric oxide released spontaneously from SNAP, and 
was not due to other actions of intact SNAP itself, but rather was due to toxic effects of 
some degradation products of SNAP (generated before the time of addition to cultures) 
other than nitric oxide.  
 
Overall,  these  experiments  performed  before  solving  the  problem  of  fresh  culture 
medium  toxicity  gave  some  helpful  information.  They  showed  that  CGNs  are 
susceptible to perhaps more than one type of oxidative stress injury. They also showed 
that the toxicity models of both externally applying hydrogen peroxide and externally 
applying  the  X  /  XO  combination  are  similar  in  that  both  are  completely  (but  not 
necessarily exclusively) mediated by hydrogen peroxide, where an iron ion was likely 
mediating hydrogen peroxide toxicity. These experiments leave unanswered the effect 
of SOD, allopurinol, or DPI on X / XO toxicity, but a detailed investigation of the effect 
of these compounds was carried out in the  experiments performed after solving the 
problem of fresh culture medium toxicity, which will be discussed in the next section 
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4.3 Oxidative stress experiments performed after solving the 
problem of fresh culture medium toxicity 
 
After solving the problem of fresh culture medium toxicity, it was possible to conduct 
reliable experiments. In this stage of the project, it was possible to answer many of the 
questions stated earlier in the section on the Aim/Objectives in the Introduction. This 
section is divided into two main sections, the first is a comparison between X / XO and 
NADH / XO toxicities, and the second is a further investigation of X / XO toxicity. 
 
4.3.1 Comparison between X / XO and NADH / XO toxicity models 
 
Although  a  combination  of  XOR  and  X  (or  other  substrates  that  bind  to  the 
molybdenum site) is a widely used model in cell culture studies to generate ROS and to 
study their effects, the toxicity/effect of the combination of XOR and NADH (which 
binds the FAD site) in cell cultures has not been investigated in detail previously. Some 
possible reasons for this lack of interest to investigate this combination were mentioned 
in  the  Introduction,  and  it  was  also  mentioned  in  the  Introduction  that  the  in  vivo 
effect/toxicity  of  the  oxidation  of  NADH  by  XOR  might  have  been  underestimated 
previously. 
 
The idea was to compare X / XO and NADH / XO toxicity models in their potency, 
their response to blocking the different sites of XO, and the type of ROS and metals 
responsible for toxicity.  The results show that NADH / XO and X / XO combinations 
are toxic to cultures of CGNs. However, the concentration of NADH needed to cause 
the toxicity was much higher than that of the other substrate, X, which is in agreement 
with previous cell-free experiments that showed that NADH is a much weaker substrate 
than X for the bovine milk XO used here [Gilbert, 1963, Liochev et al., 1989, Nakamura, 
1991].  However, some other forms of the enzyme (e.g. bovine milk XDH, human milk 
XO,  human  milk  XDH,  human  liver  XO,  rat  liver  XDH,  and  rat  liver  XO)  have 
more/much more efficiency in oxidizing NADH than the bovine milk XO used here 
[Maia et al., 2007, Sanders et al., 1997, Zhang et al., 1998], and even some of them oxidize 
NADH with similar oxidation kinetics to the oxidation of X by the bovine milk XO. 
Therefore, much less concentration of NADH might have been enough to cause toxicity   167 
if some of these other forms were used instead. Bovine milk XO was used in this project 
because of the availability, and also because it is the most studied form of the enzyme.  
 
The  NADH  /  XO  combination  was  applied  for  only  one  hour,  where  lower 
concentrations  of  NADH  might  have  been  enough  to  induce  toxicity  if  applied  for 
longer durations. However, it was not possible to apply the NADH / XO for longer 
durations, because a previous study in this laboratory showed that XO applied alone for 
6 hr caused significant toxicity to CGNs (probably through oxidizing xanthine produced 
by the neurons, since allopurinol attenuated this toxicity) [Fatokun et al., 2007a].  
 
In both of NADH / XO and X / XO toxicities (especially the latter), the damage tended 
always  to  be  more  severe  and  more  consistent  in  HEPES-sol  compared  to  MEM-
HEPES-sol. There are many differences between these two treatment solutions which 
makes it difficult to know the reason(s) of this interesting difference in the susceptibility 
to  toxicity  without  a  systematic  investigation.  Also,  this  is  complicated  by  that  the 
opposite was observed when NADH was applied alone, where it was toxic at 2 mM (but 
not 1 mM) in MEM-HEPES-sol but not in HEPES-sol. This toxicity of NADH alone in 
only  one  of  the  treatment  solutions is  also  difficult  to  explain  without a  systematic 
investigation.  These  observations,  however,  were  not  considered  to  affect  the  main 
conclusions drawn from this project. Notice that it is unlikely that any of the observed 
effects of NADH applied alone or in combination with XO is due to an artefact due to a 
direct interaction (e.g. reduction) between NADH and the Alamar blue dye used in the 
viability assay, since as mentioned before the test compounds (including NADH) were 
not present together with Alamar blue. The test compounds were removed and replaced 
by conditioned medium for at least 16 hr before applying Alamar blue.  
 
 4.3.1.1 Effects of inhibiting the different sites on XO 
 
In agreement with previous cell-free experiments, it was found that blocking the site of 
X binding (the Mo site) with allopurinol failed to prevent the damage induced by the 
NADH / XO combination, although it prevented the damage induced by the X / XO 
combination.  This  result  is  consistent  with  the  previous  proposal  that  the  failure  of 
allopurinol in preventing tissue damage in some previous studies where XOR-mediated 
damage was suspected [Allen et al., 1990, Benders et al., 2006, Mosler et al., 2005, Coetzee et 
al., 1996] might be theoretically explained  by the inability of allopurinol to prevent   168 
NADH oxidation by XOR, and hence its inability to prevent the tissue damage [Berry 
and Hare, 2004, Harrison, 2002, Sanders et al., 1997, Zhang et al., 1998].  
 
Blocking the site of NADH binding (the FAD site) with DPI at 100 nM attenuated the 
damage  induced  by  the  NADH  /  XO  combination  applied  in  either  HEPES-sol  or 
MEM-HEPES-sol,  which  was  expected  since  DPI  is  known  to  block  this  site.  This 
(along with the failure of allopurinol to protect) suggests that the toxicity of the NADH / 
XO combination was mediated/initiated by direct enzymatic oxidation of NADH by XO 
and was not due to merely (or exclusively) non-specific interaction between the enzyme 
and the substrate. DPI also blocked the toxicity of the X / XO combination applied in 
HEPES-sol.,  but  failed  to  show  statistically  significant  protection  against  this 
combination when applied in MEM-HEPES-sol.  In any case, the results show that DPI 
can prevent X / XO toxicity  in HEPES-sol, which is in agreement with previous cell-
free experiments that showed that the FAD site is the site of ROS generation regardless 
of whether the reducing substrate binds to the Mo site (i.e. X or HX) or to the FAD site 
(i.e. NADH) [Komai et al., 1969, Sanders et al., 1997, Olson et al., 1974, Nakamura, 1991, 
Berry and Hare, 2004, Harrison, 2002].   
 
 4.3.1.2 Identification of ROS and metals responsible for the toxicity 
 
The effects of SOD-1 and catalase on the toxicity of the X / XO and the NADH / XO 
combinations were investigated in this study. In the case of X / XO toxicity, although 
catalase  provided  almost  complete  protection,  SOD-1  failed  to  produce  any  effect, 
implicating  that  although  hydrogen  peroxide  is  required  for  this  type  of  toxicity, 
extracellularly  generated  superoxide  is  not  (may  be  apart  from  its  spontaneous 
dismutation  to  hydrogen  peroxide).  Also  when  the  superoxide  scavenger,  Tiron 
[Greenstock and Miller, 1975, Hassan et al., 1980], was tried as a co-treatment, it failed to 
provide protection against X / XO toxicity. The lack of protection by co-treatment with 
SOD-1 against  X / XO toxicity is in agreement with many previous culture studies 
which have used different types of cell/organ cultures including CGNs [Fatokun et al., 
2007a, Satoh et al., 1998, Link and Riley, 1988, Mohsen et al., 1995, Duell et al., 1995, Simon 
et al., 1981, Hiraishi et al., 1987, Zigler et al., 1985], but with at least one exception which 
found protection with 6 hr co-treatment with SOD-1 against X / XO toxicity in cultures 
of CGNs [Valencia and Morán, 2004].  The protection found by the study of Valencia and 
Morán  (2004)  suggests  that  SOD-1  co-treatment  under  some  conditions  can  protect   169 
against X / XO toxicity, although no clear difference in the experimental conditions was 
suspected to account for the difference in the observed effect between this and the many 
other studies that did not find protection with SOD co-treatment. 
 
One may think that the observation (found here and in many previous studies) that SOD 
does not increase or decrease X / XO toxicity is an odd result. To put it in other words, 
SOD should either potentiate the toxicity if it is a hydrogen peroxide-dependent (and 
not superoxide-dependent) (since SOD will convert superoxide to hydrogen peroxide) 
or attenuate the toxicity if it is a superoxide-dependent, so the  result that SOD has 
neither of these two effects indeed needs an explanation. That SOD does not attenuate 
the toxicity can be explained by the lack of a role of superoxide produced extracellularly 
in the toxicity (may be apart from its spontaneous dismutation to hydrogen peroxide). 
On the other hand, a possible explanation for the inability of SOD to potentiate the 
toxicity  (assuming  that  it  is  a  hydrogen  peroxide-dependent  and  not  superoxide-
dependent) is that most of ROS produced directly by X / XO (around 80%) are known 
to be in the form of hydrogen peroxide, while the remaining 20% will be in the form of 
superoxide  (although  this  may  change  depending  on  the  experimental  conditions) 
[Fridovich,  1970].  Therefore,  adding  SOD,  which  will  convert  two  molecules  of 
superoxide into one molecule of hydrogen peroxide, will result in only a small increase 
in  hydrogen  peroxide  production  (around  10%),  and  so  there  will  be  no  significant 
increase in the X / XO toxicity. An additional explanation for the inability of SOD to 
potentiate the toxicity (again assuming that it is a hydrogen peroxide-dependent and not 
superoxide-dependent) is that even in the absence of SOD, all superoxide produced by 
X  /  XO  would  quickly  and  spontaneously  dismutate  to  hydrogen  peroxide  in  the 
extracellular  compartment  (if  given  the  time,  which  might  be  the  case  because 
superoxide may not be able to enter the cells, and also because superoxide production 
ceases long time before the end of the 1 hr treatment, see later). This means that the 
same result (i.e. dismutation of superoxide to hydrogen peroxide extracellularly) was 
going to be produced regardless of whether SOD is present or not.   
 
The fact that superoxide can quickly and spontaneously dismutate to hydrogen peroxide 
does  not  of  course  mean  that  SOD  activity  is  not  important  as  an  in  vivo  defence 
mechanism  against  oxidative  stress,  because  it  is  the  difference  in  the  efficiency 
between the enzymatic and the non-enzymatic (spontaneous) dismutation of superoxide 
that matters [Fridovich, 1983]. Although a portion of the superoxide produced in vivo   170 
will  immediately  and  spontaneously  dismutate  to  hydrogen  peroxide,  a  remaining 
portion  may  stay  active  and  travel  relatively  long  distance  before  it  eventually 
spontaneously dismutates, so unless the very efficient SOD is present, a superoxide-
dependent effect/toxicity may occur. 
 
There is a possibility that the way in which the X / XO mixture was added to the cells in 
this study may have masked a toxic role of superoxide generated from this combination. 
This is because whenever X and XO were added together to the treatment solution, this 
mixture-containing  solution  was  warmed  in  the  water  bath  for  few  minutes  before 
adding to cultures. The cell-free experiments in Figures 3-50 and 3-51 clearly showed 
that superoxide generation by X / XO combination ceases by less than 10 minutes after 
starting the reaction, where after this 10 minutes most of the short-lived superoxide 
would have already been spontaneously dismutated to hydrogen peroxide. Therefore, by 
the time of adding the mixture to cells (5-10 minutes after starting the reaction), there 
might not be a significant amount of superoxide that would otherwise produce a specific 
toxicity (may be through entering the cells). A better way of conducting the viability 
experiments was to start the X / XO reaction in the vicinity of cells, which would give 
the  generated  superoxide  time  to  be  in  contact  with  cells  where  it  may  produce  a 
specific toxic effect through entering the cells or directly interacting with them. Not 
only this, but also catalase (to deactivate extracellular hydrogen peroxide) should be 
present when the reaction is started in the vicinity of cells to make sure that an observed 
toxicity  of  X  /  XO  combination  is  due  to  superoxide  entering  the  cells  (or  directly 
interacting with them) and not merely due to its extracellular spontaneous dismutation 
to hydrogen peroxide. If there is still toxicity observed with this experimental design, a 
role of superoxide can then be confirmed by using SOD.   
 
A pilot study was undertaken for the experimental design detailed above ( n = 1). In this 
one trial, the experiment was performed as follows: the reaction of X (100  M) / XO 
(0.02 Units/ml) was started in the vicinity of neurons in the presence or absence of 
catalase (10 Units/ml) in HEPES-sol. Even with this design, catalase provided complete 
protection  (data  were  not  shown).  It  was  mentioned  in  the  Results  section  that  in 
HEPES-sol the X / XO combination always produces large and consistent toxicity at X 
concentration  of  only  15   M,  and  that  it  produces  almost  complete  toxicity  at  X 
concentration of 30  M. Therefore, using X here at 100  M was expected to cause 
almost complete toxicity (which was the case), and importantly was also expected to   171 
produce  large  amount  of  superoxide  in  the  vicinity  of  neurons.  Notice  that  in  the 
viability experiments shown in section 3.3.2.4 of the Results section, catalase was tried 
at 3 Units/ml, but it was tried in this one trial at 10 Units/ml, and this was done to make 
sure that it is able to deactivate most of hydrogen peroxide generated from X / XO 
combination, especially since X was used at 100  M where large amounts of hydrogen 
peroxide  were  expected  to  be  produced.  Although  it  was  shown  in  the  cell-free 
experiments  in  the  Results  section  that  catalase  is  contaminated  with  some  SOD 
activity, the contamination was observed at catalase (1000 Units/ml) and was less at 
catalase (300 Units/ml), with no observed contamination at catalase (3 Units/ml), so it is 
unlikely that there was a significant contamination with SOD activity at the catalase 
level  (10  Units/ml)  used  here.  Therefore,  the  absence  of  any  observed  toxicity  of 
superoxide generated in the vicinity of neurons (in the presence of catalase) suggests 
that  (as  suggested  by  the  completed  experiments  and  by  many  previous  studies) 
superoxide  generated  extracellularly  from  X  /  XO  combination  has  no  role  in  the 
toxicity  of  this  combination  (may  be  apart  from  its  extracellular  dismutation  to 
hydrogen peroxide). However, this was only a single trial experiment (n = 1), so it was 
not possible to confirm this observation.  
 
In the case of the NADH / XO combination, the experiments were conducted in the 
same way as those with the X / XO combination i.e.  NADH and XO were added to the 
treatment solution which was then warmed in the water bath for few minutes before 
adding to cultures. However, the reaction between NADH and the bovine milk XO is 
expected to be slow (since NADH, is relatively a very week substrate for this isoform of 
XO). Therefore, it is possible that most of the oxidation of NADH by XO was occurring 
during the one hour application to cells (not during the few minutes of warming as in 
the X / XO system), although this can not be confirmed.  
 
Although  NADH  /  XO  toxicity  was  similar  to  X  /  XO  toxicity  in  the  complete 
protection afforded by catalase, the former differed in that SOD-1 provided substantial 
protection. It is likely that, for many reasons, this protection by the co-treatment with 
SOD-1 was due to its elimination (dismutation) of superoxide and not due to any of the 
known non-specific actions of SOD-1 that may not involve elimination of superoxide. 
Firstly, SOD-1 was protective at concentrations as low as 3 Units/ml (which is one of 
the lowest concentrations tried in previous toxicity studies), whereas the non-specific 
actions of SOD-1 are expected to occur at high concentrations [Liochev and Fridovich,   172 
2007]. Secondly, Mn-SOD (3 Units/ml), which is known to be free of at least some of 
the non-specific actions of SOD-1 [Sankarapandi and Zweier, 1999, Liochev and Fridovich, 
2000],  was  as  protective  as  SOD-1.  Thirdly,  SOD-1  was  protective  in  both 
bicarbonate/CO2-containing solution (MEM-HEPES-sol) and a solutions without added 
bicarbonate/CO2 (HEPES-sol), which argues against a role for a peroxidase activity of 
SOD-1  in  the  observed  protection,  since  this  non-specific  activity  was  shown  to  be 
dependent on bicarbonate/CO2 [Goldstone et al., 2006, Sankarapandi  and Zweier, 1999, 
Liochev  and  Fridovich,  2004].  Fourthly,  substantial  protection  against  NADH  /  XO 
toxicity was observed by co-treatment with the superoxide scavenger, Tiron (though 
Tiron is also known to be (among other actions) an effective chelator of some metals 
including iron and molybdenum [Fridovich and Handler, 1962], an activity that can not be 
ruled out as the reason for its protection). 
 
It is likely that the protection by SOD-1 (and Mn-SOD) (especially since that it was 
used  as  co-treatment  rather  than  pre-treatment,  that  it  was  protective  at  a  low 
concentration (3 Units/ml), and was applied for only 1 hr) was due to an extracellular 
action  of  this  enzyme.  Some  previous  reports  suggested  that  SOD-1  is  unable  to 
quickly/easily  penetrate  the  cell  membrane  even  at  high  concentrations.  In  neuronal 
cultures, acute co-treatment with SOD-1 (or even pre-treatment with SOD-1 for 8-24 hr) 
did not prevent glutamate-receptor mediated excitotoxicity, despite the fact that in those 
studies, intracellular production of superoxide was found to mediate the toxicity [Patel et 
al., 1996, Lafon-Cazal et al., 1993a & b]. Also, using a very specific detection method of 
intracellular  superoxide,  it  was  shown  that  SOD-1,  although  applied  as  a  1  hr  pre-
treatment (which gave prolonged contact with cells) and at a much higher concentration 
than 3 Units/ml (up to 100 units/ml), could not scavenge intracellular superoxide in 
cultures  of  bovine  aortic  endothelial  cells  [Zhao  et  al.,  2005].  However,  uncertainty 
remains;  since  other  reports  showed  clearly  that  SOD-1  can  enter  cells  under  some 
conditions. SOD-1 (500 Units/ml) co-treated for 1 hr was able to produce a protective 
effect by entering cultured hepatocytes by endocytosis [Kyle et al., 1988], where this 
endocytosis  was  also  observed  by  another  study  that  followed  it  using  a  different 
approach [Dini et al., 1995]. However, the protection by SOD-1 against a similar insult 
using the same cell culture type (rat hepatocytes), as well as the entrance of SOD-1 to 
those cells, was not observed in another study [Ito et al., 1992], which suggests that small 
differences in the experimental conditions may have large consequences.  In neurons, 
there were also some studies where SOD-1 was producing effects suggestive of it being   173 
entering the neurons e.g. SOD-1 produced a protective effect in cultures of spinal cord 
neurons against glutamate excitotoxicity, but SOD-1 in that study was not applied as co-
treatment but rather as pre-treatment for 2 hr and at a high dose [Michikawa et al., 1994].  
 
Although it is more likely that SOD-1 (and Mn-SOD) was working here extracellularly 
rather than intracellularly to produce protection against NADH / XO toxicity, this does 
not answer the question of whether SOD was blocking an extracellular toxic action of 
superoxide or was deactivating it extracellularly before it could cross the cell membrane 
and exert an intracellular toxic action? This question is difficult to answer from the 
available results. Although superoxide (which is an anionic  radical) is  known to be 
generally  very  poor  in  crossing  biological  membranes  [Takahashi  and  Asada,  1983, 
Liochev and Fridovich, 2005], there are some exceptions in which it was shown to be able 
to do so [Liochev and Fridovich, 2005]. Actually, even in CGNs, activating the glutamate 
NMDA-receptors was shown to lead to an intracellular production of superoxide that 
was able to exit the neurons and be detected in the extracellular compartment [Lafon-
Cazal et  al.,  1993b,  Atlante  et  al.,  1997]. However, it is unclear if activating NMDA-
receptors in those studies had led to the opening of some channels or pores (or to some 
defects in membrane integrity) that allowed intracellular superoxide to exit the neurons 
through  these  channels/pores  that  would  be  otherwise  impermeable  to  superoxide. 
Therefore, it is unclear if superoxide generated here from the NADH / XO combination 
was able to enter the cells. The possibility that superoxide was not entering the neurons, 
and was instead producing its toxic action in the extracellular compartment, might be 
supported by the observed protection by co-treatment with EDTA. This general chelator 
of cations and metals [Hutcheson et al., 2004] is regarded as a biological membrane-
impermeable compound [Gazaryan  et  al.,  2007, Frederickson  et  al.,  2002,  Azuma  et al., 
2001, Abeijon and Hirschberg, 1990] (an exceptional previous study showed that EDTA 
was able to enter cells by endocytosis, but it was used at a very high concentration (6 
mM) [West and Brownstein, 1988], whereas EDTA was protective here at concentrations 
as low as 2  M). Also the mode of EDTA protection here suggests that is was blocking 
an extracellular metal-dependent toxic action (see later). Although this effect of EDTA 
does not necessarily mean that SOD (and Tiron) was blocking an extracellular toxic 
action of superoxide, it suggests so. This is because in many cases, superoxide exerts its 
toxicity through reacting with metals, and since both of SOD and EDTA (which were 
likely  working  extracellularly)  were  protective,  an  extracellular  toxic  interaction 
between superoxide and a metal might have been responsible for the toxicity.      174 
If SOD was exerting its protection through blocking an extracellular toxic action of 
superoxide,  this  can  be  through  blocking  one  of  many  candidate  toxic  actions  of 
superoxide. Superoxide can mediate a metal-catalyzed toxicity (as mentioned above) 
e.g. through mediating the conversion of hydrogen peroxide to the very reactive and 
toxic hydroxyl radical (or a similar species) [Fong et al., 1976, Halliwell, 1978, McCord 
and Day, 1978]. This conversion in biological systems results from the reaction between 
hydrogen peroxide and a reduced metal ion, usually iron or copper (Fenton reaction). 
Since the extracellular metal ion that might be present in the treatment solutions as a 
contaminant is likely to be in the oxidized form, superoxide will be required for its 
reduction, making it able to react with hydrogen peroxide to produce hydroxyl radical. 
Even if the metal is present in the reduced state, superoxide will be required to reduce it 
back when it is oxidized by hydrogen peroxide, and hence to continue the reaction. The 
presence of NADH in the system makes this possibility more likely. This is because it 
was  shown  previously  that,  in  the  presence  of  reduced  iron  and  NADH,  externally 
added hydrogen peroxide generates much more hydroxyl radicals than it generates in 
the presence of only reduced iron [Rowley and Halliwell, 1982]. Interestingly in this study 
by Rowley and Halliwell (1982), hydroxyl radical generation was blocked by SOD, 
implying that superoxide was both produced and required, may be to reduce back the 
Fe
3+ that was converted from Fe
2+ upon oxidation by added hydrogen peroxide. In the 
case  of  the  NADH  /  XO  combination  applied  here,  superoxide,  in  addition  to  its 
possible generation by such a reaction, is actually directly generated by the oxidation of 
NADH by XO, and hydrogen peroxide is also directly produced by this oxidation and 
will also be produced by the spontaneous dismutation of superoxide. If a contaminant 
metal ion is also present in the system, the requirement for extracellular production of a 
large  amount  of  hydroxyl  radical  from  the  NADH  /  XO  combination  seems  to  be 
fulfilled. 
 
To  test  this  explanation,  two  metal  chelators  were  tried,  deferoxamine  and  EDTA. 
Although co-treatment with deferoxamine did not show any protection against NADH / 
XO  toxicity,  EDTA  co-treatment  was  able  to  protect,  as  mentioned  above,  at 
concentrations as low as 2  M. On the other hand, neither deferoxamine (300  M) nor 
EDTA (2, 20, or 200  M) protected against X / XO toxicity. Therefore, the protection 
by the cell-impermeable EDTA seemed to be specific for NADH / XO toxicity and 
enforces  the  suspicion  that  the  protection  offered  by  SOD  (and  Tiron)  against  this 
toxicity  was  due  to  blocking  a  superoxide-dependent  extracellular  toxic  interaction   175 
between  hydrogen  peroxide  and  a  metal  to  produce  hydroxyl  radical  (or  a  similar 
species). The very low concentrations at which EDTA was protective argues against the 
chelation of Ca
2+ (present at 2 mM) or magnesium (Mg
2+) (present at 0.8 mM) in the 
treatment solution as the reason (or the sole reason) for the protection by EDTA. Also, 
EDTA was shown to efficiently chelate iron ions even in the presence of a large excess 
of Ca
2+ [Hutcheson et al., 2004]. 
 
The failure of deferoxamine co-treatment to protect against NADH / XO toxicity, even 
though it will chelate contaminating iron present free in the treatment solution (since it 
was left with XO for 3 hr in this treatment solution (without contact with cells) before 
adding NADH and then applying to cells, and also since  the volume of the treatment 
solution containing deferoxamine and XO before adding NADH was 95% of its volume 
after adding NADH), indicates that the NADH / XO toxicity is unlikely to involve an 
iron-mediated generation of hydroxyl radicals in the extracellular treatment solution. 
However there is a possibility that an iron contaminant was associated/bound with XO 
and  was  difficult  to  remove  (to  the  degree  that  even  3  hr  of  contact  between 
deferoxamine and XO before applying to cells was not enough for chelating this iron), 
which was able to mediate the toxicity.  Iron is known to contaminate XO by binding 
loosely to it, where this iron contaminant has been shown to resist significant chelation 
by deferoxamine while remaining susceptible to other chelators (this contaminating iron 
influenced ROS generation by XO) [Britigan et al., 1990]. 
 
On the other hand, EDTA co-treated the same way as deferoxamine was protective, as 
mentioned above, at concentrations as low as 2  M. Interestingly, this protective effect 
of EDTA seemed to be dependent on pre-incubating it with XO before starting the 
treatment. This is evident from that when the treatment solution (which contains EDTA, 
XO, and NADH) was applied to cells but without prior contact between EDTA and XO, 
EDTA no longer protected, despite the fact that EDTA was left alone in the treatment 
solution for 3 hr (without contact with cells) before adding XO and NADH and then 
applying to cells, and also despite the fact that the volume of the treatment solution 
containing EDTA before adding XO and NADH was more than 90% of its volume after 
adding XO and NADH. This suggests two things, firstly, that EDTA was protective by 
interacting directly with XO, likely chelating a contaminating metal ion associated with 
the  enzyme,  but  not  present  free  in  the  treatment  solution  and  not  associated  with 
NADH. Secondly, the interaction between EDTA and XO must be slow (since prior   176 
contact  for  some  time  (3  hr  was  tried)  between  XO  and  EDTA  before  starting  the 
treatment was required for the protection).  
 
The unidentified metal contaminant associated with XO could be iron, despite the fact 
that  deferoxamine  co-treatment  failed  to  protect,  and  this  is  because  of  the  above 
mentioned possibility that this iron was associated (loosely bound) with XO and was 
difficult  to  remove.  Another  metal  ion  which  might  have  been  responsible  for  the 
toxicity is molybdenum, since it has been shown to participate with superoxide and 
NADH in a potentially toxic reaction [Darr and Fridovich, 1984]. Molybdenum ion may 
have dissociated from XO as a result of freezing and thawing of the enzyme, making it 
available to participate with NADH and superoxide in a toxic reaction. There may be 
flexibility in the dissociation of molybdenum ion (which is an integral part of XO) from 
the enzyme, since 40% of the bovine milk XO molecules are known to be molybdenum-
free [Harrison, 2002]. Contaminating copper ion associated with XO is also a candidate, 
especially  since  EDTA  always  inhibits  copper-mediated  hydroxyl  radical  generation 
[Que et al., 1980, Aruoma et al., 1991, Makrigiorgos et al., 1995, Samuni et al., 1983, Shinar et 
al.,  1983,  Cui  et  al.,  1994,  Lloyd  and  Phillips,  1999],  while  it  can  (depending  on  the 
experimental conditions) inhibit or stimulate iron-mediated hydroxyl radical generation 
[Graf et al., 1984, Hutcheson et al., 2004, Halliwell  and Gutteridge, 1981, Grootveld and 
Halliwell, 1986, Engelmann et al., 2003, Gutteridge, 1987].  Also, it can not be ruled out that 
a  metal  contaminant-independent  pharmacological  action  of  EDTA  was  involved, 
possibly  involving  a  slowly  developing,  direct  inhibition  of  XO.  However,  the 
possibility of a metal contaminant-independent direct inhibition of XO is difficult to 
explain in the light of the failure of EDTA to protect against X / XO toxicity, even if it 
is assumed that EDTA was blocking the FAD site, since blocking this site (which is 
always the site of ROS generation) should block the toxicity of X / XO combination, as 
mentioned  before.  On  the  other  hand,  a  metal  contaminant-dependent  protection  by 
EDTA  can  be  explained  even  with  the  failure  of  EDTA  to  protect  against  X  /  XO 
toxicity, since in the NADH / XO system the presence of NADH might have well led to 
an  EDTA-inhibitable  metal-mediated  toxicity  as  mentioned  before,  and  as  will  be 
discussed further later on.  
 
Notice  that  the  protective  effect  of  EDTA  was  likely  exerted  in  the  extracellular 
compartment, for two reasons. Firstly, EDTA as mentioned before is considered a cell-
impermeable chelator, so it is unlikely that it was entering the cells, especially at the   177 
very low concentration tried, and especially that it was applied as co-treatment and was 
not given any time to be in contact with cells before applying the toxic insult. Secondly, 
it is unlikely that EDTA was producing its protective effect intracellularly, because of 
the observation mentioned before that XO has to be pre-incubated with EDTA in the 
treatment solution (before any contact with cells) for the latter to be protective. 
 
Besides the problem of indentifying the metal responsible for mediating the production 
of hydroxyl radical, there is also another two problems in proposing hydroxyl radical 
(free in the solution) as the extracellular toxic product in NADH / XO system. First, is 
that hydroxyl radical is a very short-lived species, where it would degrade/disappear not 
far from its site of generation in the extracellular compartment. Second, is the presence 
of at least two hydroxyl radical scavengers in the treatment solutions, namely: HEPES 
(at 20 mM in HEPES-sol, and 25 mM in MEM-HEPES-sol) and glucose (at 3 mM in 
HEPES-sol, and 5 mM in MEM-HEPES-sol) [Grady et al., 1988, Hicks and Gebicki, 1986, 
Halliwell et al., 1987, Shiraishi et al., 1993, Liochev and Fridovich, 1991, Sagone et al., 1983, 
Luo et al., 2001]. Even NADH will be a target for hydroxyl radical. Also, when three 
hydroxyl radical scavengers (mannitol, ethanol, and DMSO) were tried as co-treatment, 
they failed to show any protection against NADH / XO toxicity (as they failed to protect 
against X / XO toxicity). However, it can be argued that the extracellularly generated 
hydroxyl radical in the NADH / XO system was scavenged by these scavengers, but the 
result of that was the production of secondary radicals (e.g. HEPES-radical and glucose-
radical)  where  some  of  these  secondary  radicals  are  known  to  be  toxic/reactive 
themselves [Liochev and Fridovich, 1991, Luo et al., 2001]. Therefore, EDTA and SOD, 
through blocking hydroxyl radical production, may have been protective by preventing 
the production of hydroxyl radical-derived secondary radicals.  
 
If the NADH / XO toxicity  was not due to an extracellular production of hydroxyl 
radical, an alternative possibility is that this toxicity was due to a superoxide-dependent 
hydrogen peroxide-accumulating free radical chain reaction which has been described in 
some  cell-free  systems  that  contain  NADH,  superoxide,  and  a  metal  (or  a  similar 
factor), where SOD (although through converting superoxide into hydrogen peroxide) 
paradoxically  decreases  (through  blocking  the  superoxide-dependent  hydrogen 
peroxide-accumulating  chain  reaction  from  the  start)  the  overall 
production/accumulation of hydrogen peroxide. The literature abounds with reports of 
potentially toxic reactions that involve participation of superoxide and NADH [Liochev   178 
et al., 1989, Liochev and Fridovich, 1989, 1990, 1991, Darr and Fridovich 1984, Fridovich, 
1989, Chan and Bielski, 1974, Imlay and Linn, 1988, Rowley and Halliwell, 1982]. Excess of 
added NADH (which is a weak substrate for the used form of XO) will not be oxidized 
directly  by  the  enzyme,  especially  in  the  early  phase  of  the  reaction,  and  could 
participate  with  superoxide  (produced  by  the  direct  oxidation  of  NADH  by  XO)  to 
produce  toxicity.  However,  superoxide  does  not  interact  quickly  with  NADH  at 
physiological pH except in the presence of a suitable mediating agent such as a metal. In 
such a system, the events may proceed through a series of free radical chain reactions 
where superoxide and the metal participate in the oxidation of a molecule of NADH, 
leading to a long chain process [Liochev et al., 1989, Liochev and Fridovich, 1989, 
1990, 1991, Darr and Fridovich 1984, Fridovich, 1989, Imlay and Linn, 1988], such as 
the following [Darr and Fridovich 1984, Fridovich, 1989]:- 
 
- superoxide + metal → metal-superoxide complex                                                   (1) 
- metal-superoxide complex + NADH → NAD radical + metal + hydrogen peroxide   (2) 
- NAD radical + oxygen → NAD
+ + superoxide                                                     (3) 
- superoxide + superoxide → hydrogen peroxide                                                      (4) 
 
The  metal  regenerated  in  (2)  and  superoxide  in  (3)  can  recycle  via  reaction  (1), 
propagating a chain reaction. Hydrogen peroxide may accumulate in the system because 
it  is  usually  the  stable  molecule  to  which  superoxide  will  eventually  be  converted 
(equations (2) and (4)) [Darr and Fridovich 1984, Fridovich, 1989, Liochev and Fridovich, 
1990, Misra and Fridovich, 1972, Marklund and Marklund, 1974, Heikkila and Cohen, 1973]. 
The net effect of adding SOD (which will block the hydrogen peroxide-accumulating 
chain  reaction  from  the  start)  to  such  reactions  would  then  be  (although  through 
converting  superoxide  into  hydrogen  peroxide)  a  decrease  in  the  overall 
production/accumulation of hydrogen peroxide in the system. In this situation hydrogen 
peroxide, not hydroxyl radical, is a major product of the interaction between superoxide, 
metal, and NADH (molybdenum ion is a good candidate metal for such a sequence of 
reactions [Darr and Fridovich 1984]).  Also in this situation, EDTA protective effect 
would  be  due  to  blocking  such  an  extracellular  reaction  (and  not  due  to  blocking 
extracellular production of hydroxyl radical). Also, may be due to the absence of such a 
NADH-dependent reaction  in X / XO system, EDTA co-treatment failed to protect in 
that system, although the same metal contaminating XO was likely present in the X / 
XO system (since this is the same commercial preparation of XO).   179 
More support for the possibility that the NADH / XO toxicity was due to a superoxide-
dependent extracellular accumulation of hydrogen peroxide came from the observation 
that,  in  cell-free  experiments,  SOD-1  largely  inhibited  hydrogen  peroxide 
production/accumulation in the system. This effect of SOD-1 seemed to be specific for 
the  NADH  /  XO  system,  since  it  did  not  influence  hydrogen  peroxide 
production/accumulation in the X / XO system in these cell-free experiments. However, 
these assays are catalase-based, and since superoxide is known to interact significantly 
with catalase (inhibits it) [Kono and Fridovich, 1982], it is not possible to rule out other 
confounding mechanisms (other than the proposed mechanism which is the blocking of 
superoxide-dependent  accumulation  of  hydrogen  peroxide)  as  the  reason  for  the 
observed  effect  of  SOD-1  in  this  assay.  The  lack  of  effect  of  SOD-1  on  hydrogen 
peroxide  production/accumulation  in  the  X  /  XO  system  in  this  assay  does  not 
necessarily  mean  that  the  NADH  /  XO  system  was  free  of  the  above  mentioned 
confounding  mechanisms  that  might  involve  interaction  between  superoxide  and 
catalase. This is because in the X / XO system, by the time of adding catalase to the 
mixture (1 hr after starting the X / XO reaction), all superoxide produced would have 
already  been  spontaneously  dismutated  to  hydrogen  peroxide  (since,  as  mentioned 
earlier, the superoxide generation from X / XO combination ceases by less than 10 
minutes after starting the reaction), so there will be no superoxide present to react with 
catalase. On the other hand, in the NADH / XO system, it possible that superoxide was 
still being produced in the system by the time of adding catalase (i.e. 1 hr after starting 
the NADH / XO reaction). In any case, if the effect of adding SOD-1 to NADH / XO 
system was due to blocking superoxide-dependent accumulation of hydrogen peroxide 
in the system and not due to any other confounding mechanism, this supports the free 
radial  chain  reaction  explanation  for  the  apparently  paradoxical  protection  by  SOD 
against the toxicity of the NADH / XO combination.  Almost exactly the same degree of 
inhibition of hydrogen peroxide production/accumulation in the NADH / XO system by 
SOD-1 was also observed in this assay when the reaction was carried out in a HEPES-
free solution (Dulbecco's phosphate-buffered saline (DPBS)) instead of the HEPES-sol. 
This rules out that HEPES, which is know to interfere with many free radical reactions 
[Grady et al., 1988, Hicks and Gebicki, 1986, Halliwell et al., 1987, Shiraishi et al., 1993, 
Liochev and Fridovich, 1991, Hodges and Ingold, 2000, Habib and Tabata, 2004, Kirsch et al., 
1998], was responsible for the observed effect of SOD-1 in this cell-free assay.  
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Notice that the failure of SOD-1 at even 300 Units/ml to influence hydrogen peroxide 
production/accumulation in the X / XO toxicity in these cell-free experiments (as well 
as its failure in the viability experiments at this high concentration to attenuate X / XO 
toxicity) argues against the possibility of the contamination of SOD-1 (especially at 3 
Units/ml) with catalase activity.  
 
 In accord with the possibility that the NADH / XO toxicity was due to a superoxide-
dependent extracellular accumulation of hydrogen peroxide is the observation that pre-
treating (but not co-treating) the neurons with deferoxamine was protective. This effect 
of deferoxamine suggests that hydrogen peroxide is a main toxic molecule generated 
extracellularly in the NADH / XO system, and that it was exerting its toxicity through 
crossing  the  cell  membrane  and  then  probably  reacting  with  an  intracellular 
deferoxamine-sensitive iron ion to produce intracellular toxic hydroxyl radical. Also 
deferoxamine  might  have  been  protective  through  directly  scavenging  intracellular 
hydroxyl radical and/or other radicals e.g. lipid radicals [Hoe et al., 1982, Hartley et al., 
1990]. Although deferoxamine has the ability to block peroxynitrite-mediated effects 
[Bartesaghi  et  al.,  2004],  pre-treatment  with  an  inhibitor  of  nitric  oxide  synthase  (L-
NAME, 1 mM) [Patel et al., 1996, Gunasekar et al., 1995], aiming to block nitric oxide-
mediated peroxynitrite production, failed to protect against NADH / XO toxicity, which 
argues against the blockade of peroxynitrite-mediated effects as the mode of protection 
by  the  deferoxamine  pre-treatment.  Regardless  of  the  mechanism  of  NADH  /  XO 
toxicity that was inhibitable by co-treatment with SOD, Tiron, catalase, and EDTA (and 
by pre-treatment with deferoxamine), this toxicity was likely initiated by superoxide 
produced  by  the  direct  enzymatic  oxidation  of  NADH  by  XO  because  both  of  the 
enzyme and the substrate were required and also because, as mentioned before, DPI 
(which blocks the site of NADH oxidation) was protective. Fig. 4-1 shows the sequence 
of  the  more  likely  reactions  leading  eventually  to  the  toxicity  of  the  NADH  /  XO 
combination as suggested by the available results. 
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Interestingly,  as  in  the  case  with  NADH  /  XO  toxicity,  pre-treatment  (and  not  co-
treatment) with deferoxamine was protective against X / XO toxicity. This suggests that 
hydrogen peroxide was a main toxic molecule produced extracellularly in the X / XO 
system (as in the NADH / XO system) that was crossing the cell membrane and exerting 
intracellular iron-mediated toxicity. However, hydrogen peroxide production in the X / 
XO system was likely occurring through a mechanism (mainly direct production from 
Figure 4-1: Diagram showing the sequence of the more likely events leading eventually to cell damage 
in the NADH / XO system, in the light of the available results. Initially, XO directly oxidizes NADH 
extracellularly  (step  1),  which  can  by  blocked  by  DPI.  This  generates  (directly)  superoxide  (O2
.-)  and 
hydrogen  peroxide  (H2O2).  Superoxide,  unless  participating  in  a  faster  reaction,  can  quickly  and 
spontaneously dismutate to hydrogen peroxide (curved dashed black arrow). However, the results suggest 
that superoxide participates in a faster reaction, which is likely to be a free radical chain reaction involving 
(in addition to superoxide) both a metal contaminating XO (which can be silenced by EDTA) and NADH 
(which is likely available from the large excess of added NADH that is not directly oxidized by XO).  This 
free  radical  chain  reaction  re-generates  superoxide  (in  a  much  higher  amount  than  the  superoxide  that 
initiates  the  chain  reaction)  (Step  2).  The  majority  of  superoxide  radicals  do  not  enter  the  cells,  and 
hydrogen peroxide, the stable form to which all superoxide does eventually convert, accumulates in the 
system (Step 3). SOD, through its very efficient deactivation of superoxide can block (although through 
converting superoxide into hydrogen peroxide) the chain reaction from the start, and hence can prevent the 
accumulation of hydrogen peroxide in the system (which is supported by the cell-free experiments). Also, 
Tiron, through scavenging superoxide, can prevent it from initiating the chain reaction. Catalase, through 
deactivating hydrogen peroxide once produced in the system, can prevent its production/accumulation, and 
hence can prevent it from entering the cells. The final step in the toxicity is that hydrogen peroxide readily 
crosses  the  cell  membrane,  where  it  participates  with  intracellular  iron  ion  (Fe
2+)  to  generate  the  very 
reactive and toxic hydroxyl radical (OH
.) (Step 4), which can be blocked by pre-treatment (but not co-
treatment) with deferoxamine.    182 
the combination) different from the mechanism of its production in the NADH / XO 
system (likely through a superoxide-, NADH-, and metal-dependent free radical chain 
reaction), since SOD, Tiron, and EDTA co-treatments protected against the toxicity of 
the latter but not the former system. In addition to the protection found by pre-treatment 
with deferoxamine, X / XO toxicity was similar to NADH / XO toxicity in the failure of 
the pre-treatment with L-NAME to provide protection, which also argues against the 
blocking of intracellular peroxynitrite-mediated effects as the reason for the protection 
of  deferoxamine  pre-treatment  against  this  combination  (see  later  for  further 
investigation of X / XO toxicity). 
 
4.3.1.3 Feasibility of in vivo toxicity of NADH oxidation by XOR 
 
The intracellular concentrations of free NADH are reported to be in the micromolar 
range  [Yu  and  Heikal,  2009].  However,  there  seems  to  be  uncertainty  regarding  the 
concentration of intracellular free NADH, which might have been due to the difficulty 
in measuring this concentration [Canelas et al., 2008]. The uncertainty also extends to the 
ratio of free to bound intracellular NADH. For example, Vishwasrao and co-workers 
(2005) suggested that this ratio might be higher than previously estimated, and that as 
much as 40% of NADH might be present free intracellularly.  It is feasible that the 
oxidation of NADH by some forms of XOR (other than the one used here) that are 
known to be very efficient in oxidizing this substrate might produce in vivo toxicity, as 
suggested previously [Berry and Hare, 2004, Harrison, 2002, Sanders et al., 1997, Zhang et 
al., 1998].  
 
In  adding  the  NADH  /  XOR  combination  to  cells  in  vitro  (like  in  this  study),  the 
oxidation of NADH by XOR will likely take place in the extracellular compartment, 
whereas lower concentrations of NADH might cause toxicity if oxidized by intracellular 
XOR  (because  lower  levels  of  ROS  are  expected  to  cause  toxicity  if  produced 
intracellularly in the vicinity of critical targets rather than extracellularly). Also, in cell 
cultures, many cells die in the first hours of plating (as in this study), where these might 
be those cells that can not resist the culturing stress. Hence, in vivo, those cells that are 
less resistant to stress/toxicity (which will die immediately if plated in vitro) might be 
damaged by lower concentrations of an insult than if applied in vitro. Also, it is possible 
that  many  compensatory  protective  mechanisms  that  might  be  induced  in  vitro  in 
response to the culturing stress (that allow many cells to survive) do not operate in vivo,   183 
where cells can be killed by the oxidation (by XOR) of lower NADH concentrations 
than if applied in vitro. However, it can be argued for an opposite possibility, where in 
vivo tissues might be better equipped with protective mechanisms (e.g. they have richer 
antioxidant environment) to cope with insults than cells in vitro [Halliwell, 2003], and 
hence higher concentrations of toxic insults might be required to kill cells in vivo than if 
applied in vitro.  
 
An important fact that might limit the significance of the oxidation of NADH by XOR 
in vivo is the presence of NAD
+ in much higher concentrations than NADH, where the 
free cytoplasmic NADH/NAD
+ ratio was reported to be very low (< 0.01) [Canelas et al., 
2008, Sanders et al., 1997, Park et al., 1998]. NAD
+, as mentioned before, can potently 
inhibit NADH oxidation by the predominant intracellular isoform of XOR i.e. XDH 
(but notice that NAD
+ is weak in inhibiting XO compared to XDH). However, NAD
+ 
can not completely inhibit NADH oxidation by XDH, since a previous cell-free study 
has shown that XDH is still able to oxidize NADH to produce ROS even in the presence 
of high concentrations of NAD
+ [Harris and Massey, 1997].  
 
 It is possible that the toxicity of NADH oxidation by XOR might occur/increase in 
some pathological situations where NADH levels are known to increase on the expense 
of the decrease of NAD
+ levels. For example, under severe ischemic conditions, the 
cytoplasmic NADH/NAD
+ ratio in the heart was shown to increase approximately 30-
fold [Park et al., 1998]. In such a situation, a significant toxicity might be produced from 
the oxidation of NADH by the predominant intracellular isoform i.e. XDH. Also, even 
if  NAD
+  concentration  is  so  high  to  the  degree  that  it  can  potently  inhibit  ROS 
generation by XDH, it is known that under some pathological situations the XO level 
increases  either  by  the  conversion  from  XDH  or  by  the  increase  in  the 
expression/activity  of  the  total  enzyme  i.e.  XOR  [Wiezorek,  1994,  Phan  et  al.,  1989, 
Osarogiagbon et al., 2000, Thom, 1992, Schröder et al., 2006, Ischiropoulos et al., 1996, Park 
et  al.,  1998,  Berry  and  Hare,  2004,  Harrison,  2002].  In  such  a  situation,  XO  might 
significantly  oxidize  NADH  (where  NAD
+  is  relatively  weak  in  inhibiting  this 
oxidation) which might lead to significant toxicity.  
 
Although there might not be a significant amount of NADH present extracellularly in 
vivo,  NADH  is  used  in  clinical  trials  as  a  therapeutic  drug  to  treat  some  chronic 
illnesses e.g. Parkinson’s disease, Alzheimer’s disease, and chronic fatigue syndrome   184 
[Birkmayer et al., 1993, Forsyth et al., 1999, Rex et al., 2004], where administering it will 
increase greatly its availability in the circulation. Since XOR is present predominantly 
in the XO form in the circulation, a toxic effect might arise under some circumstances 
from the oxidation of the administered NADH by XO (e.g. in some acute pathological 
situations where XO levels are reported to increase by hundreds-fold [Harrison, 2002]), 
especially  since  there  might  not  be  significant  amount  of  NAD
+  present  in  the 
circulation to inhibit this oxidation (anyway, NAD
+ is a weak inhibitor of the XO form).   
 
Although this investigation of NADH / XO toxicity suggests that it was dependent on a 
XO-contaminating metal ion, this does not mean that this type of toxicity is irrelevant to 
the in vivo situations. It is known that, at least in some pathological conditions, traces of 
reactive  metals  are  present  in  vivo  either  free  or  bound/chelated  to  certain 
molecules/proteins, where this binding may not prevent the reactivity of these metals 
(actually it may enhance their reactivity/toxicity in some situations) [Graf et al., 1984, 
Hutcheson et al., 2004, Engelmann et al., 2003, Gutteridge, 1987, Sayre et al., 1999, Ong and 
Halliwell,  2004,  Thompson,  2001,  Darley-Usmar  and  Halliwell,  1996,  Halliwell  and 
Gutteridge, 1992, Halliwell, 2006]. Moreover, XO was shown to contain a high affinity 
binding site for iron, where contaminating iron (as the one proposed in this study) can 
bind to it, and it was shown that, as mentioned before, it is difficult to eradicate this 
contaminant iron if present (such a contaminant iron will be different from the iron 
atoms that are integral parts of XO). This has led some authors to discuss the possibility 
that this binding site on XO might be occupied by an exogenous iron ion in vivo, which 
can catalyse toxic reactions [Vile and Winterbourn, 1986, Britigan et al., 1990].  
 
The  results  suggest  that  the  toxicity  of  NADH  /  XO  combination  was  initiated  by 
superoxide  generated  from  the  direct  enzymatic  oxidation  of  NADH  by  XO  (see 
before).  However,  the  results  also  suggest  that  it  is  possible  for  an  in  vivo  toxic 
interaction to occur between NADH and XOR even in the absence of direct oxidation of 
NADH  by  XOR.  That  is,  in  a  situation  where  XOR  produces  superoxide  through 
oxidizing X (or HX), a toxic effect can result from the participation of this produced 
superoxide, NADH, and a metal in a free radical chain reaction (or other toxic reactions) 
even in the absence of direct oxidation of NADH by XOR. In such a situation, low 
concentrations  of  NADH  might  be  enough  to  cause  the  toxicity  (since  the  weak 
oxidation of NADH by some forms of XO will not be a factor in the availability of 
superoxide, and also since the inhibition of NADH oxidation by XOR (especially XDH)   185 
by NAD
+ will not be a factor in the availability of superoxide). Therefore, in vivo, 
NADH can react (in the presence of a suitable free or chelated metal e.g. iron, copper, 
etc.) with superoxide (generated by NADH, X, or HX oxidation by XOR) to cause a 
toxic effect.  
 
In summary, the toxicity of NADH oxidation by XOR seems to be feasible in vivo. The 
results in this project can not prove or disprove this feasibility. However, if the toxicity 
of NADH oxidation by XOR does occur in vivo (which is likely to be the case), then the 
results in this project provide some suggestions on what might be the nature of the toxic 
ROS/metals  that  mediate  this  in  vivo  toxicity.  Indeed,  proving  this  in  vivo  toxicity 
would require in vivo studies. However, it will be difficult to prove or rule out this 
toxicity, since the NADH binding site on XOR (the FAD site), unlike the X binding site 
(the Mo site), still has no specific in vivo blockers. Although DPI can block this FAD 
site in vivo, this inhibitor is not specific and can inhibit many other enzymes [Harrison, 
2002, Berry and Hare, 2004]. Therefore, there is a need for developing in vivo specific 
blockers of this site, especially since, as suggested by this cell-containing and previous 
cell-free studies, blocking the Mo site is unlikely to block a toxicity of NADH oxidation 
by XOR, and also since blocking the FAD site can inhibit ROS generated by either X or 
NADH  oxidation  by  XOR.  Also,  in  investigating  this  toxicity  in  vivo,  it  should  be 
considered that toxicity might result from an indirect interaction between NADH and 
XOR.  
 
4.3.2 Further investigation of the X / XO toxicity model 
 
In addition to investigating the toxicity of the NADH / XO combination (which was 
rarely investigated in previous studies) and comparing it to the well investigated toxicity 
of the X / XO combination, another aim of this project was to address specific questions 
regarding those aspects of X / XO toxicity where there are uncertainties about them (see 
the  section  on  Aim/Objectives  in  the  Introduction).  Some  of  these  questions  were 
addressed  (at  least  partially)  in  the  previous  section  (e.g.  the  possibility  that  XO  is 
contaminated with iron/metal). 
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4.3.2.1 Role of intracellular superoxide in X / XO toxicity 
 
The results in this and many previous studies suggest that, as discussed, superoxide 
generated from the X / XO combination in the extracellular compartment has no role in 
the  toxicity  of  this  combination  (may  be  apart  from  its  extracellular  spontaneous 
dismutation  to  hydrogen  peroxide).  However,  some  previous  reports  showed  that 
intracellular superoxide production mediates the toxicity of hydrogen peroxide that is 
either produced extracellularly from the X / XO combination or applied directly, though 
this was demonstrated in cell culture types other than CGNs [Ito et al., 1992, Kyle et al., 
1988, Hiraishi et al., 1994]. To test this possibility in CGNs, the superoxide scavenger, 
Tiron (which failed to protect against X / XO toxicity when applied as a co-treatment at 
50  M, as mentioned before), was tried here as a pre-treatment for 3 hr at 2 mM, aiming 
to give it a chance to get inside the neurons in high amount. With this experimental 
design,  Tiron  was  able  to  protect  against  X  /  XO  toxicity,  which  suggests  the 
involvement of intracellular superoxide, especially since the Tiron-containing treatment 
solution was removed before applying the toxic insult. However, Tiron is also known to 
be an effective chelator of some metals including iron and molybdenum [Fridovich and 
Handler, 1962], an activity that can not be ruled out as the reason for its intracellular 
protective effect. 
 
 An  attempt  was  also  undertaken  to  inhibit  intracellular  SOD-1  by 
diethyldithiocarbamate  (DDC,  a  potent  and  cell-permeable  inhibitor  of  intracellular 
SOD-1 [Ito et al., 1992, Hiraishi et al., 1994, Blum and Fridovich, 1983, Benov and Fridovich, 
1996],  but  of  low  specificity),  where  this  inhibition  was  expected  to  potentiate  the 
toxicity of the X / XO combination if intracellular superoxide is involved. Although 
DDC  is  not  very  specific  in  inhibiting  intracellular  SOD-1,  it  is  likely  that  its 
potentiation  of  hydrogen  peroxide-dependent  toxicity  in  at  least  some  of  previous 
studies  was  indeed  due  to  inhibiting  intracellular  SOD-1,  for  many  reasons.  Firstly, 
Hiraishi  and  co-workers  (1994)  showed  that  the  potentiation  of  hydrogen  peroxide 
toxicity closely paralleled its ability to inhibit intracellular SOD-1. Secondly, DDC was 
not  found  to  inhibit  some  other  intracellular  antioxidant  enzymes  e.g.  catalase, 
glutathione peroxidase, or glutathione reductase [Ito et al., 1992, Hiraishi et al., 1994, Blum 
and Fridovich, 1983]. Thirdly, Hiraishi and co-workers (1994) showed that DDC did not 
potentiate some other types of toxicity that are not known to be dependent on hydrogen 
peroxide/superoxide,  and  only  potentiated  hydrogen  peroxide-dependent  toxicity.   187 
Fourthly, Benov and Fridovich (1996) showed that the potentiation of the toxicity of an 
oxidative  stress  model  by  DDC  was  reversed  by  a  cell-permeable  SOD  mimetic, 
suggesting that DDC potentiated the toxicity through inhibiting intracellular SOD-1.  
 
There was no signficant potentiation of X / XO toxicity by DDC in this study. There 
was no time left in this project to try higher concentrations or longer incubation times of 
DDC (a previous study showed that increasing the pre-treatment time of DDC from 1 to 
2 hr resulted in a very significant decrease in the activity of intracellular SOD-1 [Ito et 
al., 1992]). Although the failure of DDC to potentiate X / XO toxicity might suggest that 
intracellular superoxide was not involved, this will be difficult to explain in the light of 
both the protection found by Tiron pre-treatment and the results of previous studies. 
DDC is known to interact with XO (it can be oxidized initially by the enzyme, but the 
product will inhibit the enzyme) [Fried, 1976, Kober et al., 2003], and although this is 
unlikely to influence the activity of our added XO (since DDC and XO were not present 
together), DDC might affect the activity of intracellular XOR. However, it is not clear if 
this can explain the failure of DDC to potentiate X / XO toxicity. Fig. 4-2 shows the 
sequence of the more likely events leading eventually to cell damage in the X / XO 
toxicity model based on the available results. 
 
The  possibility  raised  by  this  study  (and  supported  by  the  previous  studies  quoted 
earlier) that intracellular superoxide is involved in X / XO toxicity, suggests that the 
failure of SOD co-treatment (and Tiron co-treatment) to protect was due to both the 
failure of SOD to cross the cell membrane (and hence its failure to block the toxicity 
mediated  by  intracellular  superoxide)  and  also  the  failure  of  superoxide  generated 
extracellularly from X / XO combination to cross the cell membrane (and hence its 
failure to increase the pool of intracellular superoxide that was mediating the toxicity). 
Therefore,  in  vivo,  in  XOR-related  disorders,  the  oxidation  of  substrates  by  XOR, 
whether takes place intracellularly or extracellularly, might produce a toxicity that can 
be  mediated  by  intracellular  superoxide.  This  validates  targeting  superoxide  in 
investigating/treating disorders where XOR is suspected to a play a role.    
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Figure 4-2: Diagram showing the sequence of the more likely events leading eventually to cell death in 
the X / XO system, in the light of the available results. Initially, XO directly oxidizes X extracellularly, 
which can be blocked by blocking the Mo site on XO with allopurinol, and also probably by blocking the 
FAD site with DPI. This oxidation directly produces ROS i.e. hydrogen peroxide (H2O2) and superoxide 
(O2
.-) as co-products in this process. The majority of ROS produced directly will be in the form of hydrogen 
peroxide (80%), while the remaining will be in the form of superoxide (20%). Most of the directly produced 
superoxide radicals do not enter the cells, and they spontaneously dismutate to hydrogen peroxide in the 
extracellular compartment. Hydrogen peroxide produced directly from XO and also from the spontaneous 
dismutation of superoxide readily crosses the cell membrane to cause intracellular toxicity, where externally 
added catalase can deactivate hydrogen peroxide before it can enter the cells. Notice that although the metal 
contaminating XO that was playing a role in NADH / XO toxicity was likely present in this system (since 
this is the same commercial preparation of XO), this metal has no role in X / XO toxicity. In the intracellular 
space, hydrogen peroxide participates with intracellular reduced iron ion (Fe
2+) to produce the very reactive 
and toxic hydroxyl radical (Fenton reaction), which can be blocked by pre-treatment (but not co-treatment) 
with  deferoxamine.  Intracellular  superoxide  mediates  this  intracellular  toxicity  of  hydrogen  peroxide 
through increasing the availability of the reduced form of iron as shown (→+ve) (or by other mechanisms), 
which can be blocked by pre-treatment (but not co-treatment) with the superoxide scavenger, Tiron (though 
Tiron is also known to be an effective chelator of some metals including iron, which might be an alternative 
explanation of its protection, as shown). Intracellular SOD-1 limits this toxic action of superoxide through 
dismutating it to hydrogen peroxide, where this small amount of hydrogen peroxide is deactivated by the 
intracellular hydrogen peroxide-deactivating enzymes. Therefore, inhibiting intracellular SOD-1 may result 
in the potentiation of the toxicity, but although this potentiation of toxicity by inhibiting intracellular SOD-1 
was demonstrated in previous studies by using DDC, this was not found here (since DDC effect failed to 
reach statistical significance in the viability assay).     189 
4.3.2.2 Role of intracellular hydroxyl radical in X / XO toxicity 
 
The  results  with  Tiron  pre-treatment,  deferoxamine  pre-treatment,  and  catalase  co-
treatment (and also the results of many previous studies [Satoh et al., 1998, Link and Riley, 
1988, Mohsen et al., 1995, Duell et al., 1995, Hiraishi et al., 1987, Zigler et al., 1985]) suggest 
that the toxicity of X / XO combination was due to hydrogen peroxide generated in the 
extracellular space and then entering the neurons and participating in a Fenton reaction 
with  an  intracellular  iron  (where  this  reaction  was  likely  mediated  by  intracellular 
superoxide)  to  produce  the  very  reactive  and  toxic  hydroxyl  radical  (or  a  similar 
species). The failure of co-treatment with the hydroxyl radical scavengers (mannitol, 
ethanol, and DMSO) mentioned earlier, although might argue against the involvement 
of extracellular hydroxyl radical in X / XO toxicity, does not necessarily mean that 
intracellular hydroxyl radical was not involved. Therefore, the idea was to investigate 
the involvement of intracellular hydroxyl radical through using different scavengers of 
it  as  pre-treatment  (to  give  them  a  chance  to  accumulate  inside  the  cells)  before 
applying X / XO combination. 
 
Initially, a compound called POBN, which has the ability to scavenge hydroxyl radical 
(but also many other free radicals) was tried [Mottley et al., 1986, Pérez and Cederbaum, 
2001, Reinke et al., 1994]. POBN is a member of a large group of compounds called spin 
traps, which are used essentially as detectors of free radicals, where a spin trap reacts 
with  a  free  radical  (e.g.  hydroxyl  radical)  to  produce  a  new  species  (a  more  stable 
secondary  radical)  that  can  be  detected  by  a  method  called  electron  paramagnetic 
resonance  spectroscopy  [Reinke  et  al.,  1994,  Tarpey  and  Fridovich,  2001,  Halliwell  and 
Whiteman, 2004]. In theory (which was also shown in some viability studies), since these 
detect free radicals by scavenging them, they might protect tissues from insults that 
involve generation of toxic free radicals. However, when the neurons were pre-treated 
here with POBN at 20  mM for 1hr, instead of providing protection, it significantly 
potentiated X / XO toxicity.  Surprisingly, when POBN was applied as co-treatment 
rather than pre-treatment, it produced the opposite effect, showing significant protection 
against X / XO toxicity.   
 
The opposite effects exerted by co-treatment and pre-treatment with POBN can not be 
easily  explained.  Therefore,  the  following  discussion  is  mostly  speculative.  The 
potentiation of the toxicity by the POBN pre-treatment might have been due to the   190 
accumulation of POBN inside the cells (since the POBN-containing treatment solution 
was removed before applying the toxic insult). Although intracellular POBN was not 
toxic  itself  (since  pre-treatment  with  POBN  alone  was  not  toxic),  it  was  able  to 
potentiate the toxicity of the X / XO combination applied afterwards. This intracellular 
toxic effect of POBN might have or have not been due to free radicals (e.g. hydroxyl 
radicals) spin-trapping. If it was due to spin-trapping a free radical, it is possible that a 
species produced from spin-trapping the free radical by POBN (likely to be a secondary 
radical) was more toxic than the free radical being spin-trapped itself. This can happen 
e.g.  some  secondary  radicals  produced  from  scavenging  hydroxyl  radical  were 
shown/proposed to be more toxic than (or at least as toxic as) hydroxyl radical itself, 
may be because they have longer half lives and/or more lipid solubility [Luo et al., 2001, 
Liochev and Fridovich, 1991]. For such a possibility, some authors have warned against 
overlooking the effects of secondary radicals produced in studies that use scavengers of 
hydroxyl radical (or other radicals) as a therapeutic means [Liochev and Fridovich, 1991]. 
Another fact that suggests that trying to directly scavenge free radicals may not be a 
good  way  to  treat  oxidative  stress-related  disorders  is  that,  as  mentioned  in  the 
Introduction, a free radical (especially hydroxyl radical) is generally non selective in its 
reactions, so to scavenge it, a scavenger needs to be applied in a very high concentration 
in order to outcompete the many vulnerable biological targets (i.e. scavengers) of the 
free radical. A better way is to prevent the generation of free radicals (for example by 
using metal chelators).  
 
If the potentiation of toxicity by intracellular POBN was not due to free radical spin-
trapping, an alternative possibility is that it might have been due to its known ability to 
reduce  Fe
3+  to  Fe
2+  [Reinke  et  al.,  1994].  This  possibility  means  that  POBN  in  the 
intracellular compartment was catalysing the same or a similar reaction to that POBN 
was supposed to scavenge its toxic product i.e. Fenton reaction.  
 
The opposite effect found by POBN co-treatment (i.e. protection) is also difficult to 
explain, even if it is assumed that it was exerted extracellularly. Since POBN applied as 
co-treatment (but not pre-treatment) was present together with the X / XO combination, 
one explanation for its protection is that it was inhibiting XO. However, this explanation 
is ruled out by a previous observation that POBN even at 100 mM does not significantly 
influence XO activity [Britigan et al., 1991]. Also, it is unlikely that the protection with 
POBN  co-treatment  was  due  to  spin-trapping  superoxide  radicals  generated   191 
extracellularly  from  X  /  XO  combination  because  POBN  was  shown  to  be  slow  in 
reacting with superoxide [Britigan et al., 1991], and also because it was shown in this and 
many previous studies that extracellular superoxide is not involved in X / XO toxicity. 
Moreover,  it  is  unlikely  that  the  protection  by  POBN  co-treatment  was  due  to 
scavenging hydrogen peroxide generated in the system because POBN does not interact 
significantly  with  hydrogen  peroxide  [Britigan  et  al.,  1991].  Moreover,  the  hydroxyl 
radical scavengers (mannitol, DMSO, and ethanol) tried here as co-treatments had no 
effect on the toxicity, as mentioned before, arguing against spin-trapping extracellular 
hydroxyl radicals as the reason for protection by POBN co-treatment. Alternatively, one 
might assume that POBN (applied as co-treatment) was exerting its protective effect 
intracellularly,  but  this  is  even  more  difficult  to  explain,  since  POBN  pre-treatment 
potentiated the toxicity.   
 
If additional spin-traps (or hydroxyl radical scavengers) were used (especially as pre-
treatment), this would have given both an explanation for the observed effects of POBN 
and more verification of the proposed role for intracellular hydroxyl radical in X / XO 
toxicity (see later for suggestions for future studies).  
 
In summary, although it is likely that intracellular hydroxyl radical (or a similar species) 
is involved in X / XO toxicity, the preliminary studies did not support or argue against 
trying  to  directly  scavenge  hydroxyl  radicals  as  a  possible  means  to  prevent  this 
toxicity.  However,  it  seems  from  the  preliminary  studies  (and  from  the  nature  of 
hydroxyl radical) that it is better to prevent the generations of hydroxyl radicals than to 
try to directly scavenger it. This might also be true for some other radicals. This might 
explain the failure of some direct free radicals scavengers in clinical trials, especially 
since in clinical trials the scavengers are usually administered after the onset of the 
attack  (e.g.  stroke)  where  the  targeted  radical  might  have  long  been  produced  and 
probably caused its toxic reactions before the drug was able to reach to the damage site. 
However, this might be the only feasible way to treat free radicals-induced damage in 
the  clinical  situations,  since  preventing  the  generation  of  free  radicals  might  not  be 
feasible. However, it is possible that both trying to prevent the generation of certain free 
radicals and even trying to directly scavenge them might produce beneficial effects in 
human diseases where the oxidative stress damage is chronic e.g. Parkinson’s disease.  
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4.4 Future work 
 
Generalization is difficult in cell culture studies, so some of the observations found here 
might be different under different experimental conditions. Therefore, to obtain more 
generalization,  more  verification  of  the  experimental  conditions  is  suggested.  In 
particular, since the results suggest that a metal contamination of XO was involved in 
NADH / XO toxicity, future studies should investigate more the likely contamination of 
XO by a metal, which can be achieved through pursuing two lines of investigations. The 
first  is  using  many  preparations  of  the  bovine  milk  XO  (purchased  from  different 
sources), where if EDTA protects against the toxicity of all these preparations, it will be 
unlikely that all were contaminated with metals, and this would suggest other alternative 
mechanisms for EDTA protection. The second is screening various metal chelators (in 
addition  to  EDTA)  that  have  different  selectivity  for  metals  against  NADH  /  XO 
toxicity. Pursuing these two lines of investigations will hopefully confirm or rule out a 
role for metal contamination of XO in this toxicity. 
 
Also, to have more insights into the NADH / XOR toxicity, it would be very helpful if 
some  other  forms  of  XOR  (that  are  known  to  be  much  more  efficient  in  oxidizing 
NADH than the bovine milk XO used here) were used and compared with each other. 
 
Another suggestion is to exclude HEPES buffer from the treatment solutions (it was 
present in both HEPES-sol and MEM-HEPES-sol). HEPES has the ability to interfere 
with many free radical reactions, as mentioned before, so it is probable that some of the 
reactions  here  might  have  been  mediated,  inhibited,  or  diverted  by  the  presence  of 
HEPES. The only experiment where the effect of HEPES was tested was the cell-free 
experiment  that  investigated  the  effect  of  SOD-1  on  hydrogen  peroxide 
production/accumulation  in  the  NADH  /  XO  system,  where  the  same  result  was 
obtained in the presence and absence of HEPES (see earlier). In future viability studies, 
it is better to try different buffer solutions (and different media), since no one seems to 
be ideal.   
 
 The  results  of  this  and  many  previous  studies  suggest  that  intracellularly  (but  not 
extracellularly) produced superoxide is involved in X / XO toxicity. For future work, 
there are two suggestions. The first is to confirm the role of intracellular superoxide in 
X / XO toxicity in CGNs by trying cell-permeable SOD mimetics (e.g. MnTBAP [Patel   193 
et al., 1996]), and also by trying a better way of assessing the role of intracellular SOD-1 
than using the SOD-1 inhibitor, DDC, tried here (e.g. knocking out the SOD-1 gene). 
The second suggestion is to investigate the probability that intracellular superoxide also 
mediates  the  toxicity  of  NADH  /  XO  combination  as  it  is  the  case  with  X  /  XO 
combination  (since  in  both  systems,  extracellularly  produced/accumulated  hydrogen 
peroxide is a main toxic molecule, where intracellular superoxide was shown to mediate 
such a toxicity).  
 
Since the results of this and previous studies suggest the involvement of intracellular 
hydroxyl radical (or a similar species) in the X / XO toxicity, there are two suggestions 
for future studies. First, since the preliminary experiments in this study did not show 
that the X / XO toxicity can be prevented by directly scavenging hydroxyl radical, this 
can  be  investigated  by  using  many  spin-traps  and  hydroxyl  radical  scavengers, 
especially as pre-treatment. Second, this investigation can be extended to the NADH / 
XO toxicity, since intracellular hydroxyl radical is likely to be involved in the toxicity 
of that system as well.  
 
Investigating the effects of uric acid (which is produced from the oxidation of X by XO) 
on X / XO toxicity might produce interesting results, which could also have significant 
in vivo implications. Uric acid is known to produce both protective and detrimental 
effects  [Feig  et  al.,  2008,  Dimitroula  et  al.,  2008].    One  way  to  do  that  is  through 
comparing the toxicity of the X / XO combination with the toxicity of the acetaldehyde / 
XO combination, since although the substrate oxidation in the two systems takes place 
at the Mo site [Simon et al., 1981] which leads to ROS production at the FAD site, the 
oxidation  of  acetaldehyde  by  XO  will  not  produce  uric  acid.  Substrates  other  than 
acetaldehyde that can bind to the Mo site but their oxidation does not yield uric acid can 
also be tried.  
 
Finally,  broader  avenues  of  research  that  can  be  followed  include  investigating  the 
interplay  of  XOR  toxicity  with  other  toxic  pathways.  There  are  two  interesting 
examples. First, it was mentioned in the Introduction that intracellular XOR, through a 
non clear mechanism, augmented the toxicity of the endogenous toxic metabolite, 3-
Hydroxykynurenine  (3-HK),  when  the  latter  was  applied  to  neuronal  cultures. 
Therefore,  it  will  be  interesting  to  characterize  the  mechanism  of  this  toxic 
augmentation.  Also,  since  3-HK  is  just  one  of  many  products  of  a  large  metabolic   194 
pathway, the kynurenine pathway, it will be interesting to investigate the interplay of 
XOR  with  this  pathway,  especially  since  this  pathway  is  known  to  be  intimately 
connected  to  oxidative  stress  [Stone  and  Darlington,  2002].  Second,  since  an 
augmentative interplay in neurons between glutamate receptor-dependent excitotoxicity 
and some oxidative stress components was demonstrated previously, as mentioned in 
the Introduction, and also since blocking the glutamate NMDA-receptors was shown to 
inhibit X / XO toxicity [Satoh et al., 1998], it will be interesting to further characterize 
the interplay between X / XOR (and NADH / XOR) toxicity and the glutamate system 
in CGNs.  
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5 Conclusions 
 
A: Conclusions regarding culturing/experimental conditions 
 
Some culturing/experimental optimizations were found to both improve the status of the 
cultures  and  increase  the  reliability  of  the  viability  experiments  in  CGNs  cultures.  
These include: 1) either a serum-free medium or a conditioned medium (i.e. glutamate-
free serum-containing medium), but not fresh serum-containing medium (which will 
contain  glutamate),  should  be  used  as  the  vehicle  to  add  test  compounds.  This  is 
because  glutamate  already  present  in  the  fresh  serum-containing  medium  can  cause 
severe toxicity to CGNs; 2) for the same reason, conditioned medium can be used as the 
medium to which the neurons are restored at the end of the treatment period. In this 
regard, conditioned medium is preferred to serum-free medium, since although the latter 
has the advantage of being free of glutamate it might cause damage to the neurons if 
they are left in it withdrawn from serum (which might be necessary for the viability of 
cells) for a prolonged restoration period (like the 16-24 hr applied here); 3)  the edge 
wells  in  a  96-well  plate  should  not  be  included  in  viability  experiments  in  CGNs 
cultures, since these will likely be affected by the edge effect; 4) if Alamar blue assay is 
being used to assess the viability of CGNs, in addition to the edge wells, also  the next-
edge wells should not be included in the experiments, and only inside wells should be 
used.  This  is  because  it  was  found  here  that  the  neurons  in  next-edge  wells  give 
consistently slightly higher viability readings in the Alamar blue assay than the neurons 
in the inside wells, where although these differences are relatively small, they might 
lead to misleading conclusions. In this regard, edge wells and next-edge wells should 
not be left blank, but a cell-free medium can be added to them; 5) if a treatment medium 
uses bicarbonate/CO2 as a buffering system, a harmful rise in the pH can easily occur 
(due to the release of CO2), and to overcome this problem, such a medium can be placed 
in  a  vented-cap  flask  (i.e.  permeable  to  gases)  and  placed  in  a  CO2-incubator,  and 
retuned to this incubator immediately after each usage.  
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B: Conclusions regarding investigating XO toxicity 
 
1- The combination of NADH and the bovine milk XO induces damage to CGNs. It is 
feasible that the oxidation of NADH by some forms of XOR (other than the one used 
here) that are known to be very efficient in oxidizing NADH might produce in vivo 
toxicity.  However, it will be difficult to prove or rule out this toxicity, since the NADH 
binding site on XOR (the FAD site), unlike the X binding site (the Mo site), still has no 
specific in vivo blockers. Although DPI can block the FAD site in vivo, this inhibitor is 
not specific and can inhibit many other enzymes [Harrison, 2002, Berry and Hare, 2004].   
Also, blocking the Mo site with allopurinol did not prevent NADH / XO toxicity in this 
study,  which  is  in  agreement  with  previous  cell-free  studies,  which  might  have 
therapeutic  implications.  Therefore,  there  is  a  need  for  developing  in  vivo  specific 
blockers  of  the  FAD  site,  especially  since,  as  suggested  by  this  cell-containing  and 
previous cell-free studies, blocking the FAD site can inhibit ROS generation regardless 
of whether the reducing substrate binds to FAD site (i.e. NADH) or to the Mo site (i.e. 
X or HX).  
 
2-  A  possibility  raised  by  this  study  is  that  a  metal  (like  the  one  proposed  to 
contaminate XO used in this study) might contribute to XOR toxicity in vivo, where 
such a metal might either potentiate a toxicity induced by XOR directly oxidizing the 
substrate  or  mediate  an  indirect  interaction  between  XOR  and  the  substrate.  For 
example, in vivo, in cases where superoxide is generated by a direct oxidation of X (or 
HX)  by  XOR,  a  toxic  effect  can  result  from  the  participation  of  this  produced 
superoxide, NADH, and a metal in a free radical chain reaction (or other toxic reactions) 
even in the absence of a direct oxidation of NADH by XOR. 
 
3- Superoxide often mediates XOR toxicity, and the failure of SOD to prevent X / XO 
toxicity  in  cell  cultures  does  not  necessarily  rule  out  a  role  for  superoxide.  This  is 
because in many cases in cell culture studies, SOD might not be able to enter the cells, 
where  intracellularly  generated  superoxide  (it  does  not  need  to  be  generated  from 
intracellular  XOR)  can  mediate  the  toxicity  of  hydrogen  peroxide  generated 
extracellularly from the X / XO combination. This means that in vivo, superoxide can 
mediate  the  toxicity  of  XOR  when  oxidizing  substrates  either  extracellularly  or 
intracellularly.    197 
4- The results add support to many previous studies which suggested that intracellular 
hydroxyl  radical  (or  a  similar  species)  is  involved  in  XOR  toxicity.  However,  the 
preliminary experiments did not support or argue against directly scavenging hydroxyl 
radical  as  a  possible  means  to  prevent  this  toxicity.  However,  it  seems  from  the 
preliminary experiments (and from the nature of hydroxyl radical) that it is better to 
prevent its generation than to try to directly scavenge it. 
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